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Abstract
Glucose-6-Phosphate Dehydrogenase (G6PD) is a cytoplasmic protein involved in the
first step of the pentose phosphate pathway, that is the oxidation of glucose-6-phosphate
to 6-phosphogluconolactone with reduction of NADP+. Deficiency in G6PD activity
may result in the formation of different pathologies such as severe forms of anaemia
and respiratory distress. In individuals with Plasmodium vivax malaria infection, a
depression in G6PD activity greatly increases the toxicity of the drugs used in malaria
treatment. Tests to detect G6PD deficiencies already exist, but are relatively costly,
difficult to perform, and therefore unlikely to be used in endemic areas. The overall
aim of this project is the structural analysis of G6PD variants to provide information
that could be used in the development of low-cost and simple-to-use immunological field
tests for G6PD. Ideally it would have been possible to identify regions that are markers
to reduced, or normal activity, to be selected as antibody targets. Initially the SAAP
family of tools were used to find G6PD variants that are associated with structural effects
at a phenotype level. The selected variants were then studied with all-atom Molecular
Dynamics (MD) experiments and looked for shared behaviours among mutants. The
difficulty of collecting extensive simulation data made the interpretation of the results
challenging, and incomplete, so a united-atom force field (UNRES) was used both to
improve the sampling and to increase the numbers of mutants studied. The collected
data suggested that the reduced activity in the mutants is not the result of complete
unfolding, but it is more likely the result of a very local disruptions in the protein
structure the effects of which influence the overall stability and function of the enzyme.
To understand the mechanisms of action of the mutations better, a network analysis
using the software wordom was performed. The idea was to outline key residues (hubs) of
G6PD and observe if and how the mutations were capable of altering the communication
pathways between hubs. If a mutation, instead of damaging the structure of G6PD,
alters the interaction between two or more hubs in the network, it could explain the
linkage between the mutation and the reduced activity in G6PD. The final attempt to
characterise G6PD behaviours better was the performance of metadynamics simulations
with a focus on the role played by Proline 172. This residue has a critical role in allowing
the correct positioning of both the substrate and the co-enzyme.
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Chapter 1
Biological background
Malaria is a human infectious disease, caused by a member of the protist family of Plas-
modium. Among the five species of Plasmodium: P. ovale curtisi, P. ovale wallikeri,
P. malariæ, P. vivax and P. falciparum, the latter is the most virulent and deadly [1, 2].
Malaria is notorious for its ability to alter tissue perfusion by causing adhesion of infected
red blood cells (RBCs) to the walls of blood vessels; it also causes the eventual destruc-
tion of RBCs, thus compromising oxygen delivery. Mosquitoes (genus Anopheles) are the
vector agents which transmit parasites from person to person without suffering from the
disease themselves. Malaria is prevalent in tropical regions where a particularly humid
and hot environment provides ideal conditions for mosquitoes to breed. Currently, the
only satisfactory strategy to stop transmission of malaria is the prevention of mosquito
bites; once the parasites are inside the host body, other pharmaceutical strategies must
be adopted.
1.1 Plasmodium pathogenicity & pathopysiology
While all Plasmodium types share the same life cycle (Figure 1.1) and pathogenesis, the
outcome of malaria depends on many different factors: parasite factors (drug resistance,
antigenic polymorphisms or invasion pathways), host factors (age, genetics and immu-
nity) and geographic factors.
The infection starts when a mosquito injects parasites (sporozoites) into the host subcu-
taneous tissue. Parasites travel to the liver where they settle inside the hepatocytes and
start their maturation process. After around 48 hours, each sporozoite develops into
thousands of merozoites, which invade RBCs once released into the bloodstream. With
1
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Figure 1.1: Malaria parasite life cycle. 1) Following the mosquitoes’ bites, sporozoites
are released into the bloodstream. 2) Sporozoites travel to the liver and infect liver cells.
3) From the liver, merozoites, the mature asexual form of parasites, invade red blood
cells (RBCs) and start to multiply inside RBCs. 4) A portion of parasites converts to
gametocytes that are ingested by the mosquito. 5-6) Male and female gametes fuse to
form diploid zygotes which develop in thousands of active haploid forms (sporozoites).
Taken from the National Institute of Allergy and Infectious Diseases (NIAID).
20 new merozoites being generated per parasite, asexual parasites multiply in RBCs and
start the spread of the disease. Only a small portion of the asexual parasites convert
to gametocytes which are in turn transmitted to the female anopheline mosquito at the
next bite. P. falciparum is responsible for the largest number of cases of fatal malaria
and the belief that P. vivax infection was in most cases benign, has led to the majority of
studies focusing on P. falciparum. However, outside Africa, P. vivax accounts for almost
half of malaria cases and many studies have shown a strong association between P. vivax
infection, severe disease and death. P. vivax has a preference for reticulocytes (14 day
old immature blood cells) [3], whereas P. falciparum indiscriminately infects all kinds of
RBCs. Despite this limitation, inflammatory response during P. vivax infection is much
greater than that seen in other Plasmodium infections [4–6]. P. vivax has also shown a
lower degree of cytoadherence, causing less organ dysfunction than P. falciparum. The
advantage of this behaviour may be understood by looking at the deformation property
of RBCs; in fact, while P. falciparum escapes organs’ filtration by inducing cytoadher-
ence, P. vivax avoids destruction during passage through endothelial cells by increasing
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deformability of infected RBCs [7, 8]. The fundamental difference between P. vivax
and P. falciparum is the ability of P. vivax to become active from dormant hypno-
zoites [9, 10]. Frequent activation and patient relapses cause malaria tolerance (higher
fever threshold and attenuated symptomatology), but recurring episodes of haemolysis
and syserythropoiesis are likely to contribute to a severe form of anaemia. These patients
do not have feverish symptoms and so are less likely to seek treatment [4, 11]. Although
rare, respiratory distress, acute lung injury and coma may occur [11], but mostly only
in the presence of other factors such as concurrent infections, occult mixed plasmodium
infections, metabolic changes and micro vascular dysfunction.
1.2 Plasmodium Vivax vaccine
Malaria has always been the target of intense campaigns aimed at eradicating parasite
transmission. Nevertheless, significant progress is still to be made [12]. The emergence
of mosquito strains resistant to insecticides and parasites resistant to anti-malarial drugs
are two of the factors making malaria eradication complicated [11, 13–15]. As stated by
Arevalo-Herrera et al, “It is important to understand that owing to the complex parasite
life cycle and existence of co-infections, it is commonly accepted that, rather than a single
specific vaccine, a multi-antigen and multi-species vaccine should be developed” [16].
Currently three parasite stages have been identified as potential targets for effective anti
parasite immune response [16], which are:
1. The pre-erythrocytic stage: prevent the entrance of sporozoites into hepato-
cytes and inhibit their development, or develop drugs that would target antigens
expected to induce cellular immune response. The only two sporozoite antigens
that have been identified are circumsporozoite protein (CSP) and sporozoite sur-
face protein 2 (SSP2/TRAP) [17]. CSP is composed of an immunodominant re-
peated domain and two highly conserved flanking amino- and carboxy- regions
called “Region I” and “Region II-plus” [18–20]. SSP2/TRAP mediates adhesion
to host cells and tissue surfaces [21–23].
2. The asexual erythrocytic stage: prevent clinical manifestation and severity
of the infection, resulting in a reduction of both morbidity and mortality. Efforts
are concentrated on antigens present on merozoite surface, better to understand
the mechanism of invasion. The most studied antigens are the Duffy binding
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protein(DBP) [24, 25], the merozoite surface protein 1 (MSP1) [26–28] and the
Apical membrane antigen 1 (AMA-1) [29–31].
3. The parasite sexual development: Another potential course of action is to
block the fertilization process and parasite development inside the mosquito [32,
33].
The only drugs capable of clearing the parasites in the liver stage are the 8-aminoquinolines,
such as Primaquine and Tafenoquine (Figure 1.2).
Figure 1.2: Chemical structures of primaquine and tafenoquine [34].
1.2.1 Primaquine
Although the mechanism of action of this drug is not yet fully understood, it is thought
to interfere with the cellular respiration of the parasites, by increasing the oxygen free
radicals and deregulating the electron transport [35]. One of the advantages of Pri-
maquine is that it can be used successfully in both primary (administration before
exposure) and terminal (administration after the exposure) prophylaxis. Additionally
Primaquine is helpful in preventing the transmission of P. falciparum, by eradicating
circulating gametocytes. In areas where both P. vivax and P. falciparum are present,
infection with one parasite increases the susceptibility to the other strain, so having an
effective drug is a huge boost in malaria management. Treatments with Primaquine
show up to 90% efficacy in clearing the hepatic reservoir that causes relapses [36, 37].
Like every drug, the use of Primaquine in malaria treatment has some side effects such
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as methemoglobinemia (a disease where hemoglobin is oxidised to methemoglobin, re-
sulting in a reduced ability to release oxygen to tissues), hypersensitivity reactions and
gastrointestinal disturbance.
However the most feared hazard is the haemolysis precipitation in G6PD-deficient indi-
viduals. G6PD activity screening are available and can determine the level of deficiency,
but the size of the exposed population makes this process costly. Besides, with over 300
different allelic mutations for this X-linked recessive disorder, the phenotypes of G6PD
deficiency are extremely variable [38, 39], making the complete screening of all possible
phenotypes among a given population even more complex. An interesting aspect is that
G6PD deficiencies may confer some resistance against Plasmodium infections [27]. This
can lead to the misconception that most infected individuals are unlikely to present a
G6PD deficiency and that the use of Primaquine can be relatively safe. However evo-
lutionary selection has made the number of individuals with G6PD deficiencies increase
in endemic areas. It is always recommended that G6PD deficiency is checked before
Primaquine treatment [16, 35]. Primaquine is a powerful drug, but apart from the side
effects, other factors may influence both the efficacy and toxicity after administration.
First of all, to reduce the risk of treatment failure, developing resistance and reducing
side-effects, Primaquine is administered together with blood schizontocidal agents, mak-
ing it difficult to control the final effects. Additionally the dosage varies greatly between
individuals: Failure rates decrease with increased dose, but body size, age and ethnic
group differences make the generalization of the therapy difficult. Consequently phar-
maceutical companies are pushing towards safer drugs that can be used in treatment
of the malaria virus. The most promising alternative is Tafenoquine, a compound that
has a shorter course of therapy, down from 14 days to 3 days [40–42]. Despite these
improvements, the issue of haemolysis within G6PD deficient individuals still remains a
risk and there is therefore a need to develop a low-cost test to identify individuals with
depressed G6PD activity.
Chapter 1. Biological background 6
1.3 Glucose-6-Phosphate Dehydrogenase
Glucose-6-phosphate dehydrogenase (G6PD) is a cytoplasmatic protein whose deficiency
is the most common human enzymopathy. The enzyme active form is the result of a
rapid dimer-tetramer equilibrium, which is affected by ionic strength and pH [43, 44].
The active form of G6PD is involved in the first step of the pentose phosphate pathway
(PPP), which is the oxidation of glucose-6-phosphate to 6-phosphogluconolactone with
reduction of NADP+ to NADPH (Figure 1.3). This step is the irreversible, controlling
step of the PPP, and G6PD activity is allosterically stimulated by concentration of
NADP+ and inhibited by concentration of NADPH [45]. The PPP is important in
all cells, not only for the production of pentoses (5-carbon sugars), but also for the
production of reducing agents in the form of NADPH. NADPH is also essential for
protection against oxidative damage by maintaining a high level of reduced glutathione
(GSH) that protects the sulphydryl groups in haemoglobin and in red cell membranes
from oxidation [46]. When oxidative stress occurs, the level of GSH drops and can be
restored by glutathione reductase which requires NADPH to work. G6PD is the only
NADPH-producing enzyme that is activated by oxidative stress and, in RBCs, it is also
the only source of NADPH. If levels of GSH drop and NADPH is not produced, oxidative
damage eventually leads to cell haemolysis.
Figure 1.3: G6PD reaction diagram, obtained from the KEGG ftp site (ID R00835):
Oxidation of the CH-OH group of the D-glucose-6-phosphate to 6-phospho-D-glucono-
1,5-lactone, with reduction of NADP+ to NADPH.
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1.3.1 G6PD deficiency
The G6PD locus, with over 300 allelic variants, is the most polymorphic enzyme in hu-
mans [38, 39]. G6PD deficiency affects over 400 million people worldwide, concentrated
mainly in tropical and sub-tropical regions. Comparisons of all variant gene sequences
with the normal G6PD gene have identified 186 different mutations, divided between
single point mutations (85.4%), multiple mutations (8%), deletions (5.3%) and intron
mutations (1%). Since most of the mutations are asymptomatic, the total number of
mutations could be much higher. These variants have been grouped into five classes de-
pending on the degree of enzyme activity by the World Health Organization (WHO) [47]:
1. Class I: Severe chronic anaemia;
2. Class II: Severe deficiency (<10% activity), with intermittent hemolysis;
3. Class III: Mild deficiency (10-60% activity), hemolysis with stressors only;
4. Class IV: Non-deficient variant, normal enzyme activity;
5. Class V: Increased enzyme activity.
1.3.1.1 Clinical presentations
Neonatal jaundice and acute and chronic haemolytic anaemia are the principal man-
ifestations of G6PD deficiency [48]. Neonatal jaundice is a disease that occurs in the
presence of inappropriate levels of bilirubin. Bilirubin is a metabolite of heme catabolism
that is bound to albumin for transportation and converted into glucuronides in the liver.
Here the bilirubin is conjugated with glucuronic acid to form mono and di-glucuronides
which are eventually excreted in the bile [49]. In normal neonates, the excess bilirubin
is hydrolysed back and reabsorbed into the circulation. If this does not happen, levels of
glucuronides grow causing bilirubin encephalopathy which may lead to mental retarda-
tion. The role played by G6PD is not yet understood, but it has been proved that G6PD
deficiency leads to an increased incidence of neonatal jaundice [49, 50]. Another manifes-
tation is “acute hemolytic anaemia” in which acute episodes of intravascular haemolysis
follow the ingestion of certain kinds of food or drugs. As an example, divicine, an un-
stable metabolite of the pyrimidine β-glucoside vicine, contained in broad beans, acts as
a strong oxidizing agent, triggering the haemolysis effect. The degree of anaemia varies
with the nature of the stress and depends on the type of variants. Conversely chronic
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nonspherocytic hemolytic anaemia occurs in males with very low level of G6PD activity.
In such conditions, acute anaemia is triggered by a wider number of agents and in lower
concentrations than in those obtained with other variants. In addition, individuals with
G6PD deficiency have a higher probability of developing associated pathological con-
ditions. Sickle cell hemoglobinopathy and RBC thalassemia are frequently associated
with G6PD deficiency. The presence of multi-pathology does not alter the course of each
independent disease and does not determine synergistic effects [51–55].
1.3.1.2 G6PD variants
A single nucleotide polymorphism (SNP) is defined as a variation in a single nucleotide
that occurs in at least 1% of a ‘normal’ population. Individuals from different geograph-
ical areas usually present different sets of polymorphic variants (for a detailed list of the
most common variants see Table 1.1). The variant “Mediterranean” (Ser188Phe)[56]
is common in the Mediterranean area, the middle East and India; in Africa the main
variant is “A−” (Val68Met + Asn128Asp) [57], while in China several variants are dis-
tributed all around the country [58]. It is commonly accepted that the high frequency
of polymorphic variants has been generated because of the relative protection against
severe malaria that G6PD deficiency provides [59, 60]. Although this protection mech-
anism is not known, some studies suggest that because of the high levels of oxidative
agents, infected erythrocytes are rapidly damaged and destroyed by phagocytosis [61].
An interesting behaviour that was reported in the early biochemical characterization
papers is that, while enzyme activity in G6PD-deficiency erythrocytes decreases, the
enzyme activity in white cells does not, or only very little [62, 63]. Mutations generat-
ing G6PD deficiency are strong enough to affect enzyme activity in RBCs, but not so
severe as to decrease efficiency and activity in other somatic cells [64, 65]. The reason
behind this behaviour may be that the lack of G6PD in somatic cells is lethal [39, 66].
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Name of mutation Amino acid change(s) Comments Distribution
Gaohe 32His→Arg China,Thailand,Malaysia
Honiara 33Ile→Met, 44Ala→Gly May be a neutral muta-
tion on a G6PD Union
background
Solomon Island
Orissa 454Arg→Cys Tribal India, Mauritius,
Malaysia
Aures 48Ile→Thr Algeria, Kuwait, Saudi
Arabia,UAE, Spain
Metaponto 58Asp→Asn Italy
A− 68Val→Met,
126Asn→Asp
Found in people of African
origin.
Africa, Spain, Portu-
gal, Middle East, USA,
Cuba,Brazil etc
Namoru 70Tyr→His Tribal India (South)
Ube-Konan 81Arg→Cys Most common variant in
Japan
Japan
Vanua Lava 128Leu→Pro Malaysia, Indonesia, Vanu-
atu
Mahidol 163Gly→Ser Common variant in Thais China, South East Asia
Santamaria 181Asp→Val,
126Asn→Asp
Spain,Mexico,Costa Rica,
Algeria,Sicily
Mediterranean 188Ser→Phe Most common mutation in
many Mediterranean and
Middle East countries and
in the Indian subconti-
nent.
India,Malaysia,Italy,
Greece,
Spain,Portugal,Middle
East, Croatia, Brazil etc
Coimbra 198Arg→Cys Malaysia,Indonesia, Cam-
bodia
Seattle 282Asp→His Widespread. Only vari-
nant found in a study in
Canary Island
Sardinia, Brazil, Mexico,
Spain, Portugal, Canary Is-
land, Italy,Greece, Croatia
Montalbano 285Arg→His Italy
Viangchan 291Val→Met Most common variant in
Thailand and Cambodia
China,Thailand,Malaysia,
Cambodia,Laos,Indonesia
Kerala/Kalyan 317Glu→Lys India
Chatham 335Ala→Thr India, Indonesia, Italy,
Iran,Malaysia, Kuwait,
China,Spain, Japan
Chinese-5 342Leu→Phe China, Malaysia, Thailand
and Singapore
Ierapetra 353Pro→Ser Greece
Cassano 449Gln→His Italy, Greece
Union 454Arg→Cys Widespread Solomon Island, Vanu-
atu,Croatia, China, Italy,
Spain,Mexico, Cambodia,
Thailand,Malaysia
Canton 459Arg→Leu Common amongst
Malaysian and Chinese
people.
China, South East Asia
Kaiping 463Arg→His Most common variant in
Flores, Indonesia
China, South East Asia, In-
donesia
Table 1.1: The major polymorphic G6PD variants and their distribution [48].
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1.3.2 Screening
WHO report No.366 [47] indicates all the standardised procedures for the study of
G6PD deficiencies. The tests to assess G6PD activity can be divided into genetic and
phenotypic-biochemical approaches.
1.3.2.1 DNA-based genotyping approaches
DNA sequencing has successfully identified a great range of G6PD variants, but not all of
those are associated with a deficiency, meaning that an additional phenotypic screening
is required to determine the clinical relevance of a specific mutation. Studies on Burk-
inabe populations show how genotyping assays can be successfully used to investigate
G6PD deficiency if one or few haplotypes account for more than 90% of the mutations
presented in the population [67], and even in such cases, the correlation between geno-
type and phenotype rarely exceeds 70% [68]. A major drawback is the complexity of
these screenings: DNA-based diagnostics can be successfully used to study multiple
polymorphisms (e.g. the genetic profile of an entire population), but their costs and
complexity make them infeasible for a point-of-care diagnostic.
1.3.2.2 Phenotypic-biochemical approaches
Phenotypic testing is the most informative and frequently used diagnostic methodology
for the detection of enzymatic activity levels. Although there are more than 30 testing
kits, all of them belong to one of these categories:
• Direct tests directly determine G6PD enzymatic activity by spectrophotometry [47].
These methods detect the fluorescence of NADPH under long-wave (365 nm) UV
light in complete darkness. Reduction of NADP to NADPH occurs in the pres-
ence of G6PD, which means that the rate of NADPH formation is proportional
to G6PD activity. Beutler’s test, for example, uses a fluorescent spot test, where
fluorescence readings are performed at different intervals after incubation, and the
samples are classified in different groups based on the intensity of fluorescence.
• Indirect tests indirectly detect G6PD activity by analysing substrates that may
be associated with G6PD. One of the widest-used tests, the methaemoglobin re-
duction test (MRT)[69], measures the rate of NADPH-dependent methaemoglobin
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reduction in the presence of an appropriate redox agent. The calculated rate then
correlates with G6PD activity.
• Cytochemical assays assess G6PD activity by labelling each individual erythro-
cyte. Once the water-soluble colourless tetranitro blue tetrazolium is reduced via
the electron carrier 1-methoxyphenazine methosulfate by NADPH, dark-purple
granules are present in erythrocytes that contain G6PD activity, whereas G6PD-
deficient erythrocytes remain unstained. Cytochemical assays have the advantage
of working with individual cells (i.e. only a small sample is required), but of all
the listed approaches, they are the most expensive and difficult to perform.
Although all of these methods have proven to be effective in different conditions, neither
genetic nor phenotypic methodologies are able of capturing the full picture of G6PD
deficiency. Several factors work against the reliability of each of the methods; first of
all, the difficult environmental conditions of the endemic countries reduce the accuracy
and reliability of all of the G6PD tests. Furthermore the cost of the tests, that has to
be added to the cost of the drugs, increases the economic burden on endemic areas. All
these problems must be solved in order to win the battle against malaria and developing
a new cheap test is an urgent priority.
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1.3.3 G6PD Structure Description
Figure 1.4: The G6PD dimer (PDB code 2bhl) with the two monomers coloured in
blue and grey.
In humans, G6PD is a 59 kDa protein encoded in the telomere region of the X chro-
mosome (Xq28) [70]. The dimer is composed of two identical 514 amino acid subunits
(Figure 1.4), each containing a single active site which binds the glucose-6-phosphate
(G6P) and two NADP+ binding sites, one which binds the co-enzyme and the other
which has structural importance (Figure 1.5 and Figure 1.6). The active form exists in
both dimeric and tetrameric form, with the monomer being inactive [48, 71]. The inter-
conversion between these forms is controlled by the pH and by G6P and NADPH levels.
Wrigley et al. [72] describe how reducing the pH from 8 to 5.8, causes the proportion of
dimer G6PD to drop from 70% to 6%, while, a rise in the proportion of the tetramer
from 0 to 90 % is recorded, suggesting that at low pH (below pH 6) the equilibrium is
shifted towards the tetramer, while at high pH (above pH 8) most of the enzyme is in
the dimeric form [44]. At physiological pH, both forms exist, with the dimer being the
more favourable of the two forms. In an abundance of NADP+ and G6P, G6PD activity
is required and NADP+ can bind the structural NADP+ binding site, inducing dimer
formation by strengthening the interactions between monomers.
There are a total of 13 experimentally determined structures of the G6PD enzyme: 9
from Leuconostoc mesenteroides, 1 from Trypanosoma cruzi and 3 from human (Table
1.2). The first human structure to be crystallised (PDB code 1qki) was the tetramer
of the Canton variant (R465L) [73]. This mutant is one of the most common Chinese
variants and individuals with this mutation exhibit a class II phenotype [58, 74]. This
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Figure 1.5: The G6PD dimer (PDB code 2bhl) with the residues involved in binding
represented as a surface. The G6P binding site is coloured in red, while the co-enzyme
and the structural NADP+ binding sites are in blue and orange respectively.
Figure 1.6: The G6PD dimer (PDB code 2bhl) bound with the substrates. The G6P
is coloured in red, the co-enzyme NADP+ is in blue and the structural NADP+ is in
orange.
structure is a dimer of dimers (Figure 1.7), has a resolution of 3 A˚, and is in complex
with the structural NADP+ that binds the area between the β sheet and the C-terminus
(see Section 1.3.3.3). The monomer (PDB code 2bh9) and the dimer (PDB code 2bhl)
are both a non-natural variant (∆G6PD) obtained by the deletion of the 25 N-terminal
residues of the wild-type G6PD. The deletion does not influence the enzyme stability
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or its activity, and was done to increase the quality of the crystals obtained [73]. The
human structures are very similar to that of L. mesenteroides, with both substrate and
co-enzyme binding presenting only minor differences as a result of sequence changes.
The major difference is the fold at the C-terminus of L. mesenteroides which has a total
absence of the structural NADP+ site. This site is found in rat, mouse, wallaroo, fish
(fugu rubripes) and fruit flies, but it is absent in all prokaryotic G6PD. It is likely that
prokaryotic enzymes have a higher number of replacements, causing the C-terminal tail
to shorten making it impossible for the additional NADP+ to bind [73]. Because of
the absence of the structural NADP+ in all the Leuconostoc mesenteroides structures
and because the deletion in ∆G6PD is comparable with the wild-type, it was decided
that the human dimer (PDB code 2bhl) was the best structure to be used for all the
simulations.
Figure 1.7: The G6PD tetramer (PDB code: 1qki) with the four dimers coloured in
different colours.
The amino acid sequence of G6PD has been highly conserved through evolution [75, 76]
and multiple alignment of 35 known sequences of G6PD indicates a sequence identity
greater than 48% among eukaryotic G6PDs sequences. This number drops to a 30%
identity when prokaryotic sequences are also considered [77]. In particular three key
motifs have been identified in all G6PDs sequences: 198-RIDHYLGKE-206 (Figure 1.8
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red), 38-GxxGDLA-44 (Figure 1.8 blue) and 170-EKPxG-174 (Figure 1.8 yellow). The
first peptide is the binding and catalytic site for G6P [78, 79], while the other two
peptides are involved in NADP+ binding [80, 81].
PDB code description res [A˚] R-factor R-free ligands
2bh9 monomer (H) 2.5 0.201 0.296 G6P
2bhl dimer (H) 2.9 0.214 0.261 Co-enzyme and structural NADP+
1qki tetramer (H) 3 0.247 0.294 structural NADP+
1dpg dimer (L) 2 0.206 0.257 -
2dpg monomer (L) 2.5 0.232 0.173 Co-enzyme
1e7y monomer (L) 2.48 0.296 0.205 G6P and structural NADP+
1e7m monomer (L) 2.54 0.299 0.222 -
1e77 monomer (L) 2.69 0.285 0.180 G6P
1h9b monomer (L) 2.4 0.236 0.190 -
1h9a monomer (L) 2.16 0.226 0.187 Co-enzyme
1h94 monomer (L) 2.5 0.292 0.213 Co-enzyme
1h93 monomer (L) 2.2 0.282 0.206 -
5aq1 dimer (T) 2.65 0.226 0.200 G6P and co-enzyme
Table 1.2: All the resolved structures of the G6PD enzyme. The resolution is the
measure of the overall quality and reflects the level of detail of the structure (the
lower the better). The R-factor represents the level of refinement of the model and
describes the level of agreement between the crystallographic model and the original
X-ray diffraction data. Values above 0.5 indicates poor quality models, while values
around 0.2 are usually index of good quality. The R-free is the R-factor calculated
on a small set of random coordinates that have not been included in the refinement
process. This gives better and less-biased measure of the refinement progress. In the
table, H=Human, L=Leuconostoc mesenteroides and T=Trypanosoma cruzi
Figure 1.8: The G6PD dimer with the three highly conserved motives coloured in red
(198-RIDHYLGKE-206), blue (38-GxxGDLA-44), and yellow (170-EKPxG-174).
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G6PD is characterised by a two domain structure: an “NAD(P)-binding Rossmann-
like” domain and a “Dihydrodipicolinate Reductase; domain 2” domain (Figure 1.9).
The first domain is an α+β 3-layer(aba) sandwich structure (Figure 1.10a), commonly
found in dehydrogenases and in G6PD has the role of co-enzyme binding. The second
domain is an α+β 2-layer sandwich (Figure 1.10b), it is found in the core of G6PD
and contains the dimerisation interface that interacts with the same region in the other
unit. Although the residues in the latter region are not highly conserved, the geometry
of the interface is maintained in all organisms. The residues found in the N-terminus
are generally disordered and the formation of a disulphide bridge (C13-C446) prevents
this area from moving too much, maintaining the catalytic activity [77]. An NADP+ is
located in a positively charged crevice between the β sheet and the C-terminus. Most
of the NADP+ structure lies inside the core of the enzyme, suggesting that its removal
would affect both conformation and association of the subunits.
Figure 1.9: The G6PD dimer with the two domains coloured in only one chain. In
blue, the “NADP-binding Rossmann-like Domain” (CATH code: 3.40.50.720) spans
from V27 to I199 and from L433 to V453. In red, the central “Dihydrodipicolinate
Reductase; domain 2” domain (CATH code: 3.30.360.10) spanning from D200 to K432
and R454 to G505. The other chain is in grey.
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(a) (b)
Figure 1.10: Diagrams of the two domains in G6PD. (a) The “NADP-binding
Rossmann-like Domain” (CATH code: 3.40.50.720) and (b) the “Dihydrodipicolinate
Reductase; domain 2” domain (CATH code: 3.30.360.10). Both diagrams were obtained
from PDBsum.
1.3.3.1 The glucose-6-phosphate binding site
The glucose-6-phosphate (G6P) binding site is well ordered and is located in the pocket
between the two NADP+ binding sites. Most of the residues that interact with G6P
are conserved and correspond to those shown in Figure 1.11 [81]. Y202, H201 and K205
are part of the highly conserved G6P fingerprints 198-RIDHYLGKE-206. The catalytic
function of the enzyme is fulfilled by H263, located in the centre of the site. Mutations
K205R and K205T are known to affect G6PD kcat, demonstrating the key role of this
residue to the catalysis in humans [82]. The conserved lysine (K171) at the bottom
of the site, precedes P172 in the sequence (EKPxG) and plays a fundamental role in
guaranteeing the correct positioning of both the G6P and the co-enzyme. Although
there is a direct interaction between the Gly395 side chain and the phosphate of G6P,
this residue is not conserved in non human species.
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Figure 1.11: The hydrogen-bonding network in the substrate site.
1.3.3.2 The NADP+ binding site
Similarly to the G6P binding site, the NADP+ binding site is well ordered. The protein-
NADP+ interactions are presented in Figure 1.12. The adenine interaction environment
is mediated by a triad of residues (G110-Q111-Y112), with the hydrogen bond with
the oxygen of Tyr112 forcing the adenine ring to face the solvent. Moreover Leu142,
Val146 and Pro143, while not directly involved in the binding, contribute to creating a
hydrophobic surface for the adenine to bind.
1.3.3.3 The structural NADP+ site
The structural NADP+ site is found and conserved only in higher organisms and al-
though no evidence has been collected, it may be because a long C-terminus allows a
stronger bond with NADP+. Prokaryotes have a shorter C-terminus than eukaryotes
and therefore NADP+ cannot bind. This site is important for the enzymatic activity of
G6PD and is located between the β-sheet and C-terminus of the monomer (Figure 1.5
in orange). The NADP+ is partially buried in a cleft (positively charged) on the protein
surface (Figure 1.6 in orange) [73], without being strongly bound to the protein surface.
Instead, the presence of a hinge region around G505 allows a dynamic equilibrium in
which NADP+ may migrate to the co-enzyme site in the presence of a low concentration
of NADP+. The C-terminus is a flexible structure, and when the tail moves, a group
of negatively charged residues (E416, E417 and E419) is exposed to the surface of the
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Figure 1.12: The hydrogen-bonding network in the NADP+ binding site. The residues
interacting with the NADP+ are represented in blue.
NADP+ binding site. This patch of residues only links the positively charged nicoti-
namide ring of NADP+, prevents the linkage of NADPH when all the NADP+ is reduced
to NADPH. Another factor that may influence the binding at the NADP+ structural
site is substrate binding. Thanks to groups of residues that are close in the sequence,
but span from one binding site to another, structure modification that occurs in one site
can propagate and influence the behaviour of the other. These residues, implicated in
the cross-connection, are:
1. Arg365 and Lys366: Arg365 binds the phosphate of G6P while Lys366 interacts
with the phosphate of the structural NADP+.
2. Lys238 and Glu239: Lys238 interacts with the structural NADP+ and at the
opposite edge of the strand, Glu239 forms hydrogen bonds with G6P.
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The NADP+ binding is extremely important and, not surprisingly, some of the class I
G6PD variants (e.g. “Durham K238R”, “Aachen” and “Loma Linda N363K”) are clus-
tered around this site.
Figure 1.13: The hydrogen-bonding network in the structural NADP+ binding site.
The residues interacting with the NADP+ are represented in red.
1.3.3.4 Proline 172
The conserved Pro172 (central residue of the peptide EKPxG) mediates the movement
of the helix, allowing Lys171 to interact with both G6P through its terminal amino
group and NADP+ through the carbonyl group. Mutations in this amino acid exhibit
class I deficiency, suggesting the importance of this residue in the correct positioning of
both the substrate and the co-enzyme (Figure 1.14). In the tetramer structure, helix
αb is longer than in the dimeric structure and the proline at position 172 (Pro172) is
in trans in the tetramer while it is in cis in the dimer [73]. The cis-trans isomerisation
of Pro172 could be an important mechanism for correct functioning of G6PD, but it
could also be the result of crystallography artefacts or errors (the PDB files 2bhl has a
resolution of 2.9 A˚, while 1qki is 3 A˚). During the experiments described in Chapter 3,
all these hypotheses were considered, the state of Pro172 was monitored and a possible
explanation is proposed.
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Figure 1.14: The central position of Pro172 (yellow), between the co-enzyme (blue)
and the G6P (red) binding sites, mediates the correct positioning of both the substrate
and the co-enzyme.
1.4 Thesis Overview
The overall aim of this thesis was to study the structure of G6PD and G6PD variants
to provide information that could be used in the development of low-cost and simple-to-
use immunological field tests for G6PD. The need for such tests comes from the strong
relationship that exists between G6PD deficiency and the drugs used in malaria treat-
ment. For individuals with G6PD depressed activity, ingesting certain malaria drugs
(particularly the 8-aminoquinolines) may be dangerous as the G6PD-reduced activity
greatly increases the side effects of these drugs. The starting idea of the project was that
the depressed activity observed in the G6PD variants is the result of specific structural
changes of the G6PD structure, that are markers to reduced, or normal activity. If this
is true, it should be possible to develop a set of antibodies capable of binding specific
features of the G6PD structure, differentiating between the wild-type and the mutants.
These antibodies could then be used in the development of an immunological assay for
G6PD variants similar to a pregnancy test kit. In summary, this thesis will describe
how the joint use of the SAAP prediction methods and MD simulations, were used to
study the behaviour of G6PD mutants in an attempt to find changes in the stability of
the enzyme structure in the mutants. These changes should be detectable and similar
among the mutants, but not the wild-type. To address this problem, data on the mu-
tations and their effects were acquired using SAAPdap and SAAPpred. These tools are
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capable of describing the effects of a given mutation and outline the mutations that are
likely to affect the phenotype of a given enzyme.
• Chapter 2 introduces the computational methods used.
• Chapter 3 will present the results of extensive molecular dynamics simulations
on both the wild-type and some of the G6PD variants. In this chapter, the mu-
tants’ behaviours are compared to the wild-type. Particular attention is given to
the mechanisms that are capable of explaining the connection between structural
features and phenotypic changes.
• Chapter 4 and 6 look at other approaches (metadynamics and network analysis)
used better to understand how the effects of single point mutations are affecting
the global structure of G6PD.
• Chapter 5 will present similar work to that presented in Chapter 2, but will do
so using a coarse-grained force field: UNRES. The idea is further to increase the
sampling to witness the big conformational changes that might be caused by the
mutations.
• Chpater 7 provides a final discussion as well as conclusions and suggestions for
future work.
Chapter 2
Computational background
Protein simulation in silico is an active field in modern biology, not only because it can
help the understanding of the basic mechanisms of cell function, but also because it can
radically change our approach toward diseases. In the last decades, the improvements
in computer technology have allowed the birth of different approaches capable of han-
dling the massive quantity of data generated by laboratories all over the world. With
computer technology growing more powerful and affordable every year (e.g. GPUs),
it becomes possible to model small molecules through detailed and precise methodol-
ogy. Unfortunately, it is still not possible to use the same approach on larger system
such as proteins or protein complexes. This does not mean that it is not possible to
study those big systems, but a compromise between accuracy and practicality must be
adopted. Over the years, different methodologies have been developed, all of them with
the same idea in mind: reducing the complexity without losing details. With solid and
well-developed roots, Molecular Mechanics (MM) is considered to be one of the most
powerful.
2.1 Molecular Mechanics
Molecular modelling encompasses all the theoretical methods and techniques used to
simulate the behaviour of biological molecules. For all these techniques, the minimum
information required to describe a molecule is the location of the atoms of which it is
composed. Unfortunately this assumption is in contrast with the quantum model of
nature, but its formulation allows the study of large systems in an acceptable period of
time. MM is a technique that makes use of the laws of classical mechanics to describe
23
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the structure of molecules at equilibrium. The most informative description that can be
given to a physical system is the wave function represented by the Schro¨dinger equation
(Equation 2.1).
EΨ = HˆΨ (2.1)
Which indicates that at a stationary state (Ψ), the Hamiltonian operator (Hˆ) is the total
energy (E) of that state. To determine the correct value of EΨ, all the atoms constituting
the system (electrons, protons and neutrons) must be included in the calculations. To
reduce the complexity of the system, it is generally more convenient to split equation
2.1 only into its nuclear and electronic components.
Ψtot = Ψnuclei + Ψelectrons (2.2)
Without going into details, the Born–Oppenheimer approximation (Equation 2.2) con-
siders the electronic motion dependant only upon the nuclear position and not upon
their velocities. Since the nucleus is much heavier in mass compared with the electrons,
only motions of the nuclei are studied and the electrons are not explicitly examined [83].
The main advantage of this approach is that an atom can be simplified to a ball and the
bonds in the molecules as springs connecting the balls together. This representation of
molecules is at the base of modern force fields, and allow a lot of computational time to
be saved.
2.1.1 Force Field
A force field is a mathematical function that estimates the energy value of a system,
depending on its structural conformation. Force fields describe the forces acting on each
atom of the system, allowing the calculation of the potential energy of a molecule as
the sum of the single terms that a force field considers (i.e. bonded and non-bonded
interactions). The basic formulation of a force field is the sum of the bonded terms,
describing covalent bonds and the long-range non covalent forces. Formally:
Etot = Ebonded + Enon−bonded (2.3)
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where the first term of the equation describes the deviation from an ideal geometry.
Each term can be rewritten as a collection of simpler functions (2.29)
Ebonded = Ebond + Eangles + Edihedral (2.4)
Enon−bonded = Eelectrostatic + Evan−der−Waals (2.5)
2.1.1.1 Bonding stretching (Ebond)
Many physical systems experience a linear restoring force when displaced from their
equilibrium position. Thanks to the Born–Oppenheimer approximation (Equation 2.2)
a diatomic molecule can be expressed by two spheres connected with a spring and thus
described through Hooke’s law, where k is the force constant for the spring and x is the
deviation from ideal length.
F = −kx (2.6)
The potential energy can be derived from equation 2.6, by assuming that it is equal to
the negative of the force integrated over x, formally:
U(x) = −
∫
Fdx = k
∫
x = 12k(x)
2 (2.7)
When internuclear distances are considered, equation 2.7 can be rewritten as follows:
U(x) = 12k(r − r0)
2 (2.8)
where r and r0 are the internuclear distances respectively at a certain distance (r) and
at equilibrium (r0). Although correct, these equations only partially represent reality
because they do not consider bond breakage when the atoms are far away from each
other. A more realistic model is represented by the Morse potential (Equation 2.9) that
considers an energy cut-off beyond which rupture occurs.
U(x) = De
(
1− eβ(x−xe)
)
(2.9)
In Equation 2.9, x is the distance between the atoms and xe is the equilibrium distance,
while De and β define the well depth and width of the potential. However the use of
the harmonic oscillator instead of the Morse potential does not significantly reduce the
accuracy of an experiment because at low energy conformations, the Morse potential
and the harmonic oscillator have a very similar trend (Figure 2.1). Furthermore the
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implementation of the Morse potential calculus is extremely computationally expensive
and hence there is a preference for the use of the harmonic oscillator.
Figure 2.1: Ground-state potential energy curve for a diatomic molecule using the
harmonic oscillator model (red) and the Morse potential (green). Figure by Mark
Somoza, available under a Creative Commons Attribution-Noncommercial license.
2.1.1.2 Bending forces (Eangles)
Similarly to what is done for bonding stretching, the energy variations associated with
bond angle deformations are described by Equation 2.10:
U(θ) = 12k(θ − θe)
2 (2.10)
where θ is the angle between three atoms and θe is the value at equilibrium.
2.1.1.3 Torsion forces (Edihedral)
The torsion angle function models the motion associated with the rotation of dihedral
angles, the angles between the two half-planes formed by four atoms, around the middle
bond.
This potential is a periodic function with several minima, so can be modelled as a Taylor
expansion of the cosine function (2.11), where ω and n are defined as the dihedral angle
and the periodicy ( 2pi1...n).
U(ω) = 12kω
[
1 + cos(n(ω − ωe))
]
(2.11)
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Figure 2.2: Dihedral angle between the half-planes α and β. Figure available under
a Creative Commons Attribution-Noncommercial license.
These terms are generally different from one force field to another. The CHARMM force
field, for example, has two additional terms; one is an interaction based on the distance
between atoms separated by two bonds and the other is an improper dihedral term used
to maintain chirality and planarity [84].
2.1.1.4 Electrostatic interactions (Eelectrostatic)
The electrostatic interactions between a pair of atoms are the most complex forces to
model because the potential fades very slowly with increasing distance. There are several
implementations, but all of them are modelled on the Coulomb potential (Equation
2.12); 4pio is the dielectric function for the medium and rij is the distances between two
charged atoms qi and qj .
Ecoul =
∑
i,j
qiqj
4pi0 |rij |2
(2.12)
2.1.1.5 Van der Waals forces (Evan−der−Waals)
The van der Waals interaction represents the balance between repulsive and attractive
forces. The attractive force (power of 6), also called London’s dispersion force, arises
from the charge fluctuation in the electron cloud, while the repulsive force (power of
12) describes the repulsion of the electron clouds at close distance. When two atoms
get closer, their electron densities begin to merge and, in the absence of bond forma-
tion, Pauli repulsion causes the energy to rise rapidly. These forces are well modelled
(Figure 2.3) by the Lennard-Jones 6-12 potential (2.13).
EvdW =
[(
A
r12
)
−
(
B
r6
)]
(2.13)
with A = 4σ12 and B = 4σ6. These parameters are dependant on the atoms being
considered.  is the depth of the potential pitch, σ is the distance at which the potential
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is zero and r is the distance between atoms.
Figure 2.3: Van der Waals interaction energy between two argon atoms, as predicted
by the Lennard-Jones potential (blue) and calculated by empirical measurements (red).
Figure available under a Creative Commons Attribution-Noncommercial license.
The electrostatic interactions between hydrogen and very electronegative atoms, such as
carbon or nitrogen, are not well described by standard atomic charges, so in the majority
of force fields, hydrogen bonds are modelled implicitly as a combination of Couloumbic
and Van der Waals terms. In the case of AMBER (Equation 2.15) this is achieved by
ignoring the 12-6 interaction (hydrogen-acceptor) and adding a weak 12-10 potential.
2.1.1.6 Parametrization
The main goal of a force field designer is the development of a model that is as close
as possible to experimental measurements. Because of the huge number of existing
elements and their possible combinations, it is unlikely that there will be access to such
a massive quantity of data. A common workaround is the use of arbitrary parameters
to fit together experimental measurements and force field predictions. The deviation
is calculated using a penalty function and minimized to match the experimental values
better. Equation 2.14 is an example of such a function.
Z =
[
Observables∑
i
Occurrences∑
j
(calci,j − expti, j)2
w2i
] 1
2
(2.14)
Arbitrary parameters include explicit or implicit treatment of the atoms (all-atom vs
united atom), the inclusion of solvation terms, specific water model optimization (for
example TIP3P for both AMBER [85] and CHARMM force fields and SPC for the
GROMOS force field [86]), long-distance cut-off and many more. Different force field
use different parameters because they are designed for different purposes, using different
measurements, approaches and optimisations. It is always good practice to avoid mixing
together energy elements from different force fields.
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The other main divergence between force fields is the number of order terms used to
model the energy terms. Force fields that only use the energy terms described above are
called class I additive potentials, as opposed to class II force fields that include higher
order terms. These addictions are used to model a wider range of phenomena, such as
bond breakage and cross terms (coupling of different internal variables). Although class
II force fields are more accurate, a good parametrization allows the adequate treatment
of most common large biomolecular systems using class I [87]. AMBER and CHARMM
are two of the most-used force fields and their form is expressed in equations 2.15 and
2.16. Compared with AMBER, CHARMM has two additional terms; the Urey-Bradley
(UUB) and the improper dihedral terms. The UUB harmonic term is an addition to the
standard bond stretching and angle bending terms and models the interaction between
atoms separated by two bonds (1,3 interaction), while the second helps in maintaining
chirality and planarity.
AMBER (Assisted Model Building and Energy Refinement)
Etot =
∑
bond
Kr(r − req)2 +
∑
angles
Kθ(θ − θeq)2 +
∑
dihedral
Vn
2 [1 + cos(nφ− γ)]+
+
∑
i<k
[
Aij
R12ij
− Bij
R6ij
+ qiqj
Rij
]
+
∑
Hbonds
[
Cij
R12ij
− Dij
R10ij
] (2.15)
CHARMM (Chemistry at Harvard Macromolecular Mechanics)
Etot =
∑
bond
Kr(r − req)2 +
∑
angles
Kθ(θ − θeq)2 +
∑
dihedral
Kφ[1 + cos(nφ− δ)]+
+
∑
impropers
Kω(ω − ωeq)2 +
∑
Urey−Bradley
Ku(u− ueq)2+
+
∑
nonbonded

[(
Rmini,j
rij
)12
−
(
Rmini,j
rij
)6]
+ qiqj
ri,j
(2.16)
2.1.2 Potential Energy Surface (PES)
The best structure, from a chemical point of view, is defined as the structure with the
lowest possible energy given a certain molecule. In physiological conditions, molecules do
not exist in an isolated state, but rather in an equilibrium of a large number of different
conformations; for this reason instead of considering a single conformation for a given
chemical element, it is always better to think in terms of an ensemble of conformations
for that specific molecule. The Potential Energy Surface (PES), is the hypersurface
defined by the potential energy of a collection of atoms in all possible arrangements [88].
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The position of all the atoms is defined by their coordinates (x,y,z), therefore, every
point on the PES is described by the vector X:
X ≡ (x1, y1, z1, x2, y2, z2, . . . , xN , yN , zN ) ≡ (~r1, ~r2, . . . , ~rN ) (2.17)
For a molecule with N atoms (N≥3) the PES has 3N-6 coordinate dimensions. Six
dimensions are removed by imposing that the molecular center of the mass is at the
origin and that the molecule is aligned with the axes. Along the PES, two types of states
can be defined: local minima, which correspond to optimal low energy structures and
saddle points, which are energy barriers on paths connecting minima. Unfortunately,
the complete exploration of the PES is impossible, because of the great complexity
of biological molecules. Typically only a small slice of surface is studied every time,
but because only low energy states are explored, that slice can be considered as being
informative (see section 5.4).
The main goal of MM is the search for the point of lowest energy, called the global
minimum. Optimization theory is the field of applied mathematics that studies the
problem of minimization of a function of several dimensions. Although there is no
universal algorithm for optimization, all of them can be clustered into two families: local
search and global search.
2.1.2.1 Methods of local search
These methods are analytic approaches that are able to find, in a reasonable time and
with good approximation, the local minimum of a function. Because all of them use the
gradient to move along the PES, they cannot climb energy barriers and they therefore
stop once a minimum is reached (downhill approach).
1. Steepest Descent: For a random point of the function (xn), this technique first
calculates both the value of the function (F (xn)) and the gradient (∇) at that
point and then moves in the direction indicated by the negative of the gradient.
The main idea is to identify the fastest way down to a local minimum. Formally:
xn+1 = xn − an∇F (xn) (2.18)
with
F (x0) ≥ F (x1) ≥ F (x2) ≥ . . . (2.19)
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Eventually the sequence (xn) converges to the local minimum (Figure 2.4). The
value of the step size (an) can be calculated in different ways; although computa-
tionally expensive, the formally correct way is simply to perform a “linear search”
(proceeding by adjacent points) in the direction of the gradient.
Figure 2.4: The steepest descent algorithm allow a function to converge in a point
of minimum energy by changing direction following the negative of the gradient of the
function in a point.
2. Conjugate Gradient: Conjugate gradient methods are very similar to steep-
est descent, with the only difference being that they orient the search direction
by using a set of conjugate directions instead of only considering the gradient of
the function at a given point. Generally, compared with steepest descent meth-
ods, conjugate gradient methods are computationally cheaper, but they tend to
converge more slowly.
3. Newton-Raphson: This method is a root-finding algorithm that is able to locate
a point of minimum energy by using the first few terms of the Taylor series [89].
Given a function f(x), the Taylor series for the point x = x0 +  is:
f(x0 + ) = f(x0) + f ′(x0)+
1
2f
′′(x0)+ . . . (2.20)
The first order terms (Equation 2.21) represent the equation of the tangent line to
the curve at (x0, f(x0)) and (x1, 0) is the place where the tangent line intersects
the x-axis.
f(x0 + ) ≈ f(x0) + f ′(x0) (2.21)
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Figure 2.5: The Newton-Raphson algorithm works by calculating the intersection to
the x-axis of the tangent line of a point, and proceed until the value of the tangent line
is equal to 0.
By setting f(x0 + ) = 0, the step needed to land closer to the minimum from an
initial position x0 can be inferred from Equation 2.22.
0 = − f(x0)
f ′(x0)
(2.22)
At every step, a new  is calculated until convergence to a local minimum is reached.
The final implementation that is used iteratively in the Newton-Raphson method
is the following:
xn+1 = xn − f(xn)
f ′(xn)
(2.23)
2.1.2.2 Methods of global search
Despite their name, these methods do not guarantee that the global minimum will be
found, but they allow the exploration of a bigger slice of the PES compared with a local
search.
1. Simulating Annealing: Stochastic models based on the Monte Carlo sampling
(probability accumulation), derive from the annealing proces in metallurgy, where
a metal is heated and slowly cooled down to improve the quality of an alloy. Given
a state (point on the PES) at a certain temperature (T), a Markov chain is used to
represent all the states that have a transition probability (p) of being chosen as the
next state. If ∆E < 0 the transition occurs because a state of lower level energy
has been found; however if ∆E > 0 the transition may occur with p probability.
p = exp
(
−∆E
kbT
)
(2.24)
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The transition probability is a function of the Boltzman constant (kb) and the
temperature of the system. The latter plays a crucial role because it controls the
evolution of the system itself. At low temperature (low energy of the system), there
is a low probability of exit from a potential well (∆E > 0) and, as a consequence,
the Markov chain will converge to a minimum. The general approach to simulating
annealing is to fix an initial temperature together with a cooling schedule that
will slowly reduce the energy until a huge slice of PES has been explored and a
minimum is found. It is important to understand that the minimum found by this
method is not guaranteed to be the global minimum, but it is a good approximation
of it.
2. The Genetic Algorithm is a heuristic method that draws its origin from the
field of population genetics and tries to simulate the process of natural evolution.
The main idea is that a population of different solutions to a problem (a function),
tends naturally to evolve to the best solution(s). Genetic algorithms make use of
two forces, natural selection and sexual reproduction, to push the evolution process
towards convergence. Different implementations of this algorithm exist, but all of
them share the same rationale. That is:
(a) start: generate a random population with n chromosomes;
(b) fitness: calculate the fitness: f(x) (e.g. potential energy);
(c) new population: generate a new population in three steps:
i. based on the fitness, a pair of parents are chosen;
ii. a random pair of parental chromosomes is generated;
iii. random mutation events occur with a given probability;
(d) test: verify the stop conditions;
(e) iteration: if the stop conditions are not reached, the algorithm returns to step
(b).
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2.2 Statistical thermodynamics
Classical thermodynamics studies nature with a macroscopic approach, where the sys-
tem is considered at thermodynamic equilibrium and the atomic detail is completely
neglected. All the equations that describe the properties of a system can be written
using only four variables: Temperature (T ), Pressure (P), Volume (V ) and Number
of moles (N ). Thermodynamics reproduces the system as an ideal gas, with the result
that objects are described as point particles with elastic collisions. The statistical ther-
modynamics approach, on the other hand, tries to increase the level of information by
considering the atomistic nature of the system. As a direct consequence, all the proper-
ties must be rewritten to account for the behaviour of an ensemble of molecules in the
order of the Avogadro constant, NA. In statistical thermodynamics, a generic macro-
scopic property, A, is described as a function of the coordinates (~r) and the momenta
(~p) of all the particles of the system.
2.2.1 Boltzmann distribution
In a system consisting of Ntot particles (with Ntot in the order of Avogadro number),
all the particles belong to a specific state with energy EU . At T = 0K all the particles
of the system are at the ground state (global minimum) with EU (r0) = 0, where r
are the coordinates of the system. Statistical thermodynamics tries to understand the
probability that a certain energy state is populated. If a general state i, with EU,i > EU,0,
is populated according to Equation 2.25
Nj
Ntot
>
Ni
Ntot
⇒ Nj > Ni (2.25)
where Ni is the number of particles at the Ei state, and
1 > Ni
Ntot
> 0 (2.26)
then the state Nj is more populated than Ni, and it is therefore more probable to find
a particle there. The Boltzmann distribution (Equation 2.27) defines the temperature
(T) dependent function which assigns the probability of being populated to every state
of the system.
Ni
Ntot
= e
−Ei(ri)
kbT∑
i e
−Ei(ri)
kbT
= e
−Ei(ri)
kbT
Z(T, r) = σ(Ei(r), T ) (2.27)
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kb is the Boltzmann constant and represents the proportionality factor between entropy
(S) and the number of the accessible states (Ω) (Equation 2.28).
Si = kb ln(Ω) (2.28)
Z(T, r), also called normalizing function, is the repartition function that contains all the
information which is necessary to understand the system, since it gives all the energy
values of all the possible states. σ is a probability distribution and it can only assume
values between 0 and 1. The Boltzmann distribution exhibits the following properties:
1. The ground state is always the most populated;
2. A high energy state is always less populated than a low energy state.
3. The distribution is in accordance with the third principle of thermodynamics: The
entropy of a system depends on the temperature (T). If T = 0, the entropy is 0
and only one system is populated, but a T → ∞ then all the states will become
equally populated.
2.2.2 Phases space and Ergodic hypothesis
The total energy of a system is the sum of both kinetic and potential contributions
(Equation 2.29). The previous sections explained how a force field connects potential
energy and molecular conformation together (Equation 2.1.1).
E(p, r) = Ekinetic(p) + Epotential(r) (2.29)
Ekinetic(pi) =
p2i
2mi
(2.30)
Because kinetic energy is a function of mass (m) and momentum (p) (Equation 2.30),
the total energy depends only on the positions and on the momenta of the particles of
the system. This leads to the definition of the phase space: for a system of N particles,
the phase space is the mathematical space (X) in which all possible conformations (r)
and momenta are represented.
X = {p, r}|R6N = R3N (r)×R3N (p) (2.31)
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with
~p ={px1, py1, pz1, px2, py2, pz2, . . . , pxN , pyN , pzN}
~r ={x1, y1, z1, x2, y2, z2, . . . , xN , yN , zN}
(2.32)
where x,y,z represent the coordinates. Inside the phase space and using the Boltzmann
distribution, it is possible to rewrite any macroscopic properties and a generic function
A = f(~r, ~p) becomes
A =
∫∫
A(p, r)σ(r, T ) dp dr (2.33)
If the property studied is the energy of the system, the result will be expressed by
〈A〉ensemble =
∫∫
A(p, r)σ(E(r), T ) dp dr (2.34)
Energy, speed, pressure and volume are all continuous variables (here the integral) that
require an infinite time to be fully described. However, one can experimentally sample
a certain property over time (t), and obtain an estimation of the average values:
〈A〉ave ≈ 1
Mstep
Mstep∑
i=1
A(p(ti), r(ti)) (2.35)
with M equal to the number of steps of the experiment. Although equation 2.35 only
partially describes A, if the number of steps approaches infinity (M → ∞), 〈A〉time
becomes a good approximation of 〈A〉ensemble:
〈A〉time = lim
M→∞
1
M
∫ M
t=0
A(p(t), r(t))dt (2.36)
The fundamental principle in which 〈A〉ensemble = 〈A〉time is called the ergodic hypoth-
esis. This hypothesis implies that the system goes through every spatial and kinetic
configuration during its temporal evolution. It is not possible to calculate this contin-
uous function, but numerical integration techniques such as Molecular Dynamics (MD)
and Monte Carlo (MC), are able to approximate the solutions calculating a trajectory,
ri (Equation 2.37), in the phase space.

~ri = ~ri(t), ∀i
~pi = ~pi(t), ∀i
=

~ri = ~ri(to), ~ri(t1), . . .
~pi = ~pi(to), ~pi(t1), . . .
(2.37)
These techniques sample, for a sufficiently long time, the phase space in the informative
low energy regions of the Boltzmann distribution.
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2.3 Molecular Dynamics
Molecular dynamics (MD) is a system of numerical integration that tries to understand
the motion of the atoms of molecules in a well-defined time frame. Using physiological
conditions in the simulation, an MD experiment is able to study, in silico, the low level
energy structures that are responsible for the in vivo behaviours.
Every atom (i) is subject to a force according to the classical Newtonian definition:
~F = mi~ai (2.38)
but if the forces are conservative (the value depends only on the position), (Equation
2.38) becomes
~F = mi~ai = mi
d2~ri(ti)
dt2
= −dE(~ri)
d~ri
,∀i (2.39)
or
~F = −dE(~ri)
d~ri
= −∇E(~ri) (2.40)
Equation 2.40 suggests that the force is the negative gradient of the potential energy
(−∇E(~ri)), meaning that an atom tends to move in the direction opposite to the di-
rection of the energy function growth. Therefore, at a point of minimum energy, the
gradient is zero and the atom maintains its position. By integrating the forces which act
on every atom of the system, it is possible to express the relationship between potential
energy and position over time:

~ri = ~ri(t), ∀i
~pi = ~pi(t), ∀i
(2.41)
This system of equation Equation 2.41 is solved using the Verlet (leapfrog) algorithm,
or one of its variants.
Chapter 2. Computational background 38
2.3.1 Verlet integration
All the numerical integration algorithms use a truncated Taylor series of both the posi-
tions (r) and the momenta (p) of the atoms of the system.

ri(t+ δt) = ri(t) + r′i(t)δt+ 12r′′i (t)δt2
pi(t+ δt) = pi(t) + p′i(t)δt+ 12p′′i (t)δt2
(2.42)
Given a starting configuration (t) the algorithm calculates the values of the conformation
after a small increment of time (t+ δt).
ri(t+ δt) = ri(t) + r′i(t)δt+
1
2r
′′
i (t)δt2 = ri(t) + vi(t)δt+
1
2ai(t)δt
2 (2.43)
where vi(t) is the vector of the velocities at step t and ai(t) is the vector of the acceler-
ations at the same step (t). Because t can be calculated as the sum of both t + δt and
t− δt, (Equation 2.43) can be rewritten as
ri(t+ δt) + ri(t− δt) = ri(t) + vi(t)δt+ 12ai(t)δt
2 + ri(t)− vi(t)δt+ 12ai(t)δt
2
= 2ri(t) + ai(t)δt2
(2.44)
Using the gradient of the potential energy (Equation 2.39), the acceleration is replaced
by the force, obtaining
2ri(t) +
Fi
mi
δt2 (2.45)
and finally
ri(t+ δt) = 2ri(t)− ri(t− δt) + Fi
mi
δt2 (2.46)
where ri(t+ δt) is the term referring to the new step, 2ri(t) is the term referring to the
previous step, while ri(t− δt) refers to the second previous step.
The integration of the momenta is treated slightly differently. The first velocities (p0)
are randomly generated from the Boltzman distributions of velocities:
vi(t = 0) =
(
mi
2pikbT
) 1
2
e−
miv
2
i
2kbT
(2.47)
whith kb, m and v being the Boltzman constant, the mass and the velocities respectively.
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In statistical thermodynamics the equipartition theorem states that, at equilibrium, the
total kinetic energy (K) is shared equally among all of its parts. Equation 2.48 expresses
this relationship for a system with one degree of freedom.
K = 12kbT (2.48)
When the system is composed of N atoms, with 3 degrees of freedom each, Equation
2.48 becomes
K =
N∑
i=1
(3
2kbT
)
= 32NkbT (2.49)
During an MD simulation, the system is described using a classical mechanics point of
view, which allows easy calculation of the momenta (pi) imposing:
K =
N∑
i=1
p2i
2mi
= 32NkbT (2.50)
Once some initial coordinates (a PDB file), some random velocities and the temperature
are defined, it is possible to describe fully the evolution of a dynamic system. However,
to maintain a correct description of the dynamics, the system must be isolated (N is
constant). To achieve this, three different ensembles can be used:
• NVE (micro canonical ensemble): volume and energy are maintained constant;
• NVT (canonical ensemble): temperature and volume are maintained constant;
• NPT (isothermal–isobaric ensemble): temperature and pressure are maintained
constant;
The temperature is maintained constant using a multiplicative factor (λ) that is re-
calculated at every step. Because the system evolves over time, the kinetic energy at
t + δt differs from the values recorded in the previous step (Kt) and is calculated from
Equation 2.50
Kt+δt =
N∑
i=1
(λpi)2
2mi
= 32NkbTt+δt (2.51)
If
∆K = Kt+δt −Kt =
N∑
i=1
(λpi)2
2mi
−
N∑
i=1
p2i
2mi
= 32Nkb(Tt+δt − Tt) (2.52)
and if
pi(t+ δt) = pi(t) ∗ λ (2.53)
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then
λ =
√
Tt+δt
Tt
(2.54)
The volume is maintained constant using periodic boundary conditions (Figure 2.6), in
which the system is contained in a simulation box surrounded by an infinite number
of completely equal boxes. The boxes intercommunicate, and if a particle exits the
simulation box from one side, it will re-enter from the opposite side.
For details on the algorithm used in this project, refer to Chapter 3 and Chapter 5.
Figure 2.6: Representation of the periodic boundary conditions. The simulation
box (centre box) is surrounded by identical boxes and every time a particle leaves the
simulation box, the same particle re-enters from an adjacent box.
Figure from isaacs.sourceforge.net/phys
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2.3.2 The Sampling problem
Molecular dynamics models are a cheap and reliable tool to explore the conformational
space of biomolecules. Unfortunately the usefulness of MD methods is limited by the
quantity of PES that can be explored during a simulation: the sampling. The PES
is a complex hypersurface which describes a molecule and all its possible states and
interconnecting pathways. Because of its dimensions and complexity it is impossible
to describe its topology in fullness, and MD experiments are only capable of exploring
small slices of it. The resulting uncertainty is problematic because MD yields incomplete
information, which affects both the accuracy and the reproducibility of the experiments.
A common way of tackling this problem is the use of several short simulations, that
considered as a whole, can give a more correct description of the system studied. This
approach is fine for most molecules, but there are cases in which longer simulations are
required: protein folding and unfolding for example. In such cases, one of the ways used
to improve the sampling is to raise the temperature of the simulation. Equation 2.48
describes how the kinetic energy (K) is linked to the temperature, and suggests that
variations in temperature affect the internal energy of the molecules in the system. The
additional energy makes changes of states more probable, and therefore, the number of
conformations explored during an experiment is increased. The more the temperature
rises, the larger the sampling will be. The drawback is that, at higher temperature, the
probability of exploring biologically important structures decreases. Techniques such
as ‘replica exchange molecular dynamics’ (REMD) overcome the problem by running
several independent replicas at different temperatures and exchanging conformations
among trajectories, allowing low energy structures to sample conformations that would
not be explored otherwise. REMD simulations guarantee a massive increase in sampling,
while exploring structures biologically relevant to the problem studied. Other ways of
improving the sampling include the use of coarse grained models and metadynamics
simulations. The former consists in increasing the simulation performance by averaging
the energy over certain degrees of freedom, while the latter adds Gaussian functions to
the potential of some selected properties to fill the potential well. Generating a correct
sampling was a major problem during the G6PD simulations, and Chapter 5 and Chapter
6 will describe how the problem was treated.
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2.4 SAAP
Predicting the effects of mutations on protein phenotype is an important field of research.
Several serious diseases, such as Cystic fibrosis, neurofibromastosis, colour blindness and
sickle-cell anaemia, are caused by deleterious phenotypic changes resulting from single
amino acid changes having an effect on protein structure. The SAAP (Single Amino
Acid Polymorphism) resources [90–93] are tools capable of explaining the possible ef-
fects of mutations by mapping mutations to the protein structure and analysing their
likely effects. Single Nucleotide Polymorphisms (SNPs) are mutations that occur in at
least 1% of a normal population. In the context of analysing the effects of mutations
the term is often used for mutations which have no apparent effect on phenotype. In
contrast, Pathogenic Deviations (PDs) are low frequency mutations that are capable of
causing disease. Over time several methods aiming to analyse and predict the damaging
effects of mutations have been developed. Some methods are sequence based and cal-
culate conservation scores from multiple alignments (e.g.SIFT [94], PANTHER [95] and
MutationAssessor [96]), others use machine learning on sets of both sequence and struc-
tural data from known structures of predicted properties, such as solvent accessibility
(PolyPhen-2 [97]), and other combine the outputs from other predictors (Condel [98]).
Because each method has a different definition of the ‘boundaries’ between SNPs and
PDs, it is not easy to compare their performance directly, but their Matthews’ correla-
tion coefficient (MCC) was found to vary from 0.453 to 0.671 when tested on the HumVar
dataset (all human disease-causing, other than cancer, mutations from UniProtKB) [98].
Even though the SAAP tools are limited by the necessity of having a resolved protein
structure to work, SAAPpred, trained and tested on the same dataset and using 10-fold
cross-validation, has a MCC of 0.692, outperforming the competing methods. The anal-
ysis of a mutation using the SAAP tools starts with the SAAPdap pipeline [93]. The
idea is to understand the likely structural effects that the mutation has on the protein
structure, comparing known effects in SNPs and PDs. This is achieved by mapping the
SAAPs on the 3D structure (PDB structure required) and performing fourteen differ-
ent structural analyses, such as checking for the introduction of destabilising voids in
the structure, steric clashes with existing residues and the introduction of unfavourable
torsion angles (refer to Table 2.1 for a complete description). The collected data are
presented in both an overview mode (Figure 2.7) and a detailed one (Figure 2.8). Be-
cause the pathogenic phenotype could be the result of numerous, but small, changes
to the protein structure, the SAAPdap results are further analysed by SAAPpred [93].
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SAAPpred is a 47-feature machine learning method that uses Random Forests [99], im-
plemented in Weka [100], to predict whether the mutation is a SNP or a PD. SAAPpred
results use a confidence score system (from 0 to 1) that indicate how likely the prediction
is to be correct. Values above a fixed threshold (> 0.1) indicate mutations that are likely
associated with severe phenotypic alteration.
Analysis Description
Interface Residue is in an interfece according to solvent accesibility criteria;
Binding Residues maked interactions with a different protein chain or ligand;
SprotFT Residue is annotated as functional relevant by UniProtKB/SwissProt;
Clash Mutation introduces a steric clash with an existing residue;
Void Mutation introduces a destabilizing void in the protein core;
Cis-Proline Mutation from cis-proline, introducing an unfavourable omega torsion angle;
Glycine Mutation from glycine, introducing an unfavourable omega torsion angle;
Proline Mutation from proline, introducing an unfavourable omega torsion angle;
HBond Mutation disrupts a hydrogen bond;
Corephilic Introduction of a hydrophilic residue in the protein core;
Surfacephobic Introduction of a hydrophobic residue on the protein surface;
Buriedcharge Mutation causes an unsatisfied charge in the protein core;
SSgeometry Mutation disrupts a disulphide bond;
Impact Residue is significantly conserved.
Table 2.1: List of the SAAPdap analyses as listed in Al-Numail and Martin [93].
Figure 2.7: Example of SAAPdap output (overview mode). For each mutation (1st
column) all the likely structural effects are listed (3rd column), together with the num-
ber of resolved structures (PDB files) used for the analyses (2nd column). The sign
in parenthesis in column 3 are the numbers of structures in which the given effect is
predicted to occur. The last column presents a link (JSON) to a file which stores all
the information for that specific mutation. The colour gives an indicator, from green to
red, of the likelihood of a damaging effect based on the fraction of structures affected.
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Chapter 3
All-atom simulations
3.1 Overview
This chapter will describe how a set of G6PD mutations was selected and their effects
were studied using MD all-atom simulations. The starting idea of the project was that
the reduced catalytic activity observed in the mutants is caused by a large change in
the equilibrium between correctly folded and misfolded states, where these states are
significantly different from the correctly folded state. Initially, from the sequences of
all the possible G6PD mutants, a subset of mutants was extracted. Because the total
number of mutants was close to 3500, it was not possible to study all of them. Some
rules were therefore set, to select only a representative sample of these mutations. The
criteria used guaranteed that the mutations chosen were spread along the sequence, had
different predicted structural effects, some of which were known pathogenic mutations.
17 mutants were identified and studied. In order to find a point in which there was a
clear difference in behaviour between the wild-type and mutants, it was decided to start
MD simulations at 310 and 500 K only. At 310 K it would have been possible to observe
the protein behaviour at physiological conditions, while at 500 K the system would be
expected to have enough energy to cause the complete unfolding of G6PD. In these
conditions the enzyme stability was assessed and both temperatures, one being too low
and the other too high, were found not to be ideal to explore the G6PD conformational
space extensively. Additional temperatures were then explored in an attempt to find a
temperature at which the mutants were clearly behaving differently from the wild-type.
Therefore, simulations at 400 K, 450 K and 470 K were performed. All the data collected
45
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indicated 400 K to be the best temperature to detect G6PD instability behaviours in
the mutants.
3.2 Methodology: mutant selection
At the beginning of the project, around 186 existing G6PD variants were known [101],
but to avoid missing important cases, all possible mutations of the G6PD gene resulting
from single base changes were considered. Many mutations lead to mild to minor enzy-
matic deficiency, meaning that is only when certain malaria drugs or foods are ingested
that the effects of the mutations are triggered. For this reason, there may be individ-
uals who are unaware of their condition, because they have never used those drugs or
eaten these foods. Initially the DNA sequence, obtained from the “human metabolome
database” (http://www.hmdb.ca/proteins/5564 ) was mutated in silico to generate a list
of possible mRNAs, through single point mutations of the original sequence. The result-
ing sequences were first translated and then filtered to eliminate duplications. Of the
initial 4645 sequences, 3216 reached this point. Looking at the numbers, it appeared
impossible to study all of them with MD simulations, so the next step was to reduce
this number to a few dozen only. SAAPdap [93] was used to understand the possible
structural effects resulting from each mutation event. For each mutant, the generated
information was combined and processed by SAAPpred [93]. SAAPpred, through a ma-
chine learning algorithm, was able to predict how likely the mutation is to affect the
phenotype of the protein. The extracts shown in Figure 2.7 and Figure 2.8 are examples
of the types of information obtained from SAAPdap for G6PD. The complete results
are accessible at the following address: http://www.bioinf.org.uk/people/francesco/.
The final step of the selection process was to pick, from the list of SAAPpred results,
the most interesting and damaging mutations. This was done by setting the following
criteria:
• The mutations must have a high confidence of being damaging;
• The mutations must be spread throughout the protein structure: This
criterion was set to avoid studying only certain sections of the protein structure.
If all the studied mutations were clustered around the same features (e.g. binding
sites), it would be difficult to generalise the results, in the sense that the observed
behaviours may be determined more by the position of the mutant than by the
mutation itself;
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• Different residue types must be considered: This criterion was introduced
later on in the project. It was observed that the most damaging mutations con-
cerned some residues more than others (arginine and proline in particular, see
Figure 3.1). The introduction of this new criterion, allowed an increase in the
range of cases and the study of less represented mutations;
• Some mutations with known clinical effects must be included in the
study: The last criterion was critical because it helped validating the results
obtained using real data. Observing that some mutants with known depressed ac-
tivity present structural instability may validate the hypothesis that the depressed
activity of G6PD mutants is owing to some structural damage in their structures.
Table 3.1 lists the mutants that fill the criteria and were therefore studied.
(a) (b)
Figure 3.1: (a) Native residue frequency and (b) mutant residue frequency of the mu-
tants that were predicted damaging by SAAPpred. From the list of damaging mutants,
The figures indicate that alanine, glycine, isoleucine and arginine are the most replaced
residues in damaging G6PD variants, while proline, arginine, serine and valine are the
most common replacement residues.
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Table 3.1: List of the mutants studied with all-atom molecular dynamics simulations.
All the mutants were predicted as damaging by SAAPpred (confidence is in brackets),
with the exception of N128D. Some of the mutants are known G6PD variants (the type
is in brackets). The red box indicates the two mutations constituting A− : the only
multi missense mutant studied.
Position From To Predicted Known variant
204 Glycine Arginine X (0.8) -
306 Glycine Arginine X (0.8) -
359 Glycine Arginine X (0.79) -
264 Leucine Arginine X (0.79) -
137 Leucine Proline X (0.78) X (II)
140 Leucine Proline X (0.78) -
338 Alanine Glutamate X (0.75) -
370 Arginine Tryptophan X (0.71) -
287 Glutamate Lysine X (0.69) -
70 Cysteine Tyrosine X (0.67) X (II)
306 Glycine Serine X (0.64) X (II)
232 Cysteine Tyrosine X (0.49) X (I)
269 Cysteine Tyrosine X (0.49) X (I)
136 Arginine Cysteine X (0.45) X (II)
461 Alanine Threonine X (0.23) -
227 Arginine Glutamine X (0.15) X (III)
68 Valine Methionine X (0.07) X (III)
126 Asparagine Aspartate SNP (0.5) -
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3.3 Methodology: all-atom
The starting structure for all the simulations on the wild type was the human deletion
mutant of G6PD structure (PDB code 2bhl), in which the first 25 and the last 9 residues
have been removed [81]. All the mutant structures were obtained by mutating the wild-
type using mutmodel [102], a program that allows the replacement of a single side-chain
using the Minimum Perturbation Protocol (MPP [103]). Once a residue is specified, the
side-chain is replaced and the Chi angles are rotated to minimise bad contacts until the
best position is found. The obtained structures were checked for correctness and were
fed as input into the family of tools of the GROMACS package [104–107] for the MD
simulations steps.
All the simulations were performed using the AMBER99SB-ILDN force field [108], com-
bined with the TIP3P[109] water model and using both versions 4.6 and 5.0.4 of GRO-
MACS. AMBER99SB-ILDN is an improved variant of AMBER-99, containing backbone
and torsion parameters that better fit NMR data. Other force fields (CHARMM [84]
and GROMOS [110]) were considered, but eventually abandoned in favour of the more
used AMBER force field. The main reasons behind this decision were that:
• GROMOS is a united atom force field, meaning that it is much less accurate than
AMBER. The use of GROMOS is legitimate when computational time is taken into
account as a simulation with GROMOS is generally faster than both AMBER and
CHARMM. However simulations have proven that the time gain is not sufficiently
different to justify the use of GROMOS.
• One of the main differences between AMBER and CHARMM is that CHARMM
severely over-stabilises the formation of helical structures while AMBER tends to
underestimate their stability, but overall both AMBER and CHARMM perform
equally well. Because of the version used, AMBER matches NMR experimental
data slightly more closely, especially at high temperatures [111, 112].
3.3.1 GROMACS topology and box creation
The first step was the creation of GROMACS coordinates and topology files using
pdb2gmx. This tool takes a structure (e.g. a pdb file) and generates three outputs: a
GROMACS-format coordinate file (.gro), a force field-compliant topology file (.top) and
a position restraint file (.itp). The next steps consist of building a triclinic box around
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the protein (editconf), of solvating (genbox) and adding counter-ions to the system
(grompp and genion). The simulation box is a critical factor in every MD experiment;
the bigger the box is, the larger the amount of atoms considered for the energy calcula-
tions (greatly affecting the performance). Since MD experiments use periodic boundary
conditions, a minimum image convention must be set, this is because a protein must
never interact with its periodic image, otherwise the forces calculated would be incor-
rect. For the first simulations at 310 and 500 Kelvin, the distance to the edge of the box
was set to 1.5 nm, but because the first analyses indicated a stable system this distance
was reduced for the following simulations, First to 1.4 nm first and then to 1.3 nm. The
smaller boxes allowed an increase in performance, going from around 9 ns/day to 10 or
11 ns/day. Table 3.2 lists the boxes used in the simulations.
protein-edge distance [nm] dimensions [A˚] water molecules
1.5 119.762 x 144.124 x 113.207 59347
1.4 117.762 x 142.124 x 111.207 56957
1.3 115.762 x 140.124 x 109.207 53972
Table 3.2: Approximate dimension and number of water molecules of the water boxes
used in the simulations.
3.3.2 Energy minimisation
Before the beginning of the real dynamics, clashes or unfavourable geometries must be
removed from the system by performing Energy Minimisation (EM). A maximum of
50000 steps of steepest descent were called and each event was considered successful
when the maximum force on any atoms was less than 10 kJ/mol/nm. Some of the other
important parameters used included:
• particle-mesh Ewald (PME) for the treatment of long-range electrostatics [113];
• twin-range cut-off for the van der Waals interactions;
• cut-off distance of 1 nm. The same value was used for the short-range neighbour
list, long range electrostatic and long range van der Waals interactions.
• Periodic boundary conditions (pbc) along x,y and z directions (xyz).
These parameters were chosen mainly because they are compliant with the way the
AMBER force field was parametrised.
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3.3.3 System equilibration
Following the EM, solvent and ions must be placed uniformly around the protein; this
is done in two steps: Initially the system was brought to the desired temperature in a
100 ps NVT canonical ensemble dynamics (NVT is the ensemble in which the number of
atoms, the volume and the temperature are kept constant) and then pressure was applied
to the system until it reached the density of 1 bar, using an NPT isothermal-isobaric
ensemble (contrary to the NVT ensemble, in the NPT ensemble the pressure is kept
constant, together with the temperature and the number of atoms in the system) for
another 100 ps. During both phases the protein is frozen (-DPOSRES flag) to maintain
the geometrical conformation obtained in Section 3.3.2. Important parameters for the
equilibration phases included:
• Initial velocities were randomly generated (gen vel=yes) using different seeds
(gen seed) for every simulation;
• The Berendsen thermostat was used for coupling the temperature [114]. As de-
scribed in the introduction (Section 2.3.1), the temperature of a system is con-
trolled by rescaling the velocities at each step, by multiplying the current temper-
ature by a factor λ. However, in this way, the kinetic energy maintains constant
values over time and the correct temperature fluctuations are not reproduced.
The Berendsen thermostat overcomes this inaccuracy by coupling the system to
an external bath only at certain time steps.
• The Parrinello-Rahman barostat was used for coupling the pressure [115]. Sim-
ilarly to the Berendsen thermostat, the Parrinello-Rahman barostat couples the
pressure to an external pressure bath, allowing both the volume and the shape of
the simulation box to fluctuate.
3.3.4 Production MD
The parameters were almost the same as the NPT step, with the only exception that the
Berendsen thermostat was replaced by the Nose-Hoover thermostat [116, 117] to produce
a better kinetic ensemble. The Berendsen thermostat tends to converge quickly, and is
thus more suitable for equilibration. Once the system is near temperature convergence,
the Nose-Hoover thermostat kicks in to produce the correct energy fluctuation. Other
parameters used in the simulations included:
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• particle-mesh Ewald (PME) treatment of long-range electrostatics [113]. PME
works by converting the system into a grid of density values and calculating the
forces applied to each particle depending on its position relative to the closest cell;
• An all-bonds LINear Constraint Solver (LINCS) algorithm [118] was used for han-
dling constraints;
• Because of the presence of LINCS, the time step was increased to 2 fs. In MD
simulations, the bond oscillation is one of the factors that limits the time step.
By replacing the bond vibrations with constraints, it is possible to increase the
time step. Algorithms like SHAKE [119] reset bonds to defined values one bond
at a time, increasing accuracy, but it is too slow to be used on large systems.
The LINCS algorithm uses Lagrange multipliers to model the constraint forces,
resulting in a method that is three to four time faster than SHAKE.
• To be able to take advantage of the GPU acceleration, the Verlet cut-off scheme
was used with an nstlist (frequency of updating the neighbour list) equal to 30.
The Verlet scheme keeps a list of particles within a certain cut-off distance;
• The conformations were saved every 10 ps, with the exception of the first wild-type
replica (310 K) for which the structures were saved every 20 ps.
All the simulations ran on a single EMERALD [120] node, consisting on two 6-core
X5650 Intel Xeons and three or eight 512-core M2090 NVIDIA GPUs. Initially the
target trajectory length was 200 ns, but following the first results, this number was
raised to 500 ns.
3.3.5 Analyses
All the trajectories have been analysed using an in-house script (doitGROMACS.sh see
Appendix A) and the statistical package R [121, 122] for plotting. The script is capable
of automating the set up of an MD simulation and performing some standard analyses
on the trajectories. Before analysing the trajectories, water was removed from the
reduced-precision trajectories (.xtc); This step was not strictly required, but because of
the dimension of the trajectories, it proved much more convenient to remove everything
but the protein. The following analyses were carried out:
• The root mean square deviation (rmsd) was calculated on the protein backbone
using g rms;
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• The gyration radius was calculated on the entire protein using g gyrate;
• The root mean square fluctuation (rmsf) was calculated for both the backbone
and the side-chains using g rmsf ;
• Cluster analyses on the backbone, were performed using g cluster on a rmsd
matrix generated by g rms;
• Principal Component Analyses (PCA) were performed on the protein C-alphas
using g anaeig on a covariance matrix generated by g covar. G sham was used to
obtain a profile of the Potential Energy Surface (PES) from the first eigenvectors.
• Solvent Accessible Surface (SAS) analyses on the entire protein were performed
using g sas. The SAS algorithm builds the area that is accessible to the solvent
by rolling a sphere of defined size (a probe) over the Van der Waals surface of the
protein. Because we were interested in seeing the areas of the protein which are
accessible to an antibody, a probe bigger than the default size was used. From
existing literature, it is known that the average area of interaction is 15 A˚2 [123],
here a probe size of 0.7 nm in diameter and 24 dots per probe. The probe size
was reset to the default value of 0.14 nm when only the binding sites (Glucose,
co-enzyme and structural NADPH+) were considered. This was done to allow the
detection of small changes in surfaces values.
• Secondary structure analysis (dssp) on the main chain was performed using do dssp.
• The hydrogen bonding count (hb) was performed on the entire protein as well as
all the binding sites using g hbond.
Refer to Appendix A for a full explanation of the script and the parameters used.
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3.4 Wild-type characterisation
Before analysing the damaging effects of the mutants, and better to highlight the differ-
ences between them, it is important to characterise the wild-type and its behaviour.
3.4.1 Analysis with Elastic Network Model (ENM)
Normal Mode Analysis (NMA) is a computational technique used to study large scale
motions in biological molecules. NMA is based on the assumption that normal modes
with the largest fluctuation (low frequency) are the motions which have biological rele-
vance. NMA uses a harmonic potential (Equation 3.1) to describe the fluctuation around
a minimum energy [124]. To perform NMA, the energy of the system is first minimised,
then the Hessian matrix is calculated and the eigenvalues and eigenvectors are finally
extracted by diagonalising the Hessian matrix. Because these steps are particularly com-
putation expensive, several simplifications have been proposed over the years. Elastic
Network Models (ENMs) are NMAs in which the system is dramatically simplified into
an elastic mass of atoms (Cα) connected by springs.
Ep =
∑
d0ij<Rc
c(dij − d0ij)2 (3.1)
were dij is the distance between two atoms, c is the potential spring constant, and Rc
is an arbitrary cut-off, beyond which interactions are not considered. The ENM imple-
mentation used in this project was the “elNe´mo web-interface to the Elastic Network
Model” [125, 126] and was mainly used to locate the region of G6PD that has a normal
propensity to motion. The elNe´mo web-interface is easy to use and only needs a struc-
ture (PDB file) to run. All the basic settings for the calculation were left at their default
values. The B-factor extracted from the X-ray crystallography structure (2bhl.pdb), in-
dicates that the extremities are the most flexible regions of G6PD (Figure 3.3). There
is a noticeable difference between the two chains of the protein, and this could be con-
nected with spatial inhomogeneities in packing density, that could cause variations in
small-amplitude structural flexibility within the protein [127]. High-density regions can
accommodate only a few similar conformations, while low-density regions might allow
several conformations. With more blue shades, the N-terminus of chain B (right part of
Figure 3.3) seems to fluctuate less than that of chain A, and this difference is swapped in
the C-terminus, where chain A is more stable. Apart from the extremities, other groups
of residues (mainly around loops and short spanning helices) present higher B-factors.
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In particular, the regions from residues 311 to 330, 240 to 250 and around residues
423-428. The B-factor predicted by elNe´mo (Figure 3.2) over-estimates the flexibility at
the N-terminus, but it overall coincides with the crystal structure values. Both sources
indicate that the β core is the most stable region of the protein.
Figure 3.2: Comparison between the B-factor predicted by the NMA method and the
data in the PDB file (2bhl). The first 500 residues constitute the first chain, while the
next 500 are from the second chain.
ENM was also used better to understand the global movements of G6PD, and thus
what we may have expected from the simulations. The natural movements of G6PD are
represented by arrows in Figure 3.4, and in both figures, the N and C-terminus close
and twist around the central β domain. These movements may favour the uptake of the
substrate by allowing or denying access to the binding site.
Figure 3.3: G6PD coloured following the B-factor values included in 2bhl.pdb; from
blue (low fluctuation) to red (high fluctuation).
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(a) (b)
Figure 3.4: The figure shows the first two non-trivial modes obtained from the elNe´mo
calculations. The arrows are used to follow the conformational change that are induced
by the modes.
3.4.2 Wild-type at 310 K (37◦C)
The wild-type structure (2bhl.pdb) was simulated at 310 K (approximately 37◦C) with
three independent simulations (replicas). The initial coordinates were shared among all
the trajectories, while the velocities were different. This was done to sample the con-
formational space better. Two replicas ran for 250 ns, while a third continued only for
200 ns.
Figure 3.5: The stable fluctuation of (a) the potential energy, (b) the temperature
, (c) the pressure and (d) the density of the simulation box during a dynamics of the
wild-type at 310 K.
The simulation conditions (Figure 3.5) were well preserved in all the replicas, meaning
that the system is stable and that the simulation parameters were set correctly. The po-
tential energies are in the order of -2.49 ×106 kJ/mol with the system density oscillating
around 1002.9 kg/m3. Even though each of the replicas presented differences in their
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dynamics, all of them were similarly stable, with a rmsd (root mean square deviation)
within a 0.3 nm range. Only one replica (marked in blue in Figure 3.6) contained peaks
exceeding 0.3 nm towards the end, but the profile is not dissimilar to the others.
Figure 3.6: Comparison of rmsd for the three replicas of the wild-type at 310 K:
replica 1 is in red, replica 2 in green and replica 3 in blue.
An observation of the trajectories reveals that all the domains are stable and only the
loop regions are active in a constant rearrangement. The protein maintains its compact-
ness with only the external α+β 3-layer(aba) sandwich domains slightly oscillating on
their axes. This is made visible also by the radius of gyration which oscillates between
3.6 nm (which is the value calculated for the initial PDB structure used) and 3.7 nm.
The movements observed at this stage are very similar to the ones outlined with elNe´mo
(Section 3.4.1) and are described by a mechanism of opening and closing. The overall
stability is confirmed also by the root mean square fluctuation (rmsf) analysis (Fig-
ure 3.7), in which it is possible to have an indication of the single fluctuation of the
residues over time.
In all the replicas, the residue fluctuations are generally below 0.2 nm, with very few
peaks exceeding this value. Analysing these profiles, it was possible to locate a pattern of
fluctuation, that is seen and maintained in almost all the simulations of both wild-type
and mutants. This pattern consists of two groups of residues with rmsf values above the
average. The first group includes the N-terminus region between residue A71, for which
the rmsf begins to grow and residue Q133, for which the rmsf drops to zero. The sec-
ond group includes several other residues, scattered along the entire sequence, for which
the rmsf has peaks as high as, or higher than, the N-terminal region described before
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Figure 3.7: Rmsf profile of one of the replicas of the wild-type at 310 K. At the
bottom, the binding sites are coloured in red and blue (respectively co-enzyme and
substrate), while the regions of higher fluctuation are in green.
(A71-Q133). These residues are: R175, R246, D282, the region spanning from N311 to
P329, I380 and K432 (Figure 3.8), and are highlighted in green below the rmsf graphs
(e.g. Figure 3.7). It is particularly interesting to note that the N311-P329 portion is
home to a short three-residue helix which links the central β domain to the α helix of
the α+β 2-layer sandwich domain that constitutes the back of the dimerisation interface
(Figure 3.8 in red).
Figure 3.8: The residues that present the highest fluctuations are represented in blue.
The helix delimited by residues N311 and P329 is coloured in red.
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Principal Components Analysis (PCA) helped determine the motions which contribute
the most to the dynamics of the protein. All the replicas present movements compatible
with the ones already detected by elNe´mo (Section 3.4.1), in particular the opening and
closing over the central β hinge of the two external globular domains (Figure 3.4), which
was described earlier. This mechanism may permit or deny access to the binding site;
when the domains are close together the glucose can neither bind to, nor escape from,
the active site, while a relaxation of the structure may allow its uptake. With the PCA,
it is also possible to combine the eigenvectors that account for most of the movements,
in order to obtain a profile of the potential energy surface (PES) explored during the
simulation (Figure 3.9). The dynamics were able to sample more than one point of min-
imum energy, and a comparison between the PES and the rmsd profiles can account for
the difference in rmsd seen in the three replicas. The more energetic replicas explored
two clearly distinct points of minimum energy, while in the other replicas, there was not
enough energy to climb the saddle point between the two minima. A sudden change in
rmsd, seen after the first 100 ns, may correspond to the moment in which the system
shifted from a lower energy structure to a slightly more energetic conformation.
Figure 3.9: The first two eigenvectors are projected together to define the PES of
one of the most energetic dynamics. The dynamics overall explored two well defined
minimum.
Of a total of 960 residues, more than 700 retain their initial secondary structure during
the simulations. The α helices are the most abundant, with β-bridges (longer hydrogen
bonds) and β-sheets following. It is crucial that, at this stage, there is no interconversion
between secondary structures, i.e. a residue in a helix stays in a helix.
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Figure 3.10: The count of the number of residues for each secondary structure type of
the first replica indicates that the residues maintained their assigned secondary struc-
ture for the entire simulation.
3.4.3 Raising the temperature: Wild-type at 500 K (226◦C)
The goal of an MD experiment is to explore the PES of a molecule to look for structures
which have low values of potential energy and are therefore considered stable. At low
temperature, it may happen that the dynamics gets stuck around one of these points
and keeps sampling the same region. To overcome this limitation and to extend the
sampling, it is common practice to increase the temperature to boost the energy of the
system. The dynamics will then have enough energy to overcome saddle points and
escape from points of minimum energy.
The G6PD wild-type was studied at 500K with three different replicas: two of 200 ns
and one of 179 ns. The latter simulation failed before reaching 200 ns and is represen-
tative of the great instability in such conditions. At this temperature, it is difficult to
distinguish random motions from important ones. In fact the rmsd comparison (Fig-
ure 3.11) shows how the structure changes constantly from the beginning to the end of
the simulation, reaching a probable plateau near the end of the simulations, probably
owing to the collapse of the structure on its own centre of mass.
Correlated with the rmsd, the radius of gyration dramatically decreases to reach a value
of 3 nm (Figure 3.12). Contrary to the previous simulations, here the rmsf profiles jump
to extreme values of over 1.5 nm, as a result of the Rossmann-like domain and the re-
gions of higher fluctuations being highly exposed.
At high temperature, the number of residues which retain a defined structure drops
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Figure 3.11: Comparison of the constantly growing rmsd for the three replicas at 500
K: Replica 1 is in red, replica 2 in green and replica 3 in blue.
(a) (b)
Figure 3.12: (a) The radius of gyration of all the replicas drops dramatically during
the dynamics. (b) The great fluctuations of the residues at the N-terminus observable
through the rmsf profile of one replica of the wild-type at 500 K.
from 600 to 400 (Figure 3.13). A deeper analysis suggests that most of the lost struc-
ture comes from conversion to coils mostly from α helices and only partially from other
structures. There is a slight decrease in β sheet composition, but these regions tend to
be stable for the whole simulation, maybe because the inward collapse of the structure
protects these regions from unfolding.
The α-coil conversion is confirmed by the visual inspection of the trajectories that in-
dicate that the long and stable β sheet constitutes the central axis for the movements.
The N-terminus tends to move inwards, toward the centre of the protein, resulting in
a very compact final structure, where access to both the G6P and Co-enzyme sites is
obstructed (Figure 3.14). When the first two principal components are plotted together
(Figure 3.13b), it appears clear that the system is far from reaching convergence. These
simulations were important because they suggested that, if an unfolding event occurs,
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(a) (b)
Figure 3.13: (a) Secondary structure evolution of one of the replicas at 500 K. (b)
PES profile, obtained by combination of the first two principal components.
it may cause the collapse of the G6PD structure rather than its explosion. With this in
mind, the simulation box in the following simulations was reduced in size. A smaller box
brings a slight increase in performance owing to a smaller number of solvent atoms in
the system. At the end of the analyses, it was clear that 500 K was too high for G6PD
to maintain its structure, and it was decided to try a temperature that was between 310
and 500 K. The hope was to find a temperature low enough to keep the system stable,
but high enough to see important structural modifications resulting from the mutation
clearly. To avoid the risk of choosing another temperature that would prove to be too
high, it was decided to stay closer to 310 K and 400 K was selected.
Figure 3.14: Misfolded structure of the wild-type (red) compared with the folded one
(gray).
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3.4.4 Wild-type at 400 K (126◦C)
Initially two 200 ns long replicas were performed, one of which was extended to 1 µs
(1000 ns). This section will mainly describe the behaviour of the longer replica, describ-
ing the second one only when the two behaviours greatly diverge. Similarly to what
happened at lower temperature, the simulation conditions did not present unusual fluc-
tuations, indicating that the simulation was stable. As expected, the potential energy
oscillates around -1.99 ×106 kJ/mol and the system density is around 906 kg/m3, re-
spectively higher and lower than the wild-type at 310 K and 500 K (Table C.1). The
protein looks stable in its rmsd, drifting only 0.4 nm from the initial conformation (Fig-
ure 3.15a). The rmsd starts at 0.3 nm and slowly reaches 0.4 nm by the end of the
simulation with only two brief peaks over 0.5 ns after 400 and 500 ns respectively.
(a) (b)
Figure 3.15: During the 1µs trajectory at 400 K , both (a) rmsd and (b) radius of
gyration indicate that there are no changes in fold for the wild-type.
For most of the simulation, the radius of gyration oscillates around a constant value
of 3.72/3.73 nm. 670 ns into the simulation, the radius of gyration suddenly drops to
3.65 nm for 110 ns. The protein rapidly regains its fold and maintains it for the last
100 ns (Figure 3.15b). In Figure 3.16, the structures taken at different moments of the
trajectory are superimposed. From the figure it is possible to see how the Rossmann-like
domain bends slightly towards the centre with a movement similar to that described in
Sections 3.4.1 and 3.4.2. In addition, the unstructured residues from A300 to R330 are
free to move, affecting the radius of gyration calculation.
The rmsf does not differ very much from the ones previously described, and only few
residues had peaks above 0.25 nm. Overall the simulations show a stable first half of
simulation and a more dynamic second half.
Even though the tendency of the α helices to unfold in favour of coil is present (Fig-
ure 3.17), the conformational changes are only 0.3 nm, suggesting that differences are
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Figure 3.16: Superimposed structures at different moments of the trajectory, from
beginning (grey) to end (red). The structure corresponding to low radius of gyration
(670 ns) is coloured in light blue.
Figure 3.17: The total number of residues that has a defined structure drops during
the simulation, as a result of helices converting into coils.
mainly caused by the movements of the loops (Figure 3.16). Solvent Accessible Surface
area (SAS) analyses were performed on both the entire structure and the inside of the
binding sites (glucose, co-enzyme and structural NADPH+), in order to detect small
changes that are not able to disrupt the fold, but that could be strong enough to affect
the substrate binding. At 400 K, the protein presented a SAS area that was similar in
size to that found at room temperature (Table C.2). The total area (calculated with a
probe of 0.7 nm in radius, as explained in Section 3.3.5) was only 7 nm2 bigger, while
the difference was reduced to only 2 nm2 when the default probe, 0.14 nm in radius,
was used. This allowed the calculation of the area inside the binding site, which was
exposed to the solvent. The glucose binding sites had an average surface of 8.48 nm2, the
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Co-enzyme site of 14.47 nm2 and the structural NADP+ site of 12.82 nm2 (Table C.2).
The data collected so far indicated that 400 K is a temperature at which G6PD is
still stable, but it is also high enough to start detecting some signs of instability and
behaviour change. This suggests that 400 K could be the target temperature at which it
should be possible to show the destabilising effects of the mutants. To be sure of having
found the right temperature, a simulation where the temperature was raised by 50 K
was performed.
3.4.5 Wild-type at 450 K (176◦C)
When the temperature is raised by 50 K, the protein presents a behaviour very much
similar to the dynamics at higher temperature (500 K). The system density is already
200 kg/m3 lower dense than at 310 K and the potential energy has risen to -1.92 ×106
kJ/mol (Table C.2). Unlike to the β regions that are well defined, the α-helices of
the N-terminus of the Rossmann-like domain have already started to unfold during the
equilibration period. The rmsd reaches a plateau around 1.3 nm (Figure 3.18a), further
proof of the instability of the protein in these conditions.
(a) (b)
Figure 3.18: (a) Rmsd of the simulation at 450 K. (b) Secondary structure count of
the simulation at 450 K.
The central β-sheet region is always clearly visible, but it moved to a more compact
configuration, while the percentage of α helices drops by 50% (Figure 3.18b), with both
N-termini almost completely unfolded close to the end of the simulations (Figure 3.19).
The dynamics results in a structure that is flattened and more extended laterally com-
pared with the wild-type. In this configuration all the binding geometries are lost and
it is unlikely that the co-enzyme would bind and interact with the substrate. After the
simulation at 450 K, it was clear that also this temperature was too high for maintaining
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(a) (b)
Figure 3.19: G6PD structure at the beginning (a) and at the end (b) of the simulation
at 450 K.
G6PD stability, and 400 K was recognised as the closest value to the temperature that
causes G6PD to lose its stability. 400 K was then taken as the reference temperature
for all the future simulations.
3.4.6 Proline 172 cis-trans isomerisation
Proline 172 is the central residue of the conserved peptide EKPxG. This residue has a
key role in G6PD, because it allows the correct positioning of both the substrate and the
co-enzyme in their respective binding sites [81], by allowing Lys171 to interact with both
G6P, through its terminal amino group, and NADP+, through the carbonyl group. This
function was proposed to be the result of its cis-trans isomerisation (Figure 3.20), which
blocks the conserved EKP turn to restrict the access of the nicotinamide ring. Humans
tend to exhibit the trans form, but both forms have been found in G6PD structures. In
particular it seems that the cis-Pro172 has a more mobile co-enzyme binding site and
thus is found in the absence of the binding with it. The only G6PD variant known to
involve this residue (Volendam: P → S) exhibits class I phenotype and has the lowest
Km values than any other known variant [128].
The cis-trans isomerisation could be a real feature of G6PD or simply an artefact of the
crystal structure. In an attempt to answer this question, and to see the Pro172 isomeri-
sation, the values of the omega (ω) angle of the peptide bond between the proline and its
preceding residue (lysine) were monitored during the various dynamics simulations. As
described in Section 3.3, the wild-type structure was taken from a complex (PDB file:
2bhl) without the co-enzyme, where the Pro172 adopted a cis conformation (ω = 2.5◦).
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(a) (b)
Figure 3.20: Pro172 in both (a) cis and (b) trans configuration obtained from the
1qki PDB file. Pro172 is represented in yellow, and the other residues of the EKPxG
peptide are coloured in red.
At low temperatures (310 and 400 K), the omega angle remains around 0◦, with values
that oscillate by ± 20◦. Raising the temperature, it is possible to observe a gradual
increase in this range, up to the point at which the omega angles switched to the typical
values of a trans conformation (Figure 3.21).
(a) (b)
Figure 3.21: (a) The density distribution and (b) the values of the omega angle of
Pro172 in chain B for the dynamics of 500 K show the presence of both cis (ω around
0◦) and trans (ω around 180◦) conformation.
These results seem to confirm that the cis-trans isomerisation may occur in G6PD,
even if it was observed only at very high temperature (500 K). A study on peptide
bond isomerization at high temperature simulations [129], showed that all existing force
fields tend to allow spontaneous isomerisation of cis-trans conformations in temperatures
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higher than a specific value. For the AMBER force field, the threshold is 700 K [129].
The fact that Pro172 isomerised at 500 K (200 K lower than the threshold), and that
was the only proline in G6PD to do so, suggested that the cis-trans isomerisation of
Pro172 may be a real feature in G6PD, and that this feature could be important for the
correct functioning of G6PD.
3.4.7 Wild-type summary
Wild-type G6PD presents a structure in which the fold is destabilised only at high
temperature (above 450 K). The central β−α structure constitutes the core of the protein
working as a hinge, supporting the movement of the external domains. These movements
allow the opening and closing of the enzyme, facilitating the binding and interaction with
both the substrate and the co-enzyme. The movements of the domains are facilitated
by the presence of loops around each structure. This stability only breaks down at very
high temperature (500 K), and at an intermediate temperature (400 K) the enzyme
seems to retain its structure and features. The simulations at high temperatures helped
to identify the weakest part in the G6PD structure, the N-terminus of the Rossmann-like
domain and the helices.
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Figure 3.23: Diagram of the “NADP-binding Rossmann-like Domain” (CATH code:
3.40.50.720) obtained from PDBsum. The names of the helices and strands were added
following the naming system used in the G6PD database of mutations [101]
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Figure 3.24: Diagram of the “Dihydrodipicolinate Reductase; domain 2” domain
(CATH code: 3.30.360.10) obtained from PDBsum. The names of the helices and
strands were added following the naming system used in the G6PD database of muta-
tions [101]
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3.5 Mutant simulations
A total of 17 G6PD mutants were studied (Table 3.1), and their location on the G6PD
structure is shown in Figure 3.22. At the beginning of the project, for reproducibility
and to sample the energetic profile of the proteins better, two replicas per mutant were
started. Because the project had the aim of studying big conformational changes that
might be caused by the mutations, and because of the high computational cost of the
simulations, it was decided, for the last simulations and the mutants selected later in the
project, to focus on a single and longer replica per mutant. As a result, some mutants
have several shorter simulations while others have fewer and longer ones. To map the
different structural features onto the G6PD structure, the α helices and the β strands
were named using the lettering system represented in Figure 3.23 and Figure 3.24. Fol-
lowing the G6PD database of mutation [101], both the α helices and the β strands were
ordered alphabetically from the N- to the C-terminus, using lower case letters for the
helices (e.g. αf) and capital letters for the strands (e.g. βO). Some helices represented
in the diagrams are not named, and this is because of some discrepancies between the
representation given by PDBsum (from where the diagrams were taken) and the G6PD
database, which grouped several small helices into a longer one. For consistency, the
text follows the numbering scheme that was used in the G6PD database. Another con-
vention found in the text is the use of the prime symbol (′) to refer to mutant residues,
doing so, G204 and R204′ indicate the glycine in the wild-type and the arginine in the
mutant respectively. The mutants studied are not discussed individually and extensively
like the wild-type was, but are rather grouped and discussed depending upon of their
structural effects. Each section will focus on a different region of G6PD (the C-terminus,
the N-terminus and the enzyme core) and will present the different changes that were
detected with the dynamics at different conditions.
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3.6 Mutants affecting the C-terminus
G306R, G306S and A338E are mutants that were predicted to be damaging by SAAP-
pred, and had an ability of inducing an increase in instability of the protein C-terminus.
The instability is not dramatic to the extent of causing a global unfold of the region (or
the entire protein), nevertheless there are clear indications that the local effects caused
by the substitutions are influencing the C-terminal behaviour.
Figure 3.25: Location of the residues that mutated are capable of affecting the C-
terminal stability. Residue 306 (G306R and G306S) is in red and residue 338 (A338E)
in blue.
In G306R, a small non polar amino acid, glycine, at position 306 is replaced by a
large positively charged one, arginine. The substitution was indicated by SAAPpred
as damaging and the confidence of the result (0.8) was one of the highest among all
the mutations considered. The residue is located in the βH strand of the central α+β
2-layer sandwich domain (Figure 3.25 in red) and when the large and charged arginine
is inserted by mutmodel using the MPP protocol, it causes clashes with energy in the
order of 1863.30 kcal/mol. Following the SAAPdap data, the mutation should result
in an introduction of a charged hydrophilic residue in a conserved position of the core
of the protein. There is no evidence of individuals with this specific mutation, but the
substitution of a serine in the same position (G306S) leads to the “class II” variant
originated in China and called “Seoul” [130]. Contrary to G306R, G306S introduces a
mild clash (only 38.96 kcal/mol) only detected by SAAPdap in chain B of the PDB file
used in the simulations. The damaging effects of the serine substitution should come
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from the replacement of a mildly hydrophobic and conserved residue with a hydrophilic
one. Even though the confidence for G306S of being damaging was much lower than for
G306R (0.45 vs 0.8), it represented an good example of a mutation with a real effect on
G6PD activity.
The structural effects of both mutations were similar, but more evident and enhanced
in G306R. From a visual inspection of the trajectories it was not possible to detect
any significant change in fold compared with the wild-type. In G306R, the arginine
was oriented in a way that the hydrophilic side chain faced the solvent and because of
the restricted space in the β sheet, it clashed with the isoleucine (I480) in the parallel
strand (βO). The main effect of this interaction was the shortening of the βO strand
itself (Figure 3.26b). In G306S, the serine side chain cannot connect the two strands,
nevertheless the βH strand, where the mutation sits, shrank to half the initial length,
eventually coming back to its normal length. The same happened to the opposite strand
(βO), but here the strand was entirely converted into coil before refolding again. When
the temperature was increased (400 K), the C-terminus of G306R was unfolding more
quickly than the wild-type. After 1µs, the βO strand of the wild-type containing the
isoleucine (I480) was shortened compared with the initial structure, but was still present.
In the mutant, that same region was, after 500 ns, already a coil. Similarly, βH was
shorter in the mutant while in the wild-type its length was maintained during the entire
simulation.
(a) (b)
Figure 3.26: Close view of the effect of R306 to the βO and βH strands. In (a) the
wild-type, there is no contact between the two strand, while (b) in G306R, the arginine
overlap I480 causing βO to shrink significantly.
The arginine in G306R seemed to have the capability of changing the exposure to the
solvent of some residues in the area. Unlike the glycine of the wild-type, R306′ can now
mildly interact with the solvent (Figure 3.27b), causing R487 to double its exposure
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(from 0.64 to 1.37 nm2) and I480 to jump from 0.53 to almost 1 nm2 (Figure 3.28b).
The changes in SAS values is particularly marked in the dynamics at 400 K, where
residues close to the mutation site (P312, A313 and E315) are two to three times less
exposed to the solvent than the wild-type. These new rearrangements and interactions
cause a 4% increase in the total potential energy compare with the wild-type (Table
C.4).
(a) (b)
Figure 3.27: Average solvent accessibility area for the residues in the neighbourhood
of residue 306 (dotted red line), for (a) the wild-type and (b) G306R dynamics. The
different patterns in the two profiles indicates that the presence of R306′ is changing
how the solvent interact with the residues in the area.
(a) (b)
Figure 3.28: Average solvent accessibility area for the residues in the neighbourhood
of residue 480 (dotted red line), for (a) the wild-type and (b) G306R dynamics. The
different patterns in the two profiles indicates that the presence of R306′ is changing
how the solvent interact with the residues in the area.
In both mutants the structural NADPH+ binding site had its accessible area reduced
during the simulation (Figure 3.29b in orange). This appears to be the result of the
higher mobility of the final part of the C-terminus that, instead of facing the outside,
was found lying inside the binding site, reducing its size. Apart from the mutant site
discussed above, another observable change involved the helix between residues G247 and
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(a) (b)
Figure 3.29: SAS areas of G6PD binding sites of (a) the wild-type and (b) G306S
during the dynamics. The G6P site is in red, with the co-enzyme in blue and the
structural site in orange.
F253 (αi) that unfolds by the end of the simulations. Even though the unfolding seems
to happen at a slower rate in the wild-type, this region is not close to the mutation site
and it was seen unfolding and refolding in other simulations. This suggests that a direct
involvement of the mutations is unlikely, but it is possible to assume that the unfolding
of the C-terminal region could have increased its stability. The rest of the residues did
not present any other different or unusual behaviours compared with the wild-type. It
is interesting to notice how the region from N311 to R330, that was recorded as a region
of high fluctuation in the wild-type, did not move more than the wild-type. The high
fluctuation of the region may have masked any other effects caused by R306′.
The dynamics of both G306R and G306S indicates that the mutations are not capable
of completely unfolding G6PD in physiological conditions. Nevertheless an increase in
instability in the region surrounding the mutations was observed. In R306′ , the arginine
side chain does not have enough space to relax and it forces the surrounding residues
(e.g. I480) to acquire different conformations, inducing a premature unfolding of the
surrounding β strands. Because the C-terminus of G6PD is involved in interactions
with the structural NADPH+, the increase in instability caused by R306′ could weaken
the affinity with the structural NADPH+, eventually affecting the dimer stability. Unlike
R306′-I480 in G306R, S306′ does not interact with any residues in the nearby strand
resulting in a C-terminus that is less affected by the mutation destabilising effect than
G306R. Also in G306S, βO shortened during the dynamics, but contrary to G306R, it
eventually refolded. This may be an indication of the fact that G306S is damaging,
but the damage is not strong enough to maintain the strand unfolding. The fact that
G306S is a class II variant and its position close to the structural NADPH+ binding
site, may indicate that the disturbance caused by G306S may not be enough to destroy
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G6PD structure, but is enough to trigger a series of interactions that eventually lead to
a class II variant. When a more damaging mutation (G306R) is involved, similar, but
heightened effects are observed.
Analogously to G306R the glutamate in A338E (Figure 3.25 blue) causes the βH and
βI strands to separate until the N-terminal segment of βH (T336 and F337) eventually
unfolds (Figure 3.30b). In the wild-type, A338 is deep in the core of the enzyme, shielded
from any contacts with the solvent. Instead, in A338E, the rearrangements of the area
around the mutation expose E338′ to the surface.
(a) (b)
Figure 3.30: (a) In A338E, the initial part of βH unfolds under the effects of the
glutamate (red) in the adjacent strand. (b) The wild-type is presented as a reference.
The size of the structural NADP+ (Figure 3.31b) noticeably increases compared with
the wild-type (Figure 3.31a). This difference is only 1 nm2 if calculated as the average
size value over the trajectory, but contrary to the wild-type, in which the size decreases
to values of 10 nm2 at the end of the simulation, in A338E the same area grew to values
oscillating around 15 nm2 (Table C.4). It is probable that E338′ is involved in this
behaviour.
(a) (b)
Figure 3.31: SAS areas of G6PD binding sites of (a) the wild-type and (b) A338E
taken over the entire trajectories. The G6P site is in red, with the co-enzyme in blue
and the structural site in orange.
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3.7 Mutants affecting the N-terminus
Similarly to what happened in the C-terminus, when a damaging mutation occurs in
the N-terminus of G6PD, very local effects connected to region instability are generated.
Among the mutants studied, Y70H, R136C and A− are representative examples of the
damage caused. The distortions to the N-terminus can be grouped into mutants affecting
the top helices of the Rossmann-like domain and mutants destabilising the co-enzyme
binding site. The A− mutant (Figure 3.32 in blue) belongs to the first group, while
Y70H (Figure 3.32 in red) and R136C (Figure 3.32 in yellow) to the second.
Figure 3.32: Location of the residues that mutated are capable of affecting the N-
terminal stability. A− is in blue, Y70H in red, L140P in orange and R136C is in
yellow.
The A− mutation is one of the few multiple missense G6PD variants. The combination
of V68M and N126D results in a class II mutant [131]. This G6PD variant probably
originated from the non-deficient single-mutant A variant, which only has the substitu-
tion of the valine (V68M). Even though SAAPdap found no significant local structural
effects, and only one of the mutations (V68M) that constitute this variant was indi-
vidually predicted as damaging by SAAPpred with a very low confidence (0.02), A− is
considered of great importance because it is one of the most common variants in African,
or African ancestry, populations [132]. Previous studies suggested that the depressed
activity of A− is probably caused by interactions between the two mutated residues,
leading to an increase in hydrophobic area exposed to the solvent [133]. The mutant
does not have different affinity for G6P, but a lower affinity for NADP was observed in
A− , compared with the wild-type [132].
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The dynamics show that D126′ destabilised αc, which unfolds when M68′ is oriented
in a way that its side chain points to αc. The βB strand, which is where M68′ is
located, is stable when αc unfolds and unstable when αc is folded (Figure 3.33). These
conformational changes indicates that, unlike the other mutants studied, in the case
of A− it may be possible to detect a clear structural effect of the mutation on the
Rossmann-like domain of the enzyme. Even though the mechanism of action is not very
clear, this study was also capable of confirming the propensity of A− to favour β-sheet
structures as proposed in a previous study [133]. When the M68′ side chain points to
D126′ (Figure 3.33a), helix αc unfolds and there is a clear change in exposure to the
solvent in the area. When the M68′ side chain sits parallel to the β strand of which it is
part (βB), αc maintains its conformation and it is βB which unfolds (Figure 3.33b). In
both cases, M68′ was always in the core of the domain, protected from any interactions
with the solvent. This reciprocal movement involved only the residues close to the
mutations, as the rest of the region did not considerably diverge from the wild-type.
(a) (b)
Figure 3.33: Relationship between αc (blue) and βB (orange) in A− dynamics. (a)
When the M68′ side chain points to the αc helix, αc unfolds, while (b) when the M68′
side chain sits parallel to the βB strand, αc refolds and βB unfolds.
Contrary to A− , the mutations Y70H and R136C distort the co-enzyme binding site.
Mutant Y70H occurs in the βB strand, in between two other mutations studied: L140P
and A− . In terms of steric effects, a histidine is not dramatically different from a
tyrosine, but because of the charged side chain, SAAPdap indicates the burial of a
charged hydrophilic residue in the core of the protein and the disruption of hydrogen
bonds as possible local structural effects. Y70H, which was predicted by SAAPpred as
being damaging with a confidence of 0.67, is a class II G6PD variant called Namouru,
which was first reported in the small group of Pacific islands of Vanuatu [134]. Also
R136C is a class II variant (Valladolid), and it is characterised by normal heat and
Chapter 3. All-atom simulations 80
kinetic properties [135]. Zara et al. [135] suggest that the low RBCs residual activity
may be the result of the reduced affinity for the enzyme substrate. The native residue,
R136, sits in a cleft inside the Rossmann-like domain and forms hydrogen bonds with
the surrounding residues, in particular with the backbone of G131. SAAPdap indicates
the disruptions of hydrogen bonds and the removal of the charge as possible local effects.
The replacement with the cysteine breaks these bonds, causing further instability in the
region. R136C was predicted to be damaging by SAAPpred with a confidence score of
0.45. Contrary to the arginine, C136′ cannot be involved in any hydrogen bonds and
all the arginine bonds with any αc residues (backbone of G131 and N122) or the side
chain of C158, located in the loop between αd and βE, were lost. The mutation of
C158Y is also a class II variant, called Shenzen. Because C158Y was found capable of
affecting the co-enzyme binding stability, it is possible that interactions of C136′ with
C158 could produce a similar effect. The two residues are too far from each other (6A˚
measured with PyMOL) to create a disulphide bridge. Both mutants cause the partial
unravelling of helix αe (L177-L190) but with different mechanism and effects. In the
wild-type, the arginine (R136) side chain is involved in hydrogen bonds that stabilise
the adjacent αc helix. In R136C, these bonds are not maintained and helix αe is free to
enter and distort the co-enzyme binding site when it unfolds. This happened also in the
wild-type after almost 300 ns, but in R136C, the unravelling happened after only 100ns.
The helix eventually refolded, but it was enough to have an effect on both size and
geometry of the co-enzyme binding site. The fact that the unravelling is quicker than all
three wild-type replicas indicates that this could be a significant effect of C136′. When
helix αe unfolded, the structured parts of the helix moved toward the centre of the co-
enzyme binding site. The cis conformation of Pro172 restricted the movement and forced
these residues onto the outside, resulting in a more compact and disordered binding site
(Figure 3.34b). In accordance with what was observed by Zara et al., the distortion may
be big enough to change the co-enzyme affinity in the mutant. In Y70H the resulting
co-enzyme is bigger than the wild-type. The mutation increases the motility of the
exposed helices constituting the N-terminal Rossmann-like domain eventually allowing
some water molecules to enter the mutant core (Figure 3.35a). Residue H70′ had a small
increase in area exposed to the solvent (calculated as the mean over the trajectory),
suggesting that H70′ was exposed in some frames of the trajectory, but for most of
them, it kept its position buried in the protein core (Figure 3.35b). The movements
of the N-terminus destabilises the helix αd even more, such that it eventually unfolds,
speeding up the distortion of the co-enzyme binding site. However, the exact mechanism
by which H70′ causes this chain of events was difficult to detect.
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(a) (b)
Figure 3.34: Change in the geometry of the co-enzyme binding site in two replicas
of R136C. The residues that binds the NADP in the wild-type are coloured in yellow,
while the same residues are coloured in red to outline the different positions that is
found in R136C.
(a) (b)
Figure 3.35: (a) H70′ interacting with a molecule of water during the dynamics. (b)
The location of H70′ (red) buried inside the ‘NAD(P)-binding Rossmann-like’ domain
of Y70H.
(a) (b)
Figure 3.36: Deformation of the co-enzyme binding site in Y70H (a) compared with
(b) the wild-type.
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3.8 Mutants affecting the core
Figure 3.37: Location of the residues that mutated are capable of affecting the core
stability. G204R is in blue, A461T in red, R227Q in orange, L264R in yellow and
C269Y is in pink.
Similar to G306R, the SAAPdap analysis suggests that the presence of R204′ introduces,
in G204R (Figure 3.37 blue), a charged hydrophilic residue in the core of the protein,
with clashes in the order of 419.62 kcal/mol. The mutation site is in a small helix,
spanning four residues, three of which (His 201, Tyr 202 and Lys 205) are involved in
hydrogen bonding with the substrate. As a consequence the mutation, not only dam-
ages the structure by introducing a large charged residue, but it also directly affects
the binding with the substrate. SAAPpred predicted G204R to be damaging with a
confidence of 0.8. In the crystal structure of the wild type (PDB code 2bhl), G6P was
bound to the protein and in both chains the region H201-H205 was folded into a helix.
During the simulation, it was observed that for both the wild-type and G204R, the small
helices tended to alternate between folded and unfolded states. Because the simulations
were performed in the absence of G6P bound to the chains, it may be that G6P binding
stabilises the helix, and that its absence may increase the disorder of the area, allowing
the short helix to unfold/fold. The arginine side chain is much larger than the glycine
one, but the arginine side chain is capable of positioning in a cleft above the residue.
In this position, during the simulation, the nitrogens of its side chain are capable of
interacting with the residues of the surrounding helices: R439, D443, E206 and Q209
(Figure 3.38b).
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(a) (b)
Figure 3.38: In yellow are represented all the (a) polar contacts in which G204 is
involved in the wild-type, and (b) that of the R204′ side-chain in G204R. R204′ interacts
with the surrounding residues (R439, D443, E206 and Q209) reducing the motility of
the region.
In this position, R204′ can now interact with the solvent, forcing the rearrangement of
the surrounding residues with D200, which was forced to a different position, resulting
in a decrease in solvent accessible area (Figure 3.39b). A similar decrease happened for
the residues interacting with the arginine side chain: R439, D443, E206 and Q209.
(a) (b)
Figure 3.39: Average solvent accessibility area for the residues in the neighbourhood
of residue D200 (dotted red line) for the (a) the wild-type and (b) G204R dynamics.
The different patterns in the two profiles indicates that the presence of R204′ is changing
how the solvent interacts with the residues in the area.
These interactions were always present during the simulations, suggesting that they
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might act as constraints to the arginine movement, resulting in an helix with less ca-
pability of folding/unfolding. In Bautista et al [82] it was observed that, in the G6PD
variants involving K205 (K205T and K205R), the mutation causes a severe drop in kkat,
without affecting the Km, suggesting that K205 is dispensable for substrate binding,
but essential for catalysis. G204R may act in a similar manner: the stiffened helix does
not cause any major structural disruptions, but it changes and maintains a different
geometry inside the binding site.
Another damaging mechanism affecting the core is represented by the distortion of the
αi helix which form the supporting base of the G6P binding site. The mutant A461T is a
G6PD variant which was first isolated in individuals from the Yunnan chinese province.
Xiaoquin et al. [136] limited themselves to the detection of the mutation, without provid-
ing any enzymatic or structural information. In the pool of people that was studied, the
authors found a mixture of other variants common in China, allowing them to suggest
similarities with both the Canton and Kaiping variants (both class II). In the refer-
ence database of G6PD variants [101], A461T was classified as “NR” (non reported).
Residue 461 is contained in the central section of the long αn helix on the back of G6PD
(Figure 3.37 in red) and, contrary to the alanine, the threonine (T461′) can interact
with the glutamine (Q261) in the adjacent αi helix (Figure 3.40a). Helix αi spans 17
residues from I255 to A272 and constitutes the supporting base of the G6P binding site
(Figure 3.40b). During binding, helix αi is ordered and D258 and H263 interact with
G6P,while in absence of it, the last section of αi is less ordered and disruptions in the
helix was observed several times in other simulations. The threonine could interfere with
this mechanism, affecting the way the binding site overall behaves.
(a) (b)
Figure 3.40: (a) Bulge on the αi helix caused by Q261 (yellow) interacting with
T461′ (red). The dotted lines are the polar contacts of T461′ as detected by PyMOL.
(b) Close up view of helix αi (red). The residues binding G6P are coloured in blue,
while Q261 is in yellow.
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The distortion of the base is increased in L264R, which was capable of dramatically
reducing the size of the G6P binding site. This was possible because L264 is a central
residue in helix αi that constitutes the base of the G6P binding site. When the leucine
was replaced by the arginine, αi broke into two independent pieces (Figure 3.41b). The
first ten residues (I255-H263) of helix αi deformed quite often in previous simulations,
but L264R was the first mutant in which there is a clear separation of the two segments
of the helix.
(a) (b)
Figure 3.41: Representation of the αi helix as found in L264R (a) at the beginning
and (b) at the end of the dynamics. The wild-type structure is superimposed in grey.
A particular case is represented by the class II variant known as ‘Mexico City’ (R227Q) [137],
in which the effects of Q227′ can travel from the surface of the protein to its core, di-
rectly affecting G6P binding. The mutation is in the loop (P223-A231) that connects
together the βG strand of the central β region with the αg helix that precedes the triad
of residues that binds G6P (H201, H202 and K205). Q227′ forces a change in position of
the residues forming a patch around the mutation. The surface residues are connected
by a sequence of residues that reaches the core of the protein before going back to the
mutation site (Figure 3.42a). The movements induced by Q227′ are capable of travelling
from the surface to the core and misalign two important binding residues: K360 and
R365.
During the dynamics it was observed that Q227′ is surrounded by six residues (N226,
D228, E347, D350, V352 and H374) forming a patch of residues similarly exposed to
the solvent. Among these residues, all but D350, which saw its exposed area growing
by half, did not change significantly the way they interacted with the solvent. Even
though these changes may not in themselves explain the damaging effects of R227Q,
they describe very well a mechanism that could explain how the damage is propagated
throughout the G6PD structure. The difference in side chain between the arginine and
the glutamine forces the surrounding residues to redistribute around Q227′. On the sur-
face, the residues forming a part of the patch surrounding Q227′ (E347, D350 and V352)
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(a) (b)
Figure 3.42: (a) Representation of the residues surrounding Q227′ (red). In yellow
are K360 and R365, which are part of the G6P binding site, and in blue all the residues
surrounding the mutation (N226, D228, E347, D350, V352 and H374). The sequence
of 20 residues that connects the G6P binding site to the surface of G6PD is in light
blue. (b) Surface view of R227Q. Q227′ is in red, with the residues surrounding the
mutation (N226, D228, E347, D350, V352 and H374) in blue. K360 and R365, the
residues binding G6P are in yellow, while in light blue are indicated the residues that
connect the surface patch and the G6P binding site.
are connected to H374, which completes the surface patch, by a sequence of 20 residue
(Figure 3.42). Among the 20 residues, two are known to bind G6P in its binding site:
K360 and R365 (Figure 3.42). The movements caused by the mutation can propagate,
through the sequence of 20 residue, to the binding site, orienting K360 and R365 side
chains in a non-optimal position for G6P binding. Evidence of this mechanism is that
during the dynamics of R227Q, R365 is less exposed to the solvent than in the wild-
type. If what is proposed is true, it could explain why R227Q is a class III variant and
R227L (a larger difference from arginine) is a class II variant. In R227L, the hydrophobic
leucine is forced away from the surface causing larger structural rearrangements in the
area.
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3.9 Mutants with additional behaviours
Figure 3.43: Location of the residues that differ from the mutants described in the
previous sections. G359R is in blue, L137P in red, E287K in orange, R370W is in yellow
and C232Y is in pink.
Some mutants were initially selected for the study, but it was not possible to collect more
than a single trajectory and they were discontinued. The reasons vary from mutants
that did not present differences from the wild-type dynamics (L137P or E287K), mutants
for which it was not possible to explore the damaging mechanism further (C232Y, see
below) and finally mutations that were selected for study towards the end of the project
when time was limited (G359R and R370W). This section contains a brief description
of their trajectories and their possible mechanisms of action.
Mutant C232Y has a tyrosine replacing a cysteine at the beginning of the βG strand. It
causes a severe decrease in G6PD activity (class I), thermal instability, low affinity for
NADPH and product inhibition by NADPH itself [138]. SAAPdap indicates that the
tyrosine side chain causes clashes ranging from 126.12 to 2130.24 kcal/mol, and C232Y
was predicted as damaging by SAAPpred with a confidence of 0.49. During the single
150 ns trajectory, it was noted that the tyrosine of C232Y was interacting with V499
(Figure 3.44a). V499 is both the end of the αl helix and the beginning of a long loop
that reaches the end of the G6PD sequence. This long loop allows NADP+ to enter the
structural NADP+ binding site and stabilises its stay by providing three binding residues
(Figure 3.44b). It is possible that, in C232Y, the tyrosine could cause the low affinity
by reducing the mobility of the long loop in the C-terminus, resulting in an inaccessible
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NADPH structural site. Even though C232Y presented an interesting mechanism, the
truncated structure (see Section 3.3) did not allow to study the changes in stability of
the C-terminal loop, and the study of this mutant was halted.
(a) (b)
Figure 3.44: (a) The Tyrosine interacting with V499 in the adjacent helix. (b) The
NADPH binds to the the non truncated wild-type (2bh9.pdb). The long loop at the
end of G6PD is coloured in orange, while Y232’ is in red.
G359R is another unknown variant in which a glycine is replaced by an arginine. Similar
to both G204R and G306R, G359R has a high confidence of being damaging (0.79 as
predicted by SAAPpred) and, in the 500 ns long trajectory at 400 K, it was possible
clearly to observe the damage caused by this mutation. The arginine side chain did not
have enough space to relax itself, causing all the surrounding structures to grow apart
and relocate. Eventually, the αo helix and the surrounding helices unfolded (Figure 3.45
in yellow), leaving only the β strands intact. Furthermore, the structural NADP+ bind-
ing site was found to be much bigger than the wild-type. In the wild-type, it ranged
between 12 and 15 nm2, while in G359R, it was constantly above 15 nm2 with peaks
of 20 nm2. Even though the arginine side chain is oriented away from the G6P binding
site, the effects of all the rearrangements caused the G6P binding site to shrink. The
shrinkage did not have the same magnitude as the expansion of the structural NADP+
binding site, nevertheless it was visible.
R370W is a G6PD variant not yet described in humans, and it occurs in a residue that
interact with the structural NADP+ to stabilise G6PD. In the wild-type, the R370 side
chain stays parallel to the βK strand, leaving the binding site free (Figure 3.46a). In
R370W, the tryptophan assumed a position in the middle of the binding site. This
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(a) (b)
Figure 3.45: Unfolding of the αo helix in G359R. (a) At the beginning and at the (b)
end of the dynamics. R359′ is in yellow.
movement made it close to Y503 on the opposite loop, causing the structural NADP+
binding site to reduce its size (Figure 3.46b).
(a) (b)
Figure 3.46: Representation of the area around residue 370, in red, as seen in (a) the
wt and in (b) R370W.
L137P and E287K are both mutants that did not show any sign of a different behaviour
compared to the wild-type (Figure 3.47 and Figure 3.48). L137P was predicted to be
damaging by SAAPpred with a confidence of 0.78 and introduces clashes at a site where
the backbone torsion angles could not accommodate a proline, while the introduction
of a lysine in E287K disrupts hydrogen bonds of a residue involved in binding and was
predicted to be damaging by SAAPpred with a lower confidence than L137P (0.69).
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(a) (b)
Figure 3.47: Representation of the area around residue 137, in red, as seen in (a)
the wt and at (b) the end of the dynamics of L137P. The proline has no effects on the
surrounding area.
(a) (b)
Figure 3.48: Representation of the area around residue 287, in red, as seen in (a) the
wt and at (b) the end of the dynamics of E287K. The lysine has no effects on the helix.
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3.10 A note on Pro172 in the mutants
Section 3.4.6 described the characteristics and behaviour of Pro172 during the dynamics
of the wild-type. In the simulations at temperatures below 500 K, Pro172 always stayed
in the cis conformation and trans values of the ω angle were recorded only at 500 K.
The mutants were not studied at 500 K, and there were no records of any cis-trans shift
in their dynamics.
During the analysis of G204R and Y70H, it was noted a feature of the V169-L176
loop, which could be evidence of the structural importance of Pro172. This observation
came after noticing that, during the dynamics, the αe and αd helices tend to invade
the co-enzyme binding site, resulting in its deformation. In Y70H for example, the
start of movement of the N-terminus coincides with the unfolding event of the αd helix
(Figure 3.49a). The absence of this helix allowed the αe helix to push forward towards
the co-enzyme binding site (Figure 3.49b), reducing the co-enzyme binding site area.
Because the start of movement of the N-terminus coincides with the unfolding event of
the αd helix (Figure 3.49b in red and blue) it is possible that the cis conformation of
P172 forces a twist in the V169-L176 loop, which was helping to keep the preceding
helix (D176-L190) away from the co-enzyme binding site. The absence of this helix
allowed the αe helix to push forward towards the co-enzyme binding site (Figure 3.49b),
distorting the co-enzyme binding site area (Figure 3.36). Possible cis-trans isomerisation
of Pro172 is further explored using metadynamics in Chapter 4.
(a) (b)
Figure 3.49: The role of Pro172 (black) in maintaining αe away from the co-enzyme
binding site. (a) αd in both folded (red) and unfolded (blue) conformations. (b) In the
absence of αd, αe (red and blue) moves inside the co-enzyme binding site.
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3.11 Discussion
Table 3.3: The main mutants studied, together with a brief overview of their structural
effects observed during the simulations. N-term refers to the Rossmann-like domain,
where the co-enzyme binds, while C-term refers to the terminal region of the central
Reductase domain, where the structural NADP+ binds. G6P stands for the area around
the G6P binding site.
Mutant Class Location Effects
G306R - C-term premature unfolding of the C-term
G306S II C-term destabilising effects on the C-term
G204R - core/G6P restrains on the helix movements
L140P - N-term no noticeable effects
Y70H II N-term distorted co-enzyme binding site
C269Y I core/G6P no noticeable effects
A338E - C-term premature unfolding of the C-term
R227Q III surface change in SAS exposure around G6P
A461T NR G6P deformed helix in G6P
R136C - N-term distorted co-enzyme geometry
A− III N-term unfold/refold of the areas surrounding the mutations
L264R - G6P breakage of the helix at the base of G6P
Figure 3.50: The regions which were indicated by the dynamics as regions of high
fluctuation are coloured in orange (one chain only).
All the work presented in this chapter is based on the assumption that the depressed
activity registered in the G6PD variants is the result of specific structural changes in the
G6PD structure, which are shared among the mutants and are therefore detectable by a
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small set of antibodies. To test the truthfulness of the assumption, the likely structural
effects of G6PD mutations were studied first with the SAAPtools and then with extensive
MD simulations on a small subset of damaging (predicted and not) mutants. The study
of the effects of these mutations has proven to be challenging, mainly because of the
difficulty in collecting extensive simulation data and in the overall interpretation of the
results. The dimer of G6PD, with 958 residues and almost 8000 atoms, is considered
a large system to be studied with molecular dynamics. A single 500 ns trajectory can
take months of simulation time and, as a direct consequence, in several cases it was not
possible to study the same mutant with different independent simulations (replicas).
Furthermore the absence of abundant structural information on G6PD and its variants
made the choice of mutations to study and the extraction of results more difficult.
The core of this project was the structural analysis of G6PD variants to locate some
behaviours shared among them and not present in the wild-type. Extensive all-atom
MD simulations, had indicated that the mutations are not capable of causing severe
structural alteration to the protein structure. Instead, each case had its own small and
local rearrangements that sometimes made the connection between structural damage
and depressed activity phenotype possible (Table 3.3).
At the beginning it was thought that a high quantity of unstructured regions (coils,
loops and turns) in the protein may play a key role in maintaining G6PD function,
acting as “cushions” around the important structures, the coils could have been ca-
pable of absorbing the damaging effect of the mutations. The hypothesis that G6PD
had a significant amount of coils and loops, compared to other proteins, was tested
by comparing the percentage of unstructured regions found in G6PD over the protein
structures in the Protein Data Bank. Initially all resolved structures were considered,
but later the analysis was repeated only for dehydrogenase structures first and enzymes
known to be vital to sustain life then. To reduce the noise and refine the results (e.g.
partial structures, small peptides and accessory structure) the analysis was performed
only on the structural domains recognised by CATH [139]. The representative structure
(≤ 35 % sequence identity) for every homologous superfamily was selected, leaving out
NMR structures and proteins shorter than 30 amino acids. The secondary structure
information was then extracted and counted. The percentage of coils in the N-terminal
Rossmann-like domain is 19%, with 44% of alphas and 37% of betas. In the second
dihydrodipicolinate reductase domain, where G6P binds, the percentage of coils drops
to 11%, with 49% alphas and 39% betas.
Chapter 3. All-atom simulations 94
Figure 3.51: Distribution of the three different types of secondary structure of the
CATH structural domains. The averages of each group are shown on top of each
distribution. The x-axis is in logarithmic scale.
The alpha and beta distributions have long tails, so the nonparametric Mann-Whitney
test, which does not require normal distributions, was used to check if the percentage
of coils in G6PD was significantly less than or greater than the same value in another
sample (distribution of the CATH domains (Figure 3.51). The Rossmann-like domain
in G6PD has almost 3% more coils, contrary to the dihydrodipicolinate reductase do-
main that has 4% less. The Mann-Whitney test on the data suggests that G6PD may
have a significant difference in coils in both domains (p-value < 2.2×10−16), but it is
unlikely that a connection between the percentage of coils and protection against the
damaging effects of mutations really exists. In fact, 4% only represents 8 and 11 of the
residues that constitute the two G6PD domains respectively. In an attempt to show
any correlation between the SAAPpred performance and the WHO class classification
of G6PD variants, all the existing mutations were associated with their confidence of
being damaging obtained from SAAPpred. The resulting distributions (Figure 3.52)
indicate that SAAPpred is capable of correctly detecting the moderate to severe G6PD
mutations (class III and II), but the most of the class I mutations are not predicted as
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highly damaging. This outcome can be understood by looking at how the mutations
are distributed around the binding site of G6PD (Figure 3.53). The most of the class
III and II are located more than 10 A˚ away from any of the binding site, while class I
mutations tend to be closer to the binding sites (< 5 A˚).
Figure 3.52: Distribution of the SAAPpred confidence of the mutations associated
with known G6PD variants. The mutations that are existing variants, but were not
predicted damaging by SAAPpred (SNP) are on the left of the dotted line (only for
representation purposes their values were fixed to -0.01).
Figure 3.53: Distribution of the distances of the residues that are associated with
known variants from any of the binding site. The dotted line indicates the average
values of each class.
The intensity of the damage of a mutation could therefore correlate with its distance
from a binding sites. Mutations close to the binding sites are likely to be damaging
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because they alter the protein binding capability, rather than because of a serious struc-
tural damage. In contrast, for mutations far from a binding sites the nature of the
substitution (e.g. G to R rather than G to A) plays a more important role in defining
the resulting damage to the protein structure. Residue L128 for example, is far from
any binding site and causes a class II phenotype when mutated to an arginine (L128R),
and a class III when mutated to a proline (L128P). Several class I mutations are not
detected as damaging by SAAPpred because very subtle changes close to a binding site
can have a significant effect even though there is a minimal structural disruption. This
suggests the possibility of adding distance to a binding site residue as another parameter
in SAAPpred.
Overall the simulation data indicate that the mutations are relatively stable and more
than globally disrupting the enzyme structure, they seem to accentuate the dynamic na-
ture of G6PD, causing instability in the neighbouring areas. Mutant Y70H for instance,
is capable of inducing a premature unfolding of the N-terminus, eventually causing a
distortion in the co-enzyme binding site geometry. G204R increases the rigidity of the
G6P binding site, probably affecting the way G6PD rearrange itself around G6P, ulti-
mately affecting its binding. As a last example, the arginine found in G306R disrupts the
stability of the β sheet at the C-terminus, increasing the instability and binding capa-
bility at that terminal region. Because the ultimate goal of this project was the hunt for
shared modifications among mutants, it is not possible to state that an antibody-based
assay could be developed to detect mutations in G6PD. It is possible to generalise the
effects with similar outcomes (e.g. it destabilises the N-terminus), but apart from the
A− mutant, which presents a well defined structural alteration, all the other mutants
have very subtle and different local changes in the structure.
This outcome is perhaps not surprising. Most mutations predicted as damaging with the
highest confidence by SAAPpred have not been observed in people, presumably because
such mutations abolish activity completely and consequently are lethal. Most muta-
tions that cause depressed activity, and are observed in nature, tend to be predicted
by SAAPpred as damaging with a lower confidence. Because of the high importance of
G6PD activity, mutations that cause complete G6PD inactivity are lethal and therefore
not observed. Nevertheless, even these can be accommodated through minor structural
rearrangements despite the protein becoming inactive. To conclude, the depressed ac-
tivity observed in several G6PD variants is likely to be connected with the disruption of
key features, such as substrate binding and dimer stability, more than global or partial
unfolding of G6PD.
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This chapter demonstrated how the effects of the mutations act on a local scale and are
not capable of causing global unfolding of G6PD structure. Because all the simulations
done were in the order of nano-seconds, it was necessary to replicate and increase the
confidence of these results, to reach the micro-second time scale. In an attempt to observe
large scale movements and rearrangements, coarse-grained simulations were used and the
work done is presented in Chapter 5.
Chapter 4
Additional studies: metadynamics
Pro172 constitutes the central residue of the conserved EKPxG peptide involved in
NADP+ binding, and it has been found in both cis and trans conformations. It was
proposed that the cis-trans isomerisation of Pro172 plays a key role in the correct po-
sitioning of both G6P and NADP+ for the catalysis [73]. In Chapter 3 this mechanism
was monitored to determine the reality of its existence, and this chapter describes an
attempt at using metadynamics to obtain a better understanding of the role played by
Pro172 in substrate-co-enzyme interaction.
4.1 Metadynamics
Detailed all-atom MD simulations are computationally expensive. The potential energy
functions used are complex, allowing only small integration steps (fs) to be used to
capture the different motions in the systems. These factors limit the capacity of studying
some of the most important biological phenomena such as protein folding, molecular
recognition or structural transitions. Coarse-grained models (Chapter 5) are generally
capable of overcoming these limitations at the expense of detail. Sometimes the sample-
accuracy compromise is acceptable, but for cases where the atomistic description cannot
be replaced, metadynamics can be successfully used to observe events out of reach for
normal MD simulations (e.g. rare events) [140–142]. Metadynamics works by exploring
the properties of a system as a function of a finite number of collective variables (CVs),
which are geometric parameters that describe some chemically important process in the
system. Anything can be treated as CVs, but ideally the best CVs have clear different
states in the dynamics (e.g. initial, intermediate and final conformations) and should
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also normally be difficult to sample, meaning that they describe slow events. Examples
of CVs are atom pairs, distances, angles, dihedrals, number of contacts, hydrogen bonds,
and so on. In normal dynamics the low probability of spontaneously escaping a minimum
is the basis of the long time scale required to observe these rare events. The increased
sampling achieved by metadynamics is the result of the addition of Gaussian functions
to the potential of the selected CVs, that allows the filling of the potential well and the
consequent escape from the current minimum [143, 144] (Figure 4.1).
Figure 4.1: Schematic representation of the function mechanism of metadynamics.
Gaussian functions (yellow lines) are added to the potential energy. In time, enough
Gaussians will have filled the potential well and allowed the green ball to escape from
the current minimum to another (red ball). [145]
Generally the external potential added is modelled as:
VG(S(x), t) = ω
∑
t′=τG,2τG,...
exp(−(S(x)− s(t
′))2
2δs2 ) (4.1)
where s(t) = S(x(t)) is the value of the CV at time t, ω is the Gaussian height, δs is the
Gaussian width and τG is the frequency of Gaussian additions. If ω and δs are too large,
the PES will be explored quickly, but large errors will be present, while if these quan-
tities are too small, the calculation will be accurate but very slow. The time required
to escape a minimum also depends on the number of Gaussians that are added to the
system, and this number is proportional to ( 1δs)d where d is the number of CVs used. Be-
cause of this relationship, the choice of the CVs and the moments of the Gaussian must
be made carefully. Parallel tempering metadynamics (PTMetaD) [146] was the method
used in the project, and it differs from standard metadynamics in the fact that multiple
metadynamics replicas run in parallel at different temperatures. During the simulation,
exchanges of coordinates between adjacent replicas is attempted with frequency equal
to 1τx (with τx being the frequency of Gaussian addition). If the exchange is accepted,
the coordinates are swapped and the velocities rescaled. With PTMetaD, performance
of both parallel tempering and metadynamics are increased and higher energy regions
are explored.
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In MD simulations, the temperature (T ) plays a key role because it provides the system
with energy (see Section 2.3.2). By increasing the temperature of the simulation box,
the system acquires kinetic energy, increasing the possibility of escaping from the current
minima and sampling other conformational space. The functional biological structures
are stable at low potential energy, meaning that canonical MD at low temperatures tend
to get trapped in local point of minimum energy. However, keeping the temperature too
high is dangerous, as the conformations explored can be significantly different from the
biologically functional ones. One approach is to enhance the sampling of the confor-
mational space by running several independent replicas at different temperatures, and
periodically exchange the coordinates of the system among the replicas. This allow con-
formations with similar potential energy to sample, over time, conformations at different
temperatures, overcoming energy barriers more easily.
Figure 4.2: Schematic representation of the REMD run [147]. At certain intervals, the
conformations of two neighboring replicas are exchanged based on acceptance criterion.
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4.2 Metadynamics methodology
The software used was GROMACS with the PLUMED [148] plug-in being responsible
for the metadynamics calculations. PLUMED groups a set of routines that work on top
of MD software (e.g. GROMACS) and is designed to perform free-energy calculations as
a function of many CVs using different methodologies, such as metadynamics. Only the
wild-type was studied and two simulations of 16 and 6 temperatures were performed.
For both, the temperature range was obtained by increasing the initial temperature
(310 K) by 5 K, until the desired number of temperatures was obtained. The simulation
with 6 temperatures ran for 93 ns, while the other for only 13 ns. Exchanges between
temperatures were attempted every 500 steps (1 ps), and the same frequency was used
for the addition of Gaussians of height = 1 and sigma = 0.35 kJ/mol (0.084 kcal).
Because coordinates were exchanged, the resulting trajectories were continuous with
respect to the ensemble, but not with respect to the simulation time. To rebuild each
trajectory through the correct temperature space, the demux.pl script (included in the
GROMACS distribution) was used. The CVs studied were the two distances between
the Cβ of Pro172 and the centre of mass (CoM) of R72 and R365. The two arginines
constitute the farthest extremities of the G6P (R365) and the co-enzyme (R72) binding
sites, and their movement was considered as a good indication of the movement of both
the substrate and co-enzyme in relation to Pro172.
Figure 4.3: Representation of the distances used for the metadynamics calculation.
On the surface of G6PD, the G6P and co-enzyme binding sites are coloured in red
and blue respectively. At their far ends, R72 is coloured in light-blue, while R365 is
in salmon. The dotted lines describe the distances between these residues and Pro172
(yellow). The figure was prepared with PyMOL.
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4.3 Results
Before starting to describe the results, it must be said that the metadynamics simulations
were not successful as planned. First, the time required to run a PTMetaD experiment
was greatly underestimated. If a single MD simulation can make use of all the computer
resources allocated, in a PTMetaD experiments, these are shared between the several
replicas. On top of that, metadynamics calculations are performed at certain steps,
affecting performance even further. By way of example, the 13 ns simulation with
16 temperatures took almost three months before it was discontinued. Second, the
temperature interval (5 K) was too big to allow the correct exchange rate between
replicas. A more correct setting, for a system as big as G6PD, would have had more
than 150 replicas with temperature intervals in the order of 0.4 K. To perform such
a simulation was unrealistic because of both hardware and time requirements. These
two limitations were mainly the result of a combination of the size of the system and
inexperience in performing metadynamics simulations. Nevertheless it was possible to
obtain some data from the longest simulation.
(a) (b)
Figure 4.4: Diagram of the exchanges between replicas occurred in the metadynamics
simulations with (a) 6 and (b) 16 temperatures.
Figure 4.4a shows that only three exchanges occurred during the dynamics. The first
exchange happened after 13.7 ns between the low temperature replicas at 310 K and
315 K (Figure 4.4 in red and dark yellow), while the other two events involved the replicas
at the highest temperatures, 330 K and 335 K (Figure 4.4a in blue and magenta),
and happened after 12 and 58 ns respectively. The low exchange rate indicates that
instead of having a PTMetaD run, the experiment can be considered as six independent
metadynamics runs. When the dynamics were analysed, it was possible to recognise
three behavioural groups. In the first group, the dynamics did not escape the minimum
of energy and, as a consequence, the metadynamics did not fully explore the CVs’ space.
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In replica 1, for example, the global FES profile (Figure 4.5) shows only one single
potential well and, when the FES is estimated as a function of the CVs (Figure 4.6), it
appeared clear that the system was stuck in a minimum.
Figure 4.5: Example of single minima FES, obtained by 2d projection of the values
of CV1 (x-axis) over CV2 (y-axis) for replica 1.
(a) (b)
Figure 4.6: Example of single minima FES, obtained by 1d projection of the values
of (a) CV1 and (b) CV2 only, for replica 1. The x-axis describes distance values in nm
while on the y-axis the values in Kcal/mol indicates the depth of the potential well.
In the second group, the dynamics had enough energy to exit the initial minimum, but
it was not capable of fully sampling other minima (Figure 4.7). In replica3 for example,
both CVs reached saddle points (Figure 4.8a) without visiting any other minima. The
last group contains those dynamics runs that were capable of escaping from the potential
well and successfully sampled other minima (Figure 4.9). It is not surprising that this
group is composed of the higher temperature replicas: 330 and 335 K.
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Figure 4.7: Example of FES with multiple minima FES, obtained by 2d projection
of the values of CV1 (x-axis) over CV2 (y-axis) for replica 3.
(a) (b)
Figure 4.8: Example of single minima FES, obtained by 1d projection of the values
of (a) CV1 and (b) CV2 only, for replica 3. The x-axis describes distance values in nm
while on the y-axis the values in kcal/mol indicates the depth of the potential well.
Figure 4.9: Example of multiple minima FES, obtained by 2d projection of the values
of CV1 (x-axis) over CV2 (y-axis) for replica 5.
The proposed mechanism for Pro172 functioning is that by moving, it favours the in-
teraction of K171 with G6P through its terminal amino group and with the co-enzyme
through its carbonyl group [73]. To accomplish this role, it is fundamental for Pro172 to
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(a) (b)
Figure 4.10: Example of multiple minima FES, obtained by 1d projection of the
values of (a) CV1 and (b) CV2 only, for replica 5. The x-axis describes distance values
in nm while on the y-axis the values in kcal/mol indicates the depth of the potential
well.
oscillate from and towards both binding sites. The aim of the experiment was to monitor
the CVs over the trajectories to identify the values of the distances that describe distinct
energy-favourable conformations. Ideally, only two values (states) should exist: one that
represents the residues at their maximum and the other at their minimum distance from
Pro172. In the reference PDB file (2bhl), the centre of mass (CoM) of R72 and the CoM
Pro172 are 20.8 A˚ apart while the COM of R365 is 21.1 A˚ from the COM of Pro172
(Figure 4.11), suggesting that the expected values of the two states should be in the
neighbourhood of 21 A˚ (or 2.1 nm).
Figure 4.11: Measure of the value of the two CVs in the reference structure (PDB
file 2bhl).
The projections of the CVs along the trajectory of one replica (Figure 4.12) indicates
that while the values of CV1 only oscillated around a single state centred at 2.4 nm
(Figure 4.12a), CV2 had two well defined distances; one with oscillations centred at
2.5 nm and the other at 1.5 nm. In another case, the CVs’ projections only assumed
one distance state each (Figure 4.13). The overscale (5 or 6 nm) peaks that are found in
some replicas, suggested that the dynamics were close to overtaking some saddle point,
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but the energy of the new state was too high and therefore could not be maintained.
(a) (b)
Figure 4.12: Projection of (a) CV1 and (b) CV2 over time for replica 1.
(a) (b)
Figure 4.13: Projection of (a) CV1 and (b) CV2 over time for replica 3.
In the most energetic replica (replica6), it was possible to notice how the decrease of
one distance (Figure 4.14a) was balanced by the increase of the other (Figure 4.14b).
This could be in accordance with the proposed mechanism in which the positioning of
the binding sites is controlled by the movement of Pro172. When Pro172 gets closer to
one site (e.g. the co-enzyme binding site), the distance between Pro172 and the other
site (e.g. the G6P binding site) increases.
When the coordinates of the conformations with lower energy were extracted from the
trajectories, a connection was noted between the movements of the two arginines and the
position of Pro172. When Pro172 does not move during the trajectories (Figure 4.15)
and maintains the same position as in the reference structure (2bhl), there are no changes
in either position or orientation of the R72 and R365 side chains (Figure 4.15). Whereas,
when Pro172 moves towards R72, R72 orients itself in the direction of Pro172 while R365
maintains its position (Figure 4.16a). This movement is enhanced at higher tempera-
tures, where the Pro172-R72 distance is even shorter (Figure 4.16b).
These movements seems to suggest that instead of moving in unison, Pro172 gets closer
Chapter 4. Metadynamics 107
(a) (b)
Figure 4.14: Projection of (a) CV1 and (b) CV2 over time for replica 4.
(a) (b)
Figure 4.15: Snapshot of the position of R72, R365 and Pro172 at different moment
of the dynamics. When Pro172 (yellow) maintains the same position as the reference
structure (grey), its distances from R72 (blue) and R365 (red) do not change. In grey
the same residues as are found in the reference PDB structure (2bhl).
(a) (b)
Figure 4.16: Snapshot of the position of R72, R365 and Pro172 at different moment
of the dynamics. (a) When Pro172 (yellow) moves, it goes towards R72 (blue), which
orients its side chain towards Pro172, while R365 (red) keeps its positioning stable in
the G6P binding site. (b) The same mechanism is enhanced at higher temperature. In
grey the same residues as are found in the reference PDB structure (2bhl).
to R72, with the effect of bringing the co-enzyme to the G6P binding site. G6PD binds
G6P in its core and therefore the substrate binding site movements are more restricted
than those in the co-enzyme binding site. The co-enzyme, in fact, binds in an area that
is at the end of the Rossmann-like domain, which has a wider freedom of movement
(Figure 4.17). As the simulations indicate, Pro172 has the role of getting the co-enzyme
closer to the binding site, allowing the interaction between the two.
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4.4 Discussion
Metadynamics simulations were used in order to understand the role of Pro172 in the
binding sites interactions. Pro172 is the central residue of the conserved EKPxG peptide
and it is directly involved in the correct positioning of the substrate and co-enzyme
binding sites better. In the dimer used for the simulations (PDB code 2bhl) the proline
is in cis conformation, but in the tetramer (PDB code 1qki), seven subunit are found
in trans. In Leuconostoc mesenteroides, Pro149 (the respective of Pro172 in human) is
found in cis conformation in all the complexes, with exception of one subunit in which is
in trans in the absence of the coenzyme (PDB code 1dpg [149]). Because of the existence
of both forms, it has been proposed that a trans-cis isomerisation of Pro172 could favour
the movement of the αe helix, allowing Lys171 to interact with both the co-enzyme and
the substrate [81]. The importance of Pro172 function is further stressed by the fact that
the Volendam variant, which replaces Pro172 with a serine, exhibits class I depressed
activity phenotype and its Km values are the lowest of all the known variants [128].
The metadynamics simulations were used to monitor the distances of Pro172 to the ex-
tremes of the bindings sites, to find evidence of the oscillating movement of Pro172 from
one site to the other. This movement would show how constraint Pro172 is, clarifying
its role in G6PD functioning. The results indicate that the distances assume specific
values in a range of 1.5 nm to 3 nm. When the conformations are extracted from the
trajectories, it appears clear how these values are compatible with the residues being
farthest from and closest to Pro172. Overall, the movement of the binding sites relative
to the proline seems to indicate two things. First, R365, which represents the G6P bind-
ing site, is more constrained than R72 (the co-enzyme binding site) in its movement.
This could be because of the substrate location in the core of the enzyme (Figure 4.17 in
red). Second, the Pro172 movements are more often associated with R72 getting closer,
and therefor with the co-enzyme binding site approaching the substrate. The overall
conclusion is that Pro172 could really mediate the interaction between the substrate
and the co-enzyme, by bringing the co-enzyme closer to the substrate in the centre of
the enzyme. No clear evidence was found to support the necessity of a trans-cis isomeri-
sation of Pro172, but it could be that a residue capable of adopting both cis and trans
conformations leads to lower activation-energy barriers and is therefore preferred.
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Figure 4.17: Location of the binding sites on the G6PD structure. The G6P binding
site (red) is in the core of the enzyme, while the co-enzyme binds the blue area of the
N-terminal Rossmann-like domain.
Chapter 5
Coarse-grained simulations
Several biological events happen because of the great flexibility expressed by the proteins
involved. Flexibility in the structure allows proteins to move and adapt to different
conditions by rearranging their structure over time. The time scale of these movements
varies with the increase in the number of elements involved. Local motions happen
in femto-seconds (fs), domains take micro-seconds (µs) to rearrange, and folding or
unfolding can take milli-seconds (ms) or more. All-atom molecular dynamics (MD)
is the most accurate computational technique to study these properties of proteins,
but the great accuracy is balanced by the great computational cost. The movements
of small peptides can easily be studied using hundreds or thousands of CPU/GPUs
in modern supercomputers, but even these resources are not enough to characterise
the dynamics of complex systems (e.g. membrane proteins) fully. Coarse-grained (CG)
models are alternatives to atomistic MD simulations, which dramatically reduce the
computer resources needed at the cost of detail. Because of the reduced detail, certain
specific interactions (e.g. protein-solvent interactions) cannot be studied properly, but
despite their simplicity, these methodologies provide high quality results.
This chapter will describe how the UNRES force field was used to study G6PD and
G6PD variants’ dynamics above the µs time frame. This magnitude should make the
observation of large scale movements and rearrangements in the mutants possible.
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5.1 The UNRES force field
The UNRES force field [150] is a physics-based united-residue force field derived as a
potential of mean force (PMF), which averages the energy over the degrees of freedom
that are not included in the UNRES formulation (Equation 5.1). PMF force fields
are obtained from MD or MC simulations by recording how the energy changes as a
function of a coordinate of the system (e.g. distance between two atoms or the variation
of the torsion angles). In the UNRES force field, examples of the degrees of freedom
that are averaged are the solvent and dihedral angles such as χ values. The peptide
chain is represented by UNRES as a sequence of Cα atoms connected by virtual bonds
to united peptide groups (p) and side chains (SC) (Figure 5.1). Only side chains and
peptide groups are used during the calculation of the forces, while the Cαs are used to
maintain the geometry of the other groups (dC and dX in Figure 5.1). Figure 5.2 and
Figure 5.3 show G6PD represented using the classical model as a reference and as the
UNRES model respectively. The energy terms in UNRES were obtained from ab initio
quantum mechanical calculation of PMF models, while the SC terms were derived from
all-atom simulations of model pairs of side chains in water [150]. The main advantage
that UNRES offers is a dramatic extension of time scale up to three orders of magnitude
compared with all-atom methods. This means that slow events, such as folding, which
happen in µs can be observed in UNRES simulations which are only nano seconds (ns)
long [150]. Because of this difference in time, all the measures of time presented in this
chapter are in “molecular time units” (1 mtu = 48.9 fs) unless otherwise specified. 100
mtu of UNRES simulations are equivalent to almost 5 ps (100*48.9 fs = 4.89 ps), which
corresponds to approximately 5 ns of real time simulation .
Figure 5.1: The UNRES model of polypeptide chain. The Cα are connected by virtual
bonds with peptide-bond centres (p) and united side chains (SC) [150].
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Figure 5.2: The all-atom G6PD dimer structure (PDB code 2bhl) visualised in line
mode by PyMOL. The hydrogens were removed to improve the clarity of the figure.
Figure 5.3: The G6PD dimer structure (PDB code 2bhl) after conversion to the
UNRES reduced-model structure.
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The equations below describe the UNRES formulation and Tables 5.1 and 5.2 give a
description of the parameters and energy terms used.
U =
∑
j
∑
i<j
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∑
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(5.1)
where the fn(T ) terms (Equation 5.2) represent the temperature-scaling multipliers,
which are introduced to eliminate undesirable peaks in the heat capacity at high tem-
peratures:
fn(T ) =
ln[exp(1) + exp(−1)]
ln
{
exp[(T/T0)n−1] + exp[−(T/T0)n−1]
} (5.2)
The terms USCiSCj and USCipj represent the mean free energy of the hydrophobic interac-
tions between the side chains (implicitly containing the side chain-solvent interactions),
and the excluded volume potential of the side-chain-peptide-group interactions respec-
tively. The peptide-group interaction potential is split into two terms: UvdWpipj which de-
scribes the Lennard-Jones interaction energy between peptide-group centers, and U elpipj ,
which is the average electrostatic energy between peptide-group dipoles. Utor, Utord,
Ub and Urot are the virtual-bond-dihedral angle terms, while Ubond(di) is a harmonic
potential of virtual-bond distortions, where di describes the length of the virtual bond.
Each term is multiplied by a weight, wx.
Similarly to every other force field, UNRES has different formulations specifically de-
signed for the study of particular systems. The flavour used in this project is the
E0LL2Y force field [151–154], a 6-12 anisotropic Gay-Berne (shifted Lennard-Jones) po-
tential [155], particularly good in describing proteins with mixed content of α helices
and β sheets.
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The UNRES model was initially developed to predict protein structure by global min-
imisation of the potential energy using the Conformational Space Annealing (CSA)
method [156, 157]. This approach was successfully used to perform ab initio prediction
of protein structures and simulations of protein-folding phatways using the Langevin
dynamics [158, 159]. The study of the thermodynamics characteristics of protein folding
was further enhanced with the implementation of a replica exchange molecular dynamics
(REMD) algorithm, and the support of multi-chain protein simulations [160, 161].
Table 5.1: The principal energy terms’ weights for the E0LL2Y force field. As de-
scribed in section 5.1, SC and p stand for side-chain and peptide group, while electro-
static and local cooperativity are represented as el and loc respectively.
Energy term Value Description
WLONG 1.00000 U(SC-SC) and U(SC,p) terms.
WSCP 1.23315 U(SC-p) term.
WELEC 0.84476 U(p-p) term.
WANG 0.62954 virtual-bond angle bending term (Ub).
WSCLOC 0.10554 side-chain rotamer term (USC)
WTOR 1.84316 torsional term (Utor).
WCORR4 0.00000 local-electrostatic cooperativity terms (U (4)el;loc)
WCORR5 0.00000 local-electrostatic cooperativity terms (U (5)el;loc).
WCORR6 0.00000 local-electrostatic cooperativity terms (U (6)el;loc).
WEL LOC 0.37357 local-electrostatic cooperativity terms (U (3)el;loc).
WTURN3 1.40323 local-electrostatic cooperativity terms (U (3)turn).
WTURN4 0.64673 local-electrostatic cooperativity terms (U (4)turn).
WTURN6 0.00000 local-electrostatic cooperativity terms (U (6)turn).
CUTOFF 7.00000 cut-off on backbone-electrostatic interactions.
WCORRH 0.19212 cooperativity of hydrogen-bonding interactions term (Ucorr).
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Table 5.2: The force field specific parameters of the E0LL2Y force field.
Parameter Value Description
SIDEPAR scinter GAB.parm SC-SC interaction potentials.
SCPPAR scp.parm SC-p interaction potential.
ELEPAR electr 631Gdp.parm p-p interaction potentials.
FOURIER fourier opt.parm.1igd hc iter3 3 coupling between the backbone-local and
backbone-electrostatic interactions.
THETPAR theta abinitio.parm virtual-bond-angle bending potentials.
ROTPAR rotamers AM1 aura.10022007.parm side-chain rotamer potentials.
TORPAR torsion 631Gdp.parm torsional potentials.
TORDPAR torsion double 631Gdp.parm double-torsional potentials.
SCCORPAR sccor am1 pawel.dat torsional potentials that account for the
coupling between the local backbone and
local sidechain states.
BONDPAR bond AM1.parm bonds.
THETPARPDB thetaml.5parm Additional parameters to generate random
conformations
ROTPARPDB scgauss.parm Additional parameters to generate random
conformations
5.2 Methodology: UNRES
The UNRES force field is not implemented in GROMACS, so a completely different
protocol was developed making use of the tools provided with the force field by the
developers (Figure 5.5). Starting from the same structures used for the all-atom simula-
tions, the system was first minimised in virtual-bond vectors (instead of angles) for 2000
iterations of steepest descent and then production simulations at different temperatures
were started. Because of the implicit solvent adopted by UNRES, Langevin dynamics
was used. Proteins exist in aqueous environments where collisions with other molecules
and the solvent occur. The Langevin dynamics tries to model these forces by adding
two more terms to Netwon’s second law as seen in Equation 5.3.
~Fi − γi~v + ~R(t) = mi~ai (5.3)
Collisions are modelled by a random force (~R) and the addition of a frictional drag
(γ) guarantees the correct representation of the molecule moving through the solvent
(which is not explicitly included). The scaling factor of the friction coefficient used in the
simulations was set to 0.01, and for each temperature, 12 independent simulations with
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a time step of 1.956 fs (0.04 mtu) ran for 1×106 steps. Because of the different time scale
between all-atom and UNRES, the 26 ns total trajectories obtained by combining all the
replicas are equivalent to approximately 26 µs of all-atom simulations. Energies were
saved every 2 ps and conformations every 5 ps. To control the errors of the integration
method better, the Multiple Time Step (MTS) algorithm [162] with a maximum number
of time-split steps of 512, was used. The MTS scheme integrates the slow-varying
and the fast-varying forces of the system with different time steps. Computationally
expensive forces such as electrostatic interactions, are evaluated less frequently than the
fast forces, such as bond stretches, allowing a significant speed-up in the calculation.
At the end of the simulations, the energy values, the rmsd and the gyration radius
were directly extracted from the different outputs and the full-atom structures of the
trajectories were reconstructed from the UNRES reduced model trajectories, using the
script doitGROMACS.sh (see Appendix A). For this task, the script uses the catomain
program, that adds backbone atoms to a Cα-only PDB file using a modified version
of the method of Levitt [163]. Finally, to extract the most significative conformations,
cluster analysis was performed using the Ward’s minimum variance method [164]. For
each cluster, the conformations were energy-ranked and only the structures with lower
energy were considered as representative. Because of the limited tools provided with the
UNRES force field by the developers, two main limitations affected this protocol. First
the UNRES model had some distortions in the backbone representations, meaning that
β strands were no longer assigned correctly by the ss-assignment software, such as dss
in PyMOL (Figure 5.4). Second, to run the cluster analysis, the two chains in G6PD
were linked by a ‘dummy’ residue inserted in the middle instead of TER records. This
only affects the final PDB file (not the calculations) and was the only way of performing
cluster analysis on multi-chain trajectories.
(a) (b)
Figure 5.4: Example of distortion in the β strands. (a) The wild-type as found in
the reference PDB file (2bhl) and (b) after reconstruction from the UNRES reduced
trajectory.
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all-atom PDB
Energy minimisation (unresMIN)
coarse grained PDB
Production MD (unresMD)
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data
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family of structures average structures
Figure 5.5: Diagram explaining the protocol used for the simulations and the analyses
with the UNRES force field. I/O files are in blue while the UNRES tool used are in
yellow. The binary ‘unresMD-mult ifort MPI E0LL2Y.exe’ was used for the energy
minimisation (unresMIN) and the MD steps (unresMD), while ‘cluster unres ifort.exe’
was used to perform the cluster analysis. Both binaries are distributed together with
the force field. In-house scripts (some of which implemented in doitGROMACS.sh, see
Appendix A) written in bash, perl and R, were used to extract and plot the data from
the various files produced by the UNRES tools.
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5.3 Wild-type
Table 5.3: The average values over the trajectories of the potential energy (Epot),
temperature (K), rmsd and radius of gyration (Gyration) for the replicas of the wild-
type at 310 K. For Emin, the rmsd is calculated using 2bhl.pdb (all-atom) as reference,
while all the other rmsd values use the structure obtained from the energy minimisation
(Emin) as reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2612 - 4.86 32.11
GB000 -2523 310.2 0.71 31.08
GB001 -2522 310.3 1.46 31.54
GB002 -2545 309.9 1.42 31.65
GB003 -2558 310.1 0.92 31.44
GB004 -2509 310.2 0.52 31.04
GB005 -2510 310.4 1.3 31.48
GB006 -2528 310.6 1.4 31.97
GB007 -2559 309.7 1.52 31.48
GB008 -2559 310.2 0.12 30.73
GB009 -2541 310.3 1.14 31.71
GB010 -2513 309.8 0.55 30.90
GB011 -2535 309.7 1.10 31.57
Mean -2532.7 310.1 1 31.4
At the end of the energy minimisation, the minimised structure appeared to be more
compact, compared with the correspondent all-atom structure (Figure 5.6). This is
probably a direct consequence of the way UNRES was parametrised that tends to favour
a polypeptide chain with reduced distances between the Cαs of the backbone.
5.3.1 Wild-type at 310 K
As expected, the simulations were capable of sampling a much larger section of the PES
compared to the all-atom simulations. Figure 5.7 shows the energy surface explored by
all the replicas combined. The PES profile was obtained as a function of the rmsd and the
radius of gyration, and indicates that the most energetically favourable conformations
had radius of gyration in the range from 30.5 A˚ to 31.5 A˚, corresponding to more compact
conformations (the reference PDB file has a radius of gyration equal to 36.16 A˚). This
confirms the propensity of the UNRES model to favour a more compact G6PD structure.
With the exception of a very few cases (Figure 5.8) all the replicas converged to stable
rmsd values (Figure 5.9), generally smaller than the starting conformation. The clear
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Figure 5.6: Superimposition of the minimised structures of the wild-type obtained
with both all-atom (grey) and UNRES (yellow). The UNRES model tends to favour a
more compact structure.
convergence of the simulations is another good indication of the UNRES capability of
sampling the conformational space of the protein.
Figure 5.7: PES profile of all the replicas of the wild-type at 310 K combined together.
The radius of gyration is indicated with ‘rgyr’.
Chapter 5 Coarse-grained simulations 120
Figure 5.8: Example of an rmsd profile of a simulation (replica 3 of the wild-type at
310 K) that has not reached convergence. 1mtu corresponds to 48.9 fs.
(a) (b)
Figure 5.9: Examples of converged rmsd profiles of two different replicas of the wild-
type at 310 K. 1mtu corresponds to 48.9 fs.
For the first 100 pico seconds of simulation, the wild-type maintained conformations
that were similar to what was observed in the all-atom simulations, but here, the wild-
type eventually unfolded by the end of the simulation. The central reductase domain
retained a structure that resembled that of the reference PDB file (2bhl), while in the
N-terminal Rossmann-like domain the unfolding was noticeable and mostly affected
the helices. αa and αb, the two helices exposed to the solvent on top of the domain,
unfolded completely in all the replicas (Figure 5.10), while the other helices of the domain
relocated themselves in the region, causing the more compact structure indicated by the
radius of gyration (Figure 5.11b). The more energetic replicas were characterised by the
partial unfolding of the C-terminus region, where the helices and the last two strands
(βH and βO) were replaced by coils (Figure 5.12). Overall, the results obtained indicate
that the helices and the terminal regions are the weak points of the G6PD structure,
and their movements cause G6PD to deform and form a more compact structure.
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(a) (b)
Figure 5.10: (a) Conformation of the αa and the αb helices (blue) in the wild-type.
(b) During several simulations at 310 K, both helices completely unfolded by the end
of the simulations.
(a) (b)
Figure 5.11: (a) wild-type structure as found in the reference PDB structure, and
(b) the unfolded form at the end of a representative replica of the UNRES simulation.
(a) (b)
Figure 5.12: (a) Folded C-terminus region of the wild-type structure as found in the
reference PDB structure, and (b) the same region unfolded at the end of a representa-
tive replica of UNRES simulation.
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5.3.2 Wild-type at other temperatures
To maintain a parallelism with the work done in Chapter 3, and to assess the overall
performance of the UNRES model, the wild-type was also studied at different tempera-
tures: 500, 400 and 330 K. At all temperatures, G6PD completely unfolded to the point
that any type of structure was quickly completely lost (Figure 5.13). Because the aim
of the project was the detection of changes in the equilibrium between the wild-type
and the mutants, all these temperatures were considered to be too high to extract any
useful information about G6PD stability and dynamics, and 310 K was selected as the
reference temperature for the simulations with the UNRES model.
Figure 5.13: The complete unfolded structure of G6PD at the end of a simulation at
500 K.
5.3.3 wild-type summary
Thanks to the simplified UNRES model it was possible to increase greatly the sam-
pling and observe the unfolding of G6PD at room temperature. Similar to the all-atom
simulations, the collected data suggest that the terminal regions and the helices of the
enzyme are more prone to unfolding than the central β-reductase domain. The wild-type
simulations have also shown some limitations of the UNRES model. First, the united-
group model is probably not detailed enough to describe the very local interactions and
effects of one single residue substitution. Second, the detection of common unfolding
patterns and behaviours between replicas may be difficult to detect correctly. However,
the comparison with native G6PD with the effects of the mutations should probably be
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possible in terms of changes in energies and in the overall stability of the structures. Ex-
pectations are that the UNRES simulations of the G6PD mutants should demonstrate
that the mutants destabilise G6PD structure, by inducing a premature unfolding of the
regions close to the mutation.
5.4 Damaging mutants
5.4.1 G204R
The replacement of glycine with a charged hydrophilic arginine at position 204 (R204′)
was predicted as damaging by SAAPpred with a confidence of 0.8. The total potential
energy is, on average, 21 Kcal/mol higher than the values recorded for the wild-type
and, similarly, the average rmsd values are also higher (almost double) that of the
wild-type (Tables 5.3 and 5.4). On the contrary, even if not dramatically different, the
radius of gyration is slightly smaller (31.2 A˚ vs. 31.4 A˚). It is possible that these values
are the result of some instability effects caused by the presence of R204′. Similarly to
the wild-type, all the replicas have sampled several minima and, compared with the
wild-type, these minima are more distant from each other (Figure 5.14), giving another
confirmation of the high sampling capability of the UNRES model.
(a) (b)
Figure 5.14: PES sections explored by two replicas of G204R at 310 K. The radius
of gyration is indicated with ‘rgyr’.
In all the replicas, the radius of gyration decreased over time, but it eventually stabilised
around the values found in Table 5.4, and convergence was reached by the end of the
simulations (Figure 5.15). A similar behaviour was observed for the rmsd in all the
replicas (Figure 5.16a), with only few cases (replica 4 and 7) in which the rmsd increased
(Figure 5.16b). Not surprisingly, these cases are observed in the replicas which have
energy values above the average.
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(a) (b)
Figure 5.15: Radius of gyration of two different replicas of G204R at 310 K. In both
cases it decreases over time, but it eventually converges. 1mtu corresponds to 48.9 fs.
(a) (b)
Figure 5.16: Rmsd of two different replicas of G204R at 310 K. (a) Similar to the
radius of gyration, the rmsd profile reached convergence in all the replicas, but for a
few cases as shown in (b). 1mtu corresponds to 48.9 fs.
Overall G204R behaves similarly to the wild-type. The termini of the enzyme are the
most unstable regions and they lead the unfolding in all the replicas (Figure 5.17).
Because the structures had to be reconstructed from a reduced-detail model, it was
difficult to find a clear involvement of R204′ in the unfolding dynamics. However, in
both the wild-type and G204R simulations, the UNRES model broke the helix spanning
residues H201-K205 between residues 204 and 205, where R204′ lies, and which provides
G6P binding residues (Figure 5.18a). However in G204R that segment is less constrained
than in the wild-type. The result is that this segment (R204′-K205) can move closer to
the αi helix, causing its unfolding (Figure 5.18b). The αi helix constitutes the base of the
G6P binding site, and was also seen in the wild-type to unfold partially, but the complete
unfolding of the helix (αi) can only be seen in G204R when the segment covers αi. In the
all-atom simulations, this helix was never influenced by R204′. Overall, the simulations
indicates that R204′ destabilises of the surrounding area by forcing rearrangements that
eventually cause the premature unfolding of the region. Because H201, Y202 and K205
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are actively involved in G6P binding, any movements caused by R204′ could influence the
G6P binding. What the simulations suggest is that R204′ induces a premature unfolding
of the helix (H201-K205) which is now free to move around. These movements increase
the overall instability of the region and, for example, cause the premature unfolding of
the αi helix at the base of the G6P binding site.
(a) (b)
Figure 5.17: Final configuration of the trajectories of (a) replica 12 and (b) replica
11 of G204R at 310 K. The high instability of the termini of the enzyme caused G6PD
to unfold and contract.
(a) (b)
Figure 5.18: Segment H201-K205 and the αi helix in the wild-type (grey) and in
G204R (yellow), with R204′ coloured in blue. (a) The presence of R204′ causes the
segment H201-K205 to unfold and to (b) move, during the simulations, inducing the
unfolding of the αi helix.
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Table 5.4: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations
of G204R at 310 K. For Emin the rmsd is calculated using the all-atom structure as
the reference, while all the other values use the structure obtained from the energy
minimisation (Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2518.7 - 5.1 31.7
GB000 -2522 309.9 1.91 31.2
GB001 -2528 310.3 1.8 31.2
GB002 -2527 309.9 1.92 31.2
GB003 -2490 310 1.8 31.5
GB004 -2535 310.1 1.89 31.4
GB005 -2493 310.1 1.77 31.2
GB006 -2474 310 1.97 31.2
GB007 -2508 309.9 1.7 31.7
GB008 -2515 309.8 1.7 30.9
GB009 -2524 310.2 1.92 30.8
GB010 -2510 310.2 2.11 31.6
GB011 -2518 309.7 1.86 30.5
Mean -2512 310 1.86 31.2
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5.4.2 Residue 306: G306R and G306S
Position 306 is located in the βH strand of the central α+β 2-layer sandwich domain,
and two mutants of this residue were studied: G306R and G306S. G306R was predicted
to be damaging with high confidence (0.8), but it is not an existing variant. G306S was
predicted to be damaging with a lower confidence (0.64) and is known to be a class II
G6PD variant. The study of both mutants gave not only the possibility of studying
some predicted damaging mutants, but also the opportunity of studying the damaging
mechanisms in an existing G6PD variant. In the all-atom simulations, both mutants in-
creased the instability of the region, with a propensity to cause the premature unfolding
of the surrounding β strands.
The energies calculated over the UNRES trajectories, indicate that G306R is globally
less stable than the wild-type. The potential energy is almost 30 kcal/mol higher than
the wild-type and this instability is reflected in rmsd values close to double the values
of the wild-type for all the replicas (Table 5.5). In the simulations, G306R showed a
behaviour very similar to that observed in the all-atom simulations; the presence of the
arginine causes the premature unfolding of the βH and βO strands. The βH strand is
where the mutation lies, and it was never found completely folded in the simulations
(Figure 5.19). Instead, the βO strand contains I480 which was found interacting with
the R306′side chain in the all-atom simulations (Section 3.6). The two strands are al-
ways close to each other and they reduce their lengths during all dynamics simulations
(Figure 5.20).
Figure 5.19: The βH strand in both the wild-type (grey) and G306R (yellow). Residue
306 is in blue.
Overall the C-terminal region of G306R is more unstable than the wild-type. In the
wild-type, the β strands are distorted but maintained, while in G306R the area is more
disordered. However, the unfolding is not dramatically faster in G306R, possibly be-
cause of the compactness of the area which constrains the movements of the unfolding
regions.
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(a) (b)
Figure 5.20: The βH and βO strands in (a) the wt and (b) G306R. The interaction
between R306′ (blue) and I480 (red) caused βO to shrink.
G306S presents a similar mechanism. The βH strand breaks at the mutation site (Fig-
ure 5.21b), and the βO strand shortened as a consequence of the presence of the serine
(S306′). The C-terminus of the protein moves more than it does in both the wild-type
and G306R, and this is probably because the smaller size of S306′ allows a greater free-
dom of movement to the residue compared with R306′ which is kept in place. The
result is a structure with a distorted structure at the C-terminal end (Figure 5.22 and
Figure 5.23).
(a) (b)
Figure 5.21: The βH and βO strands in (a) the wt and (b) G306S. Contrary to
G306R, S306′ cannot interact with I480 in βO and the damage only affect the βH
strand. S306′ is in blue.
(a) (b)
Figure 5.22: C-terminal region of (a) the wild-type and (b) G306S, with S306′
coloured in blue.
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Figure 5.23: C-terminus of G306S at the end of a simulation, with the region affected
by the mutation coloured in red.
The simulations with the UNRES model confirm that both G306R and G306S have
local effects on the surroundings. They both destabilise the area, shortening the βH and
βO strands and increasing the overall movement of the C-terminus. R306′, being more
damaging, has a stronger effect in unfolding the strands, while S306′ seems capable of
increasing the movements of the unfolding regions in the area. Residue 306 is close to
the structural NADPH+ binding site, suggesting a possible and direct involvement of
the mutations in NADPH+ stability.
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Table 5.5: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations
of G306R at 310 K. For Emin the rmsd is calculated using the all-atom structure as
the reference, while all the other values use the structure obtained from the energy
minimisation (Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2618.7 - 5.1 31.7
GB000 -2512 309.9 2.03 30.4
GB001 -2483 310.3 1.97 30.9
GB002 -2496 310 2.2 31.5
GB003 -2510 310 1.9 31.2
GB004 -2509 310 1.9 31.8
GB005 -2497 310.4 1.8 30.9
GB006 -2553 309.9 1.9 31.2
GB007 -2488 309.9 1.7 31.5
GB008 -2517 310 1.8 31.5
GB009 -2512 310 1.9 30.8
GB010 -2506 310.3 1.95 30.9
GB011 -2498 310.4 1.8 31.5
Mean -2506 310 1.9 31.1
Table 5.6: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations
of G306S at 310 K. For Emin the rmsd is calculated using the all-atom structure as
the reference, while all the other values use the structure obtained from the energy
minimisation (Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2634 - 5.1 31.7
GB000 -2538 310.2 1.8 30.6
GB001 -2543 310.3 1.7 31
GB002 -2527 310.2 1.9 31.4
GB003 -2520 310 2.1 30.8
GB004 -2510 310.6 1.4 31.3
GB005 -2532 310.2 1.6 30.6
GB006 -2524 310.5 1.5 31.6
GB007 -2529 310 1.4 31.4
GB008 -2544 310 1.7 31.2
GB009 -2506 310 1.8 31
GB010 -2543 310 1.5 31.4
GB011 -2523 310 1.8 31
Mean -2528 310 1.7 31.1
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5.4.3 A−
A− is the only multiple missense mutation considered in the study. It is the most com-
mon variant in Africa and in African ancestry populations and it combines V68M and
N126D, resulting in a class II variant. Individually, only V68M was predicted as damag-
ing by SAAPpred (very low confidence of 0.07), while N126D was not listed as PD (SNP
confidence of 0.5). The mutant is characterised by dynamics with similar potential en-
ergy and radius of gyration, but a higher rmsd (Table 5.7) compared with the wild-type.
The PES profile of all the replicas of the wild-type (Figure 5.7) was centred around a
radius of gyration value of 31.5 A˚, while the A− profile is shifted toward values of the
radius of gyration at the extremes of the PES explored: 30.5 A˚ and 32 A˚ (Figure 5.24).
Figure 5.24: PES profile of all the replicas of the A− mutant at 310 K combined
together. The radius of gyration is indicated with ‘rgyr’.
These shifts are the result of a greater instability of the N-terminal Rossmann-like do-
main, which is the area where the mutations are located. This domain unfolds similarly
to the wild-type, but in A− , the unfolding is faster and has more dramatic effects on the
enzyme structure. It is proposed that M68′ causes shortening of the βB strand, while
D126′ induces unravelling of the αc helix, resulting in the almost complete unfolding
of the two external helices of the domain: αa and αb (Figure 5.25b). The instability
of the region is such that the unravelling of the αb helix and of the nearby αc helix is
projected to the outside of G6PD with a movement never seen in the wild-type or any
other mutant (Figure 5.26b). In the all-atom simulation, the presence of M68′ and D126′
guided the rearrangement of the structures in the area, with the αc helix and the βB
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(a) (b)
Figure 5.25: Unfolding of the N-terminal Rossmann-like domain area close to the
mutations in (a) the wild-type and (b) in A− . M68′ and D126′ are in blue.
strand which fold/unfold depending on the orientation of their side-chains (Section 3.7).
In the UNRES simulations, it seems possible, in some replicas, to observe this unfold-
ing pattern (Figure 5.26b), but the loss of details and the great instability of the area
make the detection of the correct mechanisms not possible. Overall the UNRES model
confirms the destabilising effects of M68′ and D126′ on the N-terminal Rossmann-like
domain that accelerates the unfolding of G6PD N-terminal end.
(a) (b)
Figure 5.26: Unfolding of the top of the N-terminal Rossmann-like domainin A− .
(a) The twist and movement of the αc helix to the outside of the protein. (b) The
unravelling of the αc helix in relationship to the βB strand. The mutations are coloured
in blue.
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Table 5.7: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations of
A− at 310 K. For Emin the rmsd is calculated using the all-atom structure as the refer-
ence, while all the other values use the structure obtained from the energy minimisation
(Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2689 -
GB000 -2536 310 1.94 31.6
GB001 -2520 310.3 1.76 30.8
GB002 -2545 310 1.8 30.3
GB003 -2541 310.3 1.69 30.7
GB004 -2566 310.3 1.76 30.7
GB005 -2559 309.9 1.78 31.5
GB006 -2528 310.1 1.9 31.4
GB007 -2538 310.1 1.79 31
GB008 -2498 310.6 1.72 30.9
GB009 -2522 310.2 1.94 30.6
GB010 -2547 310.3 1.71 31.9
GB011 -2502 310.4 1.89 30.8
Mean -2533 310 1.8 31
Table 5.8: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations
of R136C at 310 K. For Emin the rmsd is calculated using the all-atom structure as
the reference, while all the other values use the structure obtained from the energy
minimisation (Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2641 - 4.46 31.3
GB000 -2547 310.2 1.86 31.1
GB001 -2537 310.3 1.81 31
GB002 -2552 310.4 1.83 31.2
GB003 -2580 309.8 1.82 31.4
GB004 -2553 310.1 1.86 31.2
GB005 -2592 309.9 1.88 31.2
GB006 -2538 310.3 1.91 31.1
GB007 -2537 310 1.7 31.4
GB008 -2539 310.8 1.81 30.9
GB009 -2571 310.3 1.79 31.6
GB010 -2574 309.7 1.85 31.3
GB011 -2567 310.1 1.75 30.5
Mean -2557 310.1 1.8 31.2
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5.4.4 R136C
R136C is a class II variant that was predicted to be damaging by SAAPpred with a
confidence of 0.45. The cysteine (C136′) is replaced in the βD strand of the core of the
N-terminal Rossmann-like domain and the all-atom simulations registered some distor-
tions in the surrounding strands that can reach the co-enzyme binding site changing
its geometry (Section 3.7). With lower potential energy, R136C is more stable, but the
simulations took more time to converge compared with the wild-type (Figure 5.27).
Figure 5.27: Rmsd profile of the replica 8 of R136C simulation, in which convergence
happens only close to the end of the simulation.
The principal effect of C136′ is the disruption of the β sheet stability. The closer strand
(βA) is completely distorted and shorter than the wild-type, while the other strand of
the sheet (βB) breaks at the partner position to the cysteine (Figure 5.28b). It is possi-
ble that the hydrogen bonds of the arginine (R136) with the αc helix had an involvement
in keeping the β sheet ordered, and that its removal destabilises the sheet stability.
In addition, the co-enzyme binding site, at the other extremity of the N-terminal Rossmann-
like domain unfolded, but it is seen to be interacting with the unfolding helix spanning
from G240 to G254 located outside the N-terminal Rossmann-like domain. This small
helix unfolds and the resulting coil enters the co-enzyme binding site (Figure 5.29). The
involvement of C136′ in this mechanism is not clear as it could either be that the un-
folding of the N-terminus shifts the co-enzyme binding site towards the other end of the
protein, or it could simply be the instability of the unfolding helix (G240-G254) which
brings them close enough to interact.
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(a) (b)
Figure 5.28: The N-terminal Rossmann-like domain in (a) the wild-type and (b) its
distorted conformation in the R136C simulations. Residue 136 is in blue.
(a) (b)
Figure 5.29: The co-enzyme binding site region in (a) the wild-type and in (b) R136C.
When the G240-G254 helix unfolds, it moves closer to the co-enzyme binding site,
obstructing it.
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5.4.5 A461T
The A461T mutant is a known G6PD variant identified in the Yunnan chinese province
whose reduced enzymatic activity has not been assessed yet, and it is therefore registered
in the G6PD database of mutations [101] as non recorded (NR) . A461T was predicted
as damaging by SAAPpred with a confidence of 0.23, and the all-atom simulations
(Section 3.8) showed that T461′ causes a distortion in the adjacent αi helix thanks to
interactions with the Q261 side chain. The αi helix constitutes the base of the G6P
binding site, suggesting that T461′ could interfere with G6P binding in A461T. The
UNRES simulations confirm this mechanisms and the following mechanism of action
was proposed: the presence of the threonine (T461′) breaks the αn helix into two well-
defined sections (Figure 5.30b), which in turn lead to the unravelling of the αi helix
(Figure 5.31). The unravelling of αi increases the instability of the preceding G240-
G254 helix, which eventually unfolds (Figure 5.32 in red). This helix moves more than
the wild-type, at the point that it was observed, in one replica only, to enter and obstruct
the co-enzyme binding site. A similar mechanism was observed in R136C, but here the
unravelling of the helix and the effect of the mutation are directly connected. Overall
A461T is less stable than the wild-type, the PES profile of the replicas shows the presence
of several well-separated wells (Figure 5.33).
(a) (b)
Figure 5.30: The αn helix in (a) the wild-type and in (b) A461T. In the mutant, the
threonine causes the helix to break.
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(a) (b)
Figure 5.31: The αn and αi helices in (a) the wild-type and in (b) A461T. In A461T,
the threonine (blue) in the αn helix (yellow) causes the αi helix (red) to unravel.
(a) (b)
Figure 5.32: The αi and the G240-G254 helices in (a) the wild-type and in (b) A461T.
The unravelling of αi (yellow) speeds up the unfolding of the G240-G254 helix (red).
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Figure 5.33: The PES sections explored by one of the replicas of A461T at 310 K.
The radius of gyration is indicated with ‘rgyr’.
Table 5.9: Average values over the trajectories of the potential energy (Epot), temper-
ature (K), rmsd and radius of gyration (Gyration) for all the independent simulations
of A461T at 310 K. For Emin the rmsd is calculated using the all-atom structure as
the reference, while all the other values use the structure obtained from the energy
minimisation (Emin) as the reference.
Replica Epot [Kcal/mol] T [K] Rmsd [A˚] Gyration [A˚]
Emin -2611 - 4.46 31.3
GB000 -2514 310.1 1.75 31.4
GB001 -2553 310.1 1.82 31.1
GB002 -2559 310.4 1.88 31.2
GB003 -2521 310.2 1.6 31.5
GB004 -2522 310 1.8 30.5
GB005 -2498 310.3 1.2 31.6
GB006 -2528 310.2 1.9 31.6
GB007 -2527 310 1.8 31.2
GB008 -2553 310.2 1.77 30.8
GB009 -2532 310.1 1.9 31.5
GB010 -2566 310 1 31.5
GB011 -2520 310.2 1.6 31.4
Mean -2532 310.1 1.7 31.2
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5.4.6 UNRES simulations of mutants where no unfolding was detected
in all-atom simulations
This section covers a set of mutants for which the all-atom simulations were not capable
of detecting any specific damaging mechanisms. Mutant L140P, for example, has a
proline inserted in the core of the N-terminal Rossmann-like domain, and was predicted
to be damaging with a high confidence (0.78), but the all-atom simulations did not
indicate any particular rearrangement or damage to the G6PD structure (Section 3.7).
The UNRES simulations exposed the damaging mechanisms in a clear way. P140′ is
located at the end of the βD strand of the N-terminal Rossmann-like domain, and the
change in the backbone torsion angle caused by the proline produces a distortion in the
closest strands of the sheet (βA and βE) which unfold (Figure 5.34).
(a) (b)
Figure 5.34: The core of the N-terminal Rossmann-like domain in (a) the wild-type
and in (b) P140′.
The unfolding is not complete and not dramatic, but it is capable of starting a series of
modifications that can have more dramatic effects. The βA strand is directly connected
to the αa helix (D42-R57), which sits below the two unstable helices of the domain (αb
and αc). The unfolding of the βA strand, caused by the presence of P140′, affects the
stability of the αa helix that in turn unravels (Figure 5.35).
The most noticeable effect of this chain of events is the destabilisation of the top of the
N-terminal Rossmann-like domain, which leads to a faster unfolding of the αb and αc
helices (Figure 5.36). As a result, the substitution of L140 to P140′ is associated with
local distortion that has the capability of propagating through the surrounding area,
eventually accelerating the unfolding of the already unstable N-terminal domain. The
fact that this mechanism was not observed in the all-atom simulations, gives confirmation
of the limitation of the all-atom simulations in studying long-scale motion events.
The mutant A338E was predicted to be damaging by SAAPpred with a confidence of
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(a) (b)
Figure 5.35: The two strands, βA (red) and βB (yellow), and the αa helix (orange)
in (a) the wild-type and (b) L140P. Position 140 is in blue.
(a) (b)
Figure 5.36: The N-terminal Rossmann-like domain in (a) the wild-type and (b) in
L140P. The unravelling of the αa helix (orange) increases the speed at which the top
of the N-terminal Rossmann-like domain unfolds. P140′ is in blue and the strands βA
and βB are coloured in yellow and red for comparison.
0.75, and it is located in the βI strand close to the C-terminus of the enzyme. The
all-atom simulations detected an overall increase in instability of the C-terminal region,
but did not demonstrate a clear mechanism of action of the mutation. The UNRES
model shows how E338′ causes the unfolding of the βI strand increasing the motility of
the C-termial region of the enzyme. The fact that E338′ sits in between the G6P and
the structural NADPH+ binding sites could suggest that motions in this region could
affect both binding sites. Finally, E287K is another mutant predicted to be damaging
(SAAPpred confidence of 0.68) which did not present any sign of different behaviour
compared with the wild-type during the all-atom simulations (section 3.9). During the
UNRES simulations, the αj helix, which contains K287′ breaks (Figure 5.37b) into two
sections. In the most energetic replicas, this was enough to cause the partial unfolding
of αj, while the other replicas did not unfold, but presented the damaged helix for the
entire simulations.
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(a) (b)
Figure 5.37: The αj helix as it appears at the end of (a) the all-atom and (b) an
UNRES simulation. The helix breaks in two where K287′ (red) is.
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5.5 Discussion
The decision to use the UNRES model was taken to overcome the sampling limitations
of the classical all-atom model, which requires months of calculations for the collection
of extensive simulation data. In contrast, the simplified UNRES model required a third
of the time, and dramatically increased the sampling of the conformational space of
G6PD. Almost all the simulations reached convergence and were capable of exploring
several energy minima, making the study of unfolding dynamics at room temperature,
for both G6PD and its mutants, possible. The UNRES model confirmed several of the
findings of the all-atom simulations, especially the idea that the very local effects of a
mutation can have an impact on the enzyme stability at a global level. The A− mutant,
for example, changes the structural equilibrium of the N-terminal Rossmann-like domain
and induces its premature unfolding. The work with the UNRES model also made it
possible to observe the damaging effects of those mutants for which the detection of any
effect was difficult or impossible with the all-atom simulations (e.g. A338E or E287K).
Unfortunately the loss of details of the simplified peptide chain representation increased
the noise, making the detection of common unfolding behaviours among the mutants
difficult, forcing a focus on a more global and general level. In the simulations, the
effects of the mutations were clear, but it proved difficult to link those effects to specific
structural movements. Nevertheless, these dynamics were important to confirm the
damaging effects of the mutations and to prove that the overall damaging mechanisms
proposed in Chapter 3 were indeed plausible.
Despite the satisfactory results obtained, at the end of the work done, it appeared
clear that the UNRES model is not really suitable to detect the effects of single point
mutations, but it is probably more suitable for other applications such as de novo folding
or thermodynamics study of protein space, where it proved to perform well [150]. This
consideration came after realising that the simplified model over accentuate the weakness
of the G6PD structure, causing quick and different unfolding pathways. The result is the
observation of the large scale movements that are likely to be caused by the mutations,
without a clear and comprehensive description of the specific damaging mechanism at the
origin of the global rearrangements observed. As a consequence of this last consideration,
it was decided to focus on the collected all-atom data to have a better understanding of
the damaging mechanisms of the G6PD variants. This work is discussed in Chapters 6.
Chapter 6
Additional studies: network
analysis
The previous chapters illustrated how MD simulations were used to understand the
effects of mutations on G6PD structure. All-atom simulations were capable of capturing
the detailed local changes, but it was not always possible to produce as much data as
would have been necessary. To try to overcome the sampling problem, it was decided to
rely on a coarse-grained force field. The UNRES simulations allowed the comparison of
global motions at a µs-time scale, but suffered from a great loss in detail. This lead to
extensive data that were difficult to interpret. It was therefore decided to spend the last
months of this project trying to extract, from the all-atom data accumulated, some clear
explanations of the internal mechanisms that cause depressed activity in G6PD variants.
For this reason, the main goal of the work presented in this chapter is to study how the
damage propagates through the G6PD structure, based on the idea that structural
effects can transmit through communication paths featuring correlated motions. The
first section of this chapter describes how the G6PD structure was converted into a
network of nodes and edges in an attempt to detect the important residues (hubs) in
G6PD dynamics. In the second section, the G6PD network was used to find the shortest
path lengths in both the wild-type and mutants, and to study how information (motion)
propagation is altered in the mutants, compared with the wild-type. Ultimately the
objective is to be able to find some examples that can demonstrate that, even if the
damage is local, the changes induced in the mutants are capable of influencing binding
sites behaviours. This could indicate that even if G6PD variants do not seem greatly to
destroy G6PD structure, they can greatly affect its function.
143
Chapter 6. Network analysis 144
6.1 Network analysis: Wordom
In the past decade, the interest in network-based analysis has grown steadily, and
different methodologies have been proposed to study protein-protein interactions and
metabolic networks. In more recent years, amino acid network (AAN [165]) models have
been used to describe protein structures in an attempt to acquire a better understanding
of proteins’ topology [166], protein folding [167], protein signalling [168] and prediction of
active centres and functions [169]. In all the different AAN formulations, Cartesian coor-
dinates (PDB files) are used to reconstruct proteins as nodes (amino acids) connected by
edges (amino acids interactions). The main difference between methods lies in how edges
are defined. In the un-weighted edge models, distance-based functions define an edge
only if the distance between nodes is less than a specific cut-off distance (Rc). Weighted-
edge models, instead, combine network theory with dynamics information from other
sources, such as MD experiments. Foor example RING is a web server that uses a
combination of van der Waals contacts, atomic distances and alpha carbon distances to
derive the amino acid network [170]. Alternatively, RINerator defines different interac-
tion types based on the residues involved and builds an undirected weighted network
with the weights of the edges that are proportional to the interaction strength [171].
Methods such as JGromacs [172], NetworkView [173] and PSN-Ensemble [174], are ca-
pable not only of building the networks from the PDB structure, but also of using MD
simulation data to generate dynamics profiles of AANs. xPyder [175], for example, uses
PyMOL to visualise common network parameters, such as hubs and intra/intermolec-
ular interactions, focusing on improving the visualisation of AANs. All these AAN
approaches have proven to be powerful tools in the study of protein behaviour and have
found a wide set of applications. Topology AANs were used to determine the role of key
residues in protein folding kinetics [176–178], to study the principles of protein-protein
interactions [179–181], to identify functionally important sites [182, 183], and to pre-
dict thermal stability [180]. AAN analysis on G6PD and its variants was performed
using the combination of both approaches implemented in wordom [184, 185]. Wordom
uses an un-weighted edge model to build the Protein Structure Network (PSN) and a
dynamics-weighted model, built combining PSN with cross-correlation information from
molecular dynamics trajectories, to calculate the shortest path length between residues
(PSNpath). Initially, all the frames of a trajectory are aligned to a reference structure
(generally the first frame) and the average structure is calculated. Then, information
on how the motions of the residues correlate with each other, is obtained using the Dy-
namic Cross-Correlation (DCC) algorithm [186], that assigns a score ranging from -1
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(completely anti-correlated) to +1 (completely correlated motions) to each residue. At
this point, the PSN of non-covalent connections between side chains is built as described
in Brinda et al. [180]; each amino acid constitutes a node of the network that is con-
nected to other nodes by edges based on the non-covalent interaction strength of their
side chains. This interaction between two residues (Iij) is calculated as
Iij =
nij√
Ni ×Nj × 100 (6.1)
where nij is the number of atom pairs between the side chains of residues (i and j)
4.5 A˚ apart, while Ni and Nj are the normalised factors for the residues type i and
j [187]. Since the interaction strength Iij depends on the property of both residues (i
and j), the normalised factors takes into account the differences in the sizes of the side
chains and their propensity to make contacts with other residues. The two residues are
connected by an edge when their interaction strength (Iij) is larger than an arbitrary
cut-off value (Imin). At Imin, a transition occurs and a large number of weak interactions
are lost. The correct value of Imin is set to the value at which the size of the largest
cluster (number of nodes) is half the size of the largest cluster at Imin equal to 0. For
G6PD, Imin was set to 3 and 2.9, depending on the temperature of the simulations;
310 K for the former and 400 K for the latter (Figure 6.1). Once the network is built,
it is possible to calculate the shortest path lengths (Lij) between nodes, defined as
the size of the shortest edge that connects two nodes (i and j) [188]. Building the
PSN may help the detection of those residues with high connectivity (hubs), that are
therefore important for the protein activity or structure. These nodes provide robustness
to the network against random mutations and help the linkage of different elements of
secondary structure together [180]. By studying how these nodes are connected in the
wild-type and in the mutants, it should be possible to observe the hidden changes in
G6PD structure that may explain the relationship between structural local changes and
the depressed activity seen in some variants. A schematic of the protocol is shown in
Figure 6.2.
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Figure 6.1: Size of the largest cluster as a function of Imin for the all-atom trajectories
of the wild-type at 310 K (3 replicas in red, black and green) and 400K (1 replica in
blue). The data were normalised by dividing the size of the clusters by the number of
residues in G6PD (N).
Start
MD trajectory
average structure aligned trajectory
CORR PSN
PSNpath
Stop
Figure 6.2: Diagram explaining the protocol used for the wordom analysis. Initially all
the frames of the MD trajectory are aligned to the reference structure (first frame) and
the average structure is extracted. This structure, together with the aligned trajectory,
is used to generate the Protein Structure Network (PSN) and to calculate the correlation
matrix residue-residue displacements (CORR) applying the Dynamic Cross-Correlation
algorithm. These steps produces a series of data which include: the 3D representation
of nodes and links, the average interaction strengths, the stable residue interactions,
the hub frequencies and correlations, the stable cluster compositions and largest cluster
size for each interaction strength (Iij). Finally, on the basis of both PSN and CORR
outputs, the shortest communication paths between hubs are generated (PSNpath).
The described protocol is applied to all the trajectories individually, and the results are
compared together. Because each trajectory was analysed individually it was possible
to observe the changes in hub in different replicas of the same mutant, allowing a better
comparison.
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6.1.1 Protein Structure Network (PSN)
In G6PD, the total number of hubs (nodes with more than 4 connections with other
nodes) existing in the wild-type was 45 at 310 K and 31 at 400 K (Figure 6.3), with
13 hubs corresponding of residues linked to existing G6PD variants. Of the latter,
group only one residue is associated with a class III variant while the rest are class
I or class II variants. 6 hubs are residues directly involved in binding (in either one
of the binding sites) and 11 are adjacent in sequence to a residue directly involved in
binding. More than half (6) of the residues involved in G6P binding are hubs, while
for the co-enzyme and structural NADPH, the proportion of hubs is around one third
(5 and 6 respectively). 3 of the detected hubs (Y70, R136 and R370) are at residues
for which MD data were generated (Chapters 3 and 5). At a first look, these numbers
seem to suggest that mutations in residues with high interconnectivity (hubs) are likely
to be associated with a G6PD variant that exhibits a class I or II depressed phenotype,
but the p-value calculated for the Fisher’s exact test on the data does not provide any
evidence against the assumption of independence of the classes, indicating that the hubs
are likely to be evenly distributed between the classes (Table 6.1).
Hubs Non-Hubs Fisher’s exact test
class I/II 12 60 72 p-value= 0.1351
class III/IV 2 34 36 odds ratio= 3.368
14 94 108
Table 6.1: The Fisher’s exact test was perfomed by comparing the number of hubs
of the wild-type (Hubs) and the number of residues that are not hubs (Non-Hubs) for
the different groups of classes. The test indicates that it is not possible to reject the
NULL hypothesis which states that are not evenly distributed between the classes.
The PSN analysis was repeated for the mutants which were already considered in the
previous chapters and their hub composition was compared to the wild-type using a
multiple alignment approach (Appendix B). Overall, the total number of hubs and their
location on the structure are maintained in the mutants, but it was possible to observe
some local differences.
G306 is never a hub in the wild-type or in any mutants, but when the glycine is re-
placed by the arginine in G306R, not only does R306′ start acting as a hub (Figure
6.4), but also some changes are recorded at Y482 (Figure 6.5). These residues are
far apart in sequence, but close in the 3D folded G6PD. MD simulations of G306R
(Chapter 3 Section 3.7) have shown that R306′ (βH) interacts with I480 in the parallel
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Figure 6.3: Total hubs detected in G6PD wild-type. In blue are represented the hubs
only found in the trajectories at 310 K, while in yellow are coloured the ones for 400 K
trajectories. In orange can be found the hubs shared between the two temperatures.
strand (βO). Even though I480 is not a hub, it is plausible that the R306-I480 inter-
action influences the adjacent residue (Y482) that in G306R stops acting as a hub in
the region. The class II variant G306S, whose damage was difficult to explain in MD
simulations, loses a hub at position 357, which is a residue that binds the structural
NADP+. The loss of a central-role residue, could be enough to lower the dimer stability.
wt NSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATK 320
G306R NSDDVRDEKVKVLKCISEVQANNVVLRQYVGNPDGEGEATK 320
G306S NSDDVRDEKVKVLKCISEVQANNVVLSQYVGNPDGEGEATK 320
.
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wt HQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306R HQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306S HQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
.
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.
480
.
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Figure 6.4: Alignment of portions of the sequence (N280-K320 and H470-G500) of
the wt and the mutants G306R and G306S, with the hubs highlighted in blue. (top)
R306 is a hub only in G306R, suggesting that the arginine changes the balance of the
are. (bottom) In G306R, the Isoleucine (I480) interacts with the new form hub (R306)
changing the behaviour of the surrounding residues (H470 and Y482) which are no
longer hubs.
G204 is located between two residues (Y202 and K205) that interact with G6P in the
binding site. In the wild-type, the glycine does not behave as a hub and the mediator
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of information (the closest hub) in the area is Y202 (H201 is only found as a hub in the
wild-type and in R136C). The arginine in G204R has more atoms to share and becomes
a hub, possibly changing the balance of the other hub in the area (Y202). A similar
mechanism could explain the effects of the arginine in the G359R mutant. This residue
is at the end of the βJ strand, in an area rich in residues involved in binding of G6P
(K360, R365) or the structural NADP+ (R357, N363, E364, K366 and R370). This area
is surrounded by a set of four hubs; F354 and R357 from one side and R370 and Q372
from the other (Figure 6.6). When the small glycine is substituted by the large and polar
arginine, the equilibrium of the region could change, modifying the capability of G6PD
to relate with both G6P and the structural NADP+. C358 and K360 act as hubs in
some mutants (L140P, A338E, Y70H), further suggesting the importance of this region.
wt RGSTTATFAAVVLYVENERWDGVPFILRC 358
A338E RGSTTATFEAVVLYVENERWDGVPFILRC 358
.
330
.
340
.
350
Figure 6.5: Alignment of portions of the sequence (R330-C358) of the wt and the
mutant A338E, with the hubs highlighted in blue. In A338E, E338′ forces both F337
and C358 to behave like hubs, disrupting the hubs distribution found in the wild-type.
In A338E, for example, there is a swap of status of C358 and F337 that become hubs
and R357 that instead loses that status. In addition, F337, the closest residue to the
mutation, is close in 3D structure which binds G6P. The fact that F337 was not a hub
in either the wild-type or in the mutants could be an indication that the changes could
be a direct effect of the glutamate in A338E (Figure 6.6).
Figure 6.6: Representation of the area surrounding R359. In red, the hub K360 is
indicated, and in yellow the area containing the binding residues is represented. The
hubs (F354, R357, R370 and Q372) forming the extremities of the region are in blue.
Y70 is a conserved hub in the wild-type and in the mutants, but not in Y70H. Several
residues close in sequence to H70′ (R72 and S73) bind the co-enzyme, suggesting that
changes of status in the area could affect co-enzyme binding. This hypothesis is strength-
ened by the observation that while, in the wild-type, both Y70 and Y118 are hubs and
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Y112 is not, in Y70H the roles are swapped and only Y112 is found as a hub (Figure 6.7).
This is particularly relevant considering that Y112 lies inside the co-enzyme binding site
and the observed changes could have consequences for co-enzyme binding. A similar
(a) (b)
Figure 6.7: Representation of the position of (a) Y70 and (b) H70′, in relation to
Y112 (blue) and Y118 (yellow). When Y70 is mutated in H70′, Y112 acts as a hub and
this change could affect the way Y112 binds the co-enzyme.
mechanism can be observed in R136C, where the changes in geometry observed in the
MD simulations could be a consequence of interactions between R136, two hubs (F138
and Y139) and a set of three residues that directly bind the co-enzyme (A141-P143-
P144-V146). As a final example, A461, which is never seen as a hub, forces Q261 to act
as one when mutated into a threonine in A461T.
Some of the observations detailed above are a direct consequence of the way the network
is built. In fact, because PSN uses the non-covalent interaction strength of the side chains
to determine the importance of residues, the conservation or loss of a hub could be the
mere result of the change in size (number of atoms) of the side-chains. Nevertheless,
these results suggest that hubs are located in key regions of G6PD structure, and that
the mutations have some role in how the hubs re-distribute in the surroundings. In
several cases, these changes could be connected to the binding sites, possibly explaining
the depressed activity.
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6.1.2 Protein Structure Network Paths
The PSN data were further used to try to detect changes in the motion paths that are
directly caused by the mutation. In proteins, some fast communication between sites
is often required for crucial functions, but sometimes long paths are used to absorb or
localize the effects of damaging perturbations. It is possible that a similar mechanism
could help G6PD to dissipate the damage induced by a mutation by redirecting it along
different paths. It also possible that non-damaging mutations (at the structural level)
could reach important sites by blocking or altering specific paths. For the wild-type
and some mutants, all the communication paths between the nodes found in the wild-
type were generated. Because usually the shortest communication paths are likely to be
the paths that more efficiently transmit information over long distances, the paths were
then ranked based on length and interaction strength and only the shortest and strongest
paths were considered. To observe only the likely alterations induced by the mutations,
the paths between nodes close to the mutation site were analysed and compared with
the data from the wild-type. In this analysis, examples were looked for that could prove
the mutations’ potential to affect G6PD function without destroying G6PD structure.
G306 is not involved in any paths in the wild-type, while in G306R, R306′ is associated
with 6042 paths. The previous section discussed how Y482 does not maintain the status
of a hub in G306R, and in fact in G306R there are half the number of paths connected
to Y482. The effects of R306′ in terms of changing the motion dynamics in the area,
can be understood by looking at a few examples. Y308 and R370 are hubs located close
to R306′, both in sequence and in 3D structure. In the wild-type, R306′ and Y482 do
not interact and Y308 and R370 are not connected, but in G306R they are, and their
communication path (Figure 6.8a) goes through both Y482 and R306′.
A similar example is represented by H263, an important hub that binds G6P in the
binding site. H263 and Y308 are not connected in the wild-type, but a 23 residue path
connects them in G306R (Figure 6.8b). It seems that the ability of R306′ to interact with
Y482 creates a triad of residues (Y308, Y482 and R306) that is capable of acting as a
bridge between areas that are generally isolated in the wild-type. These new paths could
interfere with the normal G6PD motions, eventually destabilising its structure. PSN
path analysis was also used to try to find clues on differences in behaviour between G306R
and G306S, two different mutations at the same residue. G306S is a class II variant
that SAAPpred predicted damaging with a lower score than G306R (a non-existing
variant). Even though the different nature of the two residues (serine and arginine)
could be explanation enough, the MD simulations of G306S did not clearly demonstrate
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(a) (b)
Figure 6.8: Examples of communication paths in G306R that do not exist in the
wild-type: The path from (a) Y308 and R370 and (b) H263 and Y308. R306′ is in
orange and Y482 is in yellow, while all the other residues involved are coloured in blue.
its damaging mechanism on G6PD structure (Chapter 3 Section 3.6). Similarly to what
happened in G306R, G306S is also involved in communication paths, but fewer than
G306R (6042 for G306R and 4606 for G306S). The comparison of the common paths
shows that paths in G306R tend to be shorter than in G306S. For example to connect
R357 (structural NADP+ binding) to Y482, 9 residues are required in G306S and only
3 in G306R.
G306S ⇒ R357-M496-I355-V341-L495-V304-I480-S306-A:Y482
G306R ⇒ A:R357-A:F337-A:R306-A:Y482
Both G306R and G306S are capable of propagating motions in regions that are separate
in the wild-type, but because the arginine side chain has more atoms to share, G306R
is more efficient than G306S.
As described previously, G204 is a non-hub residue that is located in the G6P binding
site, between two residues which bind G6P: Y202 and K205. In the wild-type, G204
is not a hub and there are no paths going through it, probably to avoid interference
with movements of both Y202 or K205. When the glycine is mutated into an arginine,
R204′ acts as a hub and plays a role in 3802 paths. To explore the possible effects that
this may have, the paths passing through the close hub Y202 were checked and it was
discovered that the mutation increases the connectivity of the network in the area close
to the mutation site (Figure 6.9).
In the wild-type (Figure 6.9a), H201, Y202 and K205 are involved in fewer paths, con-
trary to G204R where the same residues interact more frequently with the surroundings.
If a longer path is considered (W53-Y70), it is possible to notice how the paths diverge
right after Y202 is reached:
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(a) (b)
Figure 6.9: Increase in the number of the shortest communication paths for Y202
in the area around the mutation site for (a) the wild-type and (b) G204R. R204′ is in
orange and Y202 is in yellow, while all the residues involved are coloured in blue. The
two residues that bind G6P (K205 and H201) are in black.
wild-type ⇒ A:W53-A:R57-A:W54-A:E438-A:D435-A:K205-A:Y202-
A:F237-A:V259-A:I255-A:F250-A:D258-A:F253-A:P172-A:P144-A:Y147-A:L140-
A:M37-A:Y70
G204R ⇒ A:W53-A:R57-A:W54-A:E438-A:D435-A:K205-A:Y202-
A:H263-A:K171-A:D258-A:P172-A:F253-A:Y249-A:P143-A:V146-A:Y112-A:Y70
In the wild-type, Y202 is oriented in such a way that its side chain points to the centre
of the binding site and, in order to reach Y70, the motions first have to jump to F237
first and then to V259 (Figure 6.10 in red). In G204R instead, the Y202 side chain
points to the bottom of the binding site, interacting with H263 (Figure 6.10 in yellow),
resulting in a two residue shorter path (Figure 6.11).
This finding suggests that even if the arginine does not impact the structure at the en-
zyme on a global level, it forces a reorganisation of the surrounding residues that could
impair the capability of key residues, such as Y202 and K205, to assume the correct
position and orientation required for G6P binding.
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Figure 6.10: Schematics of the paths (W53-Y70) in the G6P binding site. In the
wild-type (red line), the path goes through the binding site, while in G204R (yellow
line), the biniding site is avoided.
(a) (b)
Figure 6.11: Example of changes in path lengths between W53 and Y70 in (a) the
wild-type and in (b) G204R. All the residues involved are coloured in blue, while R204
is in orange and Y202 is in yellow. K205, another hub that binds G6P, is in black.
Another example is represented by mutant R227Q. This mutant is located on the surface
close to the binding site, it was predicted as damaging by SAAPpred with a low con-
fidence (0.15), and is associated only with a mild depressed activity (class III). There
were no significant differences in hub distribution compared with the wild-type, but
while there are no paths passing through residue 227 in both the wild-type and R227Q,
it was possible to detect some changes in the way W349, the closest hub in 3D structure,
behaves. In fact, the mutant lost 200 paths and even though the maintained paths are
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mainly identical in residue composition, they present differences in interaction strengths,
suggesting that attractions and repulsions between Q227′ and W349 could cause W349
to move (Figure 6.12), altering the number of atoms available for the interactions (as
fewer atoms means less interaction strength between close residues).
(a) (b)
Figure 6.12: Example of changes in path lengths between W349 and Q266 in the
wild-type (a) and in R227Q (b). Q227′ is in orange and W349 is in yellow, while all
the other residues involved are coloured in blue.
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6.1.3 Discussion
A Network analysis was performed on both the wild-type and the mutants to explore
how motions travel through the G6PD structure. Initially G6PD was rebuilt as a net-
work of nodes and edges based on side-chain interactions and then these data were used
to calculate the shortest communication paths between hubs. The network analysis was
applied to G6PD and its mutants in an attempt of find evidence that the local structural
changes of a mutation can propagate through the enzyme structure, affecting its func-
tioning. All the observations obtained seem to confirm this behaviour. The mutations
were found to be capable of altering the natural balances, by modifying the roles exerted
by the residues in the area. The hubs are important residues of a protein, which has
the function of linking together the different elements of its structure. Some mutations
(G306R, G204R) introduce residues that direct the motions toward themselves, disrupt-
ing nearby hubs and potentially connecting isolated regions together. Other mutations
(Y70H), weaken the mutated residue influence, isolating the area from the highly con-
nected centres of the protein. All these changes are capable of reaching the binding
sites, possibly altering the normal behaviour of these vital sites. The result is that in
G6PD, the mutations are not capable of disrupting the global structure of the enzyme
completely, but they tend to force local rearrangements and to generate small pertur-
bations that influence the internal motion propagation, eventually causing the damaged
phenotype recorded in the mutants.
Chapter 7
Summary and Conclusion
Malaria is a dangerous disease commonly transmitted by infected mosquitoes, and there
is a strong connection between malaria and G6PD deficiency. In individuals with G6PD
deficiency, the administration of the malaria drugs of the family of the 8-aminoquinolines
may be very risky. To make malaria drugs safer, the development of low-cost and simple-
to-use immunological field tests for G6PD-depressed-activity detection is required. The
principal aim of this project was the study of the structure of G6PD and its variants to
understand the structural effects of single point mutations on its stability. The collected
information serves to assess the feasibility of using an immunological assay approach to
detect G6PD variants, which are commonly associated with depressed activity.
Chapter 3 and Chapter 5 addressed the use of all-atom and coarse grained MD simu-
lations in trying to identify common behaviours among G6PD mutants. Simulation at
different temperatures and for different times made possible the detection of the local
effects that are likely to be the origin of the depressed activity of the mutants. The
collected data suggest that it seems to be unlikely for an antibody-assay to be developed
to detect G6PD variants. It was hoped that G6PD variants would destabilise the pro-
tein leading to a partial unfolding at relatively high simulation temperature, and that
the weak parts in the structure could be identified as common to several mutations.
The effects of the mutations are in all cases very local and the mutations have a role
in increasing the disorder in the surrounding area. This effect is obtained in different
ways, but in almost all cases these effects can be connected to one of G6PD binding
sites. In G306R, for example, the larger side chain of R306′ interacts with I480 causing
a premature unfolding of the strands in an area close to the structural NADP+ binding
site. The threonine found in A461T is capable of deforming the αn helix at the base of
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the G6P binding site, while in Y70H the presence of H70′ causes a distortion in size and
geometry of the co-enzyme binding site. The only mutant that has a recognisable struc-
tural effect of the mutation is A− . Here D126′ and M68′ destabilise the αc helix and
the βB strand respectively, resulting in a specific unfolding pattern of the Rossmann-
like domain of the enzyme. The coarse grained model (UNRES) made the unfolding,
resulting from the destabilising interactions, visible, but the lack of details of the model
made the identification of common behaviour among the mutants difficult. Even though
the resulting effects of the mutants can be roughly expressed in similar manners (e.g. it
destabilises the C-terminus of the enzyme), all the structural rearrangements observed
in the mutants are specific to each mutation, and therefore the features expressed are
not shared or maintained in other mutants. It is proposed that G6PD resilience to mu-
tation damage, could be connected with the great importance that this enzyme plays
in the cell. In fact, the complete deletion of G6PD in any cell of the organism is not
compatible with life. To be functioning, G6PD must be stable and capable of reducing
the damaging effects of possible mutations.
Particular care was used to study the behaviour of Pro172. Pro172 plays a key role in the
correct positioning of both the substrate and the co-enzyme. In the literature, Pro172
was observed in both cis and trans form, so it was proposed that its function could be
achieved by cis-trans isomerisation. To investigate if this is a real mechanism or the
result of crystallography artefacts, the ω angle was monitored during the all-atom sim-
ulations. Even though Pro172 is in cis in all the simulations at low temperature (310 K
and 400 K), the trans form of Pro172 was recorded at high temperature simulations (500
K), suggesting that the cis-trans isomerisation of Pro172 may occur in G6PD. Finally,
further to understand the importance of Pro172 for the correct functioning of G6PD, it
was decided to monitor the movements of Pro172 between the G6P and the co-enzyme
binding site. In Chapter 4, metadynamics calculations were performed to study the evo-
lution of the distances of the binding sites in relation to Pro172 (distances taken from
the farthest of the residues that binds). Pro172 was found to oscillate between the two
binding sites with a propensity to lean towards the co-enzyme binding site, suggesting
that the movement of Pro172 moves the co-enzyme closer to the substrate binding site,
allowing the interaction of K171 with G6P through its terminal amino group and with
the co-enzyme through its carbonyl group.
Chapter 6 described some additional work that was done with the intention of better un-
derstanding the internal mechanisms of action of the mutations. In Chapter 5, network
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analysis was used to have an idea of how the damage, caused by the mutations, propa-
gates through the G6PD structure. Attention was given to highly connected nodes, that
are important residues that help the connection between regions of the enzyme. Changes
in these residues generally have a more severe effect because they play a central role in
allowing communications (motions) to travel through the G6PD structure. By looking
at the hub distribution in G6PD and its mutants, it was observed that mutations have
the ability of altering the equilibria in the areas surrounding the mutation sites, resulting
in differences in hubs’ behaviours. The findings suggest that some mutants are capable
of creating new paths and put in communication regions of G6PD that are isolated in
the wild-type, while others induce a reorganisation of the information routes around the
mutation sites. These perturbations impact the way information travels through the
G6PD structure eventually leads to the phenotypic changes observed in G6PD variants.
Even though the development of a small number of antibodies capable of discriminating
between mutants and wild-type upon binding was determined to be unlikely, this project
outlined some key features that can help the understanding of this robust enzyme.
7.1 Future directions
This project started with the intention of studying as many G6PD mutants as possible,
but because this number is close to 3500 possible mutants, and the fact that G6PD is a
large system to simulate, only a small subset of 17 G6PD mutations was studied. The
maim conclusion of this thesis is that the effects of the mutations are very local and, even
though there are several similarities, it is not possible to find specific common behaviours
between the mutants. Considering that a mass study is not feasible, it would be better
to focus on the most severe (class I) or most common G6PD variants, in an attempt
to find specific solutions for their detection. This could be possible for the A− variant,
which is one of the most common variants in Africa, or african ancestry, populations.
For the other variants, a more detailed analysis could reveal some other mechanisms
not identified in this project. All the simulations were performed in the absence of
substrates; it would be interesting to see how differently G6PD and the mutants behave
in the presence of both the G6PD and the co-enzyme. MD and free energy calculations
may provide information on the affinity and binding capability in the mutants. This
could prove to be challenging because of the absence of a complete parametrisation
of the G6P molecule for the force fields considered, but would prove to be extremely
helpful in assessing the changes in binding affinity of the mutants. Another possibility
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would be the comparison between the monomer and the dimer. Only the dimer is
recognised as being the active form of G6PD, but there are currently no explanations
for this behaviour. Observing the dynamics of the monomer over time could help the
understanding of the structural mechanisms that drive the dimer formation.
Appendix A
Scripting: doitGROMACS
A central role in the project was played by the shell script doitGROMACS.sh, written
and maintained throughout the PhD. A normal GROMACS workflow sees the calling
of several tools, each of them containing different parameters and files. The typing of
these long commands is repetitive, slow and subject to errors. The script allows the
automation of several steps, resulting in an increase in efficiency and precision, with a
dramatic reduction in error rates. The first version of the script was very simple and
contained only functions to equilibrate the system, run PCA and cluster analyses. Most
of the parameters were hard-coded, all the prompts were passed using echo and there
was no error control. Over time, the complexity increased to the point that the script
required a complete rewrite before the final version (v 2.0) could be released. The factors
that were considered important and which have driven the development of the code were:
• A consistent naming system: A non-trivial problem that is encountered while
working with GROMACS tools is keeping track of all the simulation files. GRO-
MACS generates several outputs with names which are set to default values (e.g.
rmsd.xvg, ev1.pdb). A user can easily change them at will, but great care is needed
to avoid confusion. This script addresses this problem by using some conventions
in file names. The data are distributed in separate “temperature” directories, con-
taining all the simulations at that specific temperature; inside, all the different
simulation files are named using the following scheme: NAMErX TIME ; where
NAME is the mutation (e.g.306r), X is the replica number and TIME is the sim-
ulation length in ns. Following this scheme, the file 400K/wtr2 800.xtc, refers to
the 800 ns long trajectory file of the second replica run for the wild-type at 400 K.
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• Universality: Initially the script was tailored around the system and require-
ments of this project. Using the script on a different system would have meant
manual editing of the script itself. This may be risky and is definitely not good
practice, so, to allow other users to use the script, some changes had to be made.
The problem was solved by using a configuration file to store most of the param-
eters and variables. A user will have to make changes only in this file leaving the
rest of the script untouched. This approach not only allows other people to use
doitGROMACS.sh, but it also improves readability and makes debugging easier.
• Error handling: The functionality of this code is guaranteed by its ability to
pass files to and from different GROMACS tools. An error in one of these tools
may generate a faulty file, causing another tool to fail. Error handling functions
stop the execution as soon as an error is detected. Furthermore, to help with
the debugging process, specific .log and .err files are generated for each executed
function.
A look at the evolution of the script over time, reflects how its changes are not simply an
addition/removal of functions, but a dynamic process that ran parallel to the evolution
of my personal programming skills. Slowly, the script evolved from a list of repetitive
echo statements and if blocks, to a well structured and organised collection of opti-
mised functions.
The script is mainly written in bash, with additional functions both in R and perl.
This script is accessible from github at the following address:
https://github.com/frac2738/doitGROMACS final.
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A.1 Main script (doitGROMACS.sh)
The main script has the role of linking everything together by taking the user commands
and passing them to the required functions. The script reads most of the parameters from
two distinctive sources: flags and a configuration file. The main difference between the
two is that flags are used to define function independent variables, while the configuration
file contains parameters that are specific and used only by certain functions (function
dependent variables). The flags are set from the console when the script is invoked and
define names, executable paths and files. The complete list of flags available can be
obtained with the command doitGROMACS.sh -h :
Option Type Value Description
---------------------------------------------------------------------------
-[no]h bool yes Print help info
-g bool bool Set gromacs 5 syntax
[ ALWAYS REQUIRED ]
---------------------------------------------------------------------------
-b string acrm Set the location of binaries
acrm - Darwin building computer
emerald - Emerald cluster
default - standard linux computer
The user can add more machines in the
binary configuration file.
-n int wt Set the name
[OPTIONAL (function dependant )]
---------------------------------------------------------------------------
-t int 200 Set the simulation length
-s string .tpr .tpr file
-f string .xtc Trajectory file
-c string .pdb Pdb file to use to start a simulation
-e string .edr Energy file
The flags -b and -n are always required and their existence is checked when the script
is invoked. All the other flags are function dependent and they are checked only when
a specific function is called. When a function is called without the correct flags, the
execution is halted and a warning message indicates which flag should be set.
16:34:45: execution halted: tpr and trj files are required (set them with -s -f)
The configuration file (doitGROMACS.config) contains all the variables that are required
by the different GROMACS tools. The force field used, the shape of the simulation box
and the simulation temperature are some of the existing options.
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...
optionFF=’6’ # force field: AMBER99S -ILDN protein , nucleic AMBER94
optionWM=’1’ # water model: TIP3P
optionBOX=’triclinic ’ # box shape
optionDISTEDGE =’1.4’ # protein -box distance [nm]
optionTEMP =’400’ # system temperature [K]
...
To allow the use on different machines, the configuration file also contains the location
of the different GROMACS tools and R binaries. When doitGROMACS is invoked, the
value of the -b flag is read and doitGROMACS checks that there is consistency between
this value and the binaries written in the configuration file. If the configuration file
points to the wrong binary, doitGROMACS will use standard linux binaries for both
GROMACS and R. At the moment 3 machine classes are supported: any linux machine
in the UCL network (acrm), the UCL cluster Emerald (emerald) and a general linux
machine (standard). The user can easily defines its own machines, by adding them
to the configuration file. For example, to use a different version of R, the user can add
RscriptEXE hello=‘/export/user/R-v1.3/bin/Rscript’ to the configuration file and
then use -b hello.
Consistency received a lot of attention and several mechanisms assure that each function
is executed only when the required files and flags have been specified. Once everything
is checked, the script prints the available options and waits for the user input.
-----------------------------
------------------- GROMACS 4.6 syntax will be used -------------------
-----------------------------
-----------
---------------------------- doitOPTIONS ----------------------------
-----------
all - Starting from scratch **
emin - Starting from E-minimization **
nvt - Starting from NVT **
npt - Starting from NPT **
h20 - Remove water from a trajectory file
cond - Check the simulation conditions (U-T-P-density)
rmsdfg - Calculate RMSD , GYRATION RADIUS and RMSF [backbone & sidechains]
dssp - DSSP analysis
dssp_perc - percentage of ss using a xpm file
contact - Compute contact maps
cluster - Cluster analysis
pca - PCA analysis
sas - SAS analysis
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sas -sites - SAS analysis on only the binding sites
hb - Hydrogen bonds analysis [not yet implemented]
hb-sites - Hydrogen bonds analysis on binding sites
ggplot - Plot with ggplot (R)
indexCreator - Create binding sites index for the mutant
omega - Calculate omega values for all the residues
mean - calculate the mean of values [2nd column]
mean_multi - calculate the mean of values [several columns]
modvim+ - replace "@" with "#" in a file
catomain - rebuild a full atoms structure from CA structure
split_states - given an unres trj extract all the frames and convert
into all -atom structures
--------------------------------------------------------------------
-----------
** Options that require a parameter file (.mdp) that MUST be placed in the
same directory; the functions only accept these files:
TEMP -min.mdp
TEMP -nvt.mdp
TEMP -npt.mdp
TEMP -md.mdp
with TEMP = temperature in Kelvin (310, 400, ...)
The doitGROMACS tarball contains some examples of mdp file.
execute option :
Examples on how to run the script can be found in section A.4.
A.2 Functions
A.2.1 Equilibration
• inputs(): function that prepares the
simulation box;
• energy minimization(): function that
minimises a protein;
• nvt(): function that equilibrates in
an nvt ensemble;
• npt(): function that equilibrates in
an npt ensemble;
This file groups the functions designed to prepare the system to a production MD sim-
ulation. The function inputs() takes a PDB file (-c flag) and creates a topology for that
protein. It then builds and solvates a box around the protein and, finally, adds ions to
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neutralise the total charge of the system. The energy minimisation, and the temperature
and pressure equilibration steps are held by the functions energy minimization(), nvt()
and npt() respectively. These last functions simply create a starting parameter file (.tpr)
from a .mdp file (specified in the config file) and run mdrun from the GROMACS suite.
For an example of how these functions work see section A.4.1.
A.2.2 Analyses
A big part of doitGROMACS.sh is represented by the collection of functions designed to
run the analyses that are generally used to analyse a trajectory (.xtc). At the moment,
the script supports the following functions:
• h20: removes the water from a trj file;
• cond: prints the simulation condi-
tions (Potential,Temperature,Pressure,
Density);
• rmsdf: calculates rmsd, rmsf and ra-
dius of gyration;
• dssp: assigns secondary structure to
each frame of the trajectory;
• cluster: runs cluster analysis;
• pca: runs PCA analysis (C-alpha);
• sas: runs SAS analysis;
• hb: counts hydrogen bonds;
• ggplot: plots the outputs of the other
functions with ggplot;
• indexCreator: generates index files
for a subset of atoms specified in the
configuration file.
• catomain: rebuilds a full structure
from a Cα-only structure.
• rama: calculates ψ, φ and ω values
for the residues.
A.2.2.1 h20
This function removes the water molecules from a trajectory and corrects any artifacts
generated by the periodic boundary conditions (pbc). The function first removes all
the water coordinates from the reduced precision trajectory (.xtc), and it then does the
same for the input file (.tpr) and creates a structure file (.gro) with the first structure in
the trajectory. This structure can be loaded into programs such as vmd or pyMOL for
visualisation. Finally, it re-centres the protein in the box and accounts for the periodicity
by removing the translations and rotations.
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A.2.2.2 cond and rmsdf
These functions have the main objective of extracting simulation conditions and energy
from a trajectory. The function cond() extracts the temperature, potential, pressure
and density profiles from the energy file (.edr). By observing how these values change
during the simulation, it is possible to predict and avoid large changes in the forces that
lead to system instabilities and simulation failures. The rmsdf() function calculates the
rmsd, radius of gyration and rmsf for the selected trajectory. For an example of how
these functions work see section A.4.2.
A.2.2.3 dssp
This function uses the dssp program [189] to assign the correct secondary structure to
each frame of a given trajectory.
A.2.2.4 pca
This function can be used to perform PCA analysis by calculating and diagonalising
the mass-weighted covariance matrix. Additionally, pca() uses the projections of the
first two eigenvectors to make a multi-dimensional free-energy plot. The raw plot is
then enhanced in R, using the ggplot() function (A.2.2.8). For an example of how these
functions work see section A.4.3.
A.2.2.5 cluster
This function executes cluster analysis using a clustering algorithm specified in the
configuration file (default is set to gromos). To avoid overcrowding of the main directory,
the function first creates a new directory, checks if an rmsd matrix already exists and
then runs the cluster algorithm. This simplifies re-running the analysis with a different
algorithm, because no time is wasted recalculating the matrix if it is already there.
A.2.2.6 sas and hb
These functions are used to calculate Solvent Accessible Surface area and to count hy-
drogen bonds. There are two version of these functions: one performs the analysis on
the entire protein (sas and hb), while the second only on specific groups defined in the
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configuration file (sas-sites and hb-sites). In this project, these second functions were
used to observe the changes in the binding sites of G6PD. All the parameters, such as
the size of the probe or the number of dots per probe, are defined in the configuration
file.
A.2.2.7 rama
This function calculates the values of the φ, ψ and ω dihedral angles for each residue in
a trajectory. The function calculates both averages over the trajectory and the values
in each frame. Additionally, it allows the user to specify a residue (e.g. pro-172), and
extract and plot the Ramachandran plot and ω distribution for that residue only.
A.2.2.8 doitRGROMACS
doitRGROMACS is an R script which contains all the subroutines used to plot (using
ggplot) the output files from the analyses. It is generally called at the end of one function
and it checks what type of file has been passed (rmsd or rmsf) and it calls the function
required by that specific file type.
A.3 Error handling
DoitGROMACS.sh works by executing several commands in sequence, meaning that, if
pipelines are not stopped when errors arise, corrupted files are passed to the next tool.
doitGROMACS.sh has several functions that check and guarantee that everything runs
smoothly. One of the mechanisms used is the checking of the exit code of commands.
The script catches the exit codes ($?) and halts the execution whenever the values differ
from zero. A prompt tells the user what has happened and details are written into the
.err file. thus making debugging easier.
checkExitCode () {
exitvalue=$?
if [ ! $exitvalue -eq 0 ]; then
error_exit " The last function returned the wrong exit code , execution halted.
Check logs for further details ."
fi
}
Appendix. doitGROMACS 169
A.4 Examples
A.4.1 System equilibration
System equilibration is generally the first thing that is done before starting a production
dynamics run. In these initial steps, the simulation box is created, solvated and all the
unfavourable geometries and interactions inside the box are removed. Temperature and
pressure are then applied until the system is stable. All this can be achieved using
doitGROMACS.
doitGROMACS.sh -b standard -n 2bhl -c 2bhl.pdb -g
The -b flags tells doitGROMACS which machine the user is using (a standard linux
machine in this case), while the -g flag indicates that the user wants to use the newer
version of GROMACS (5.0.4 or above). The value of -n sets the PREFIX used for all the
output files (e.g. 2bhl processed.pdb or 2bhl min.xtc). When the all option is selected
at the prompt, doitGROMACS starts building the simulation box around the protein in
the PDB file specified with the -c flag. After creating the topology, building the box and
solvating the system, doitGROMACS prompts the user for the number of ions required
to neutralise the total charge of the system.
NOTE 3 [file topology.top, line 46]:
System has non-zero total charge: -7.999994
Specify the number of ions to be add added to the system [+/- integer]
(e.g. + 12 or - 23) + 8
A message lists the changes and doitGROMACS starts minimising the system.
Back Off! I just backed up topology.top to ./#topology.top.2#
Replacing solvent molecule 5695 (atom 32505) with NA
Replacing solvent molecule 15786 (atom 62778) with NA
Replacing solvent molecule 12443 (atom 52749) with NA
Replacing solvent molecule 51683 (atom 170469) with NA
Replacing solvent molecule 52802 (atom 173826) with NA
Replacing solvent molecule 9001 (atom 42423) with NA
Replacing solvent molecule 18792 (atom 71796) with NA
Replacing solvent molecule 2490 (atom 22890) with NA
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When the energy has converged, doitGROMACS calls, in sequence, the functions nvt and
npt that equilibrate the now minimised system first in an NVT and then in an NPT en-
semble. At the end of every step, doitGROMACS outputs some files ( 2bhl potential.xvg,
2bhl density.xvg, 2bhl pressure.xvg and 2bhl temperature.xvg) that help the user check-
ing the stability of the system along the equilibration process (Figure A.1).
Figure A.1: Default representation (using xmgrace) of the temperature profile of the
nvt equilibration step for the wild-type.
If the system is not well equilibrated, it is possible to rerun some of the previous steps
until convergence is reached. This can be achieved by invoking:
doitGROMACS.sh -b standard -n 2bhl -c 2bhl.pdb -g
and selecting an option between emin, nvt or npt, depending on the step which needs to
be rerun. If emin and nvt are selected, doitGROMACS will take care of completing the
equilibration of the system until the end. The force field, the water model and all of the
other parameters are defined in the ‘simulation options’ section of the configuration file.
#================================= simulation options =========================
optionFF=’6’ # force field: AMBER99S -ILDN protein , nucleic AMBER94
optionWM=’1’ # water model: TIP3P
optionBOX=’triclinic ’ # box shape
optionDISTEDGE =’1.4’ # protein -box distance [nm]
Additionally, some GROMACS tools require a specific parameter file (.mdp) for their
functioning. These files must be specified in the ‘MDPs option’ section of the configu-
ration file.
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#================================== MDPs options ==============================
optionTEMP =’310’ # system temperature [K]
ioniMDP =’./ ionization.mdp ’
minMDP ="./" $optionTEMP"-min.mdp"
nvtMDP ="./" $optionTEMP"-nvt.mdp"
nptMDP ="./" $optionTEMP"-npt.mdp"
A.4.2 rmsdfg
This section describes how to use doitGROMACS to extract the rmsd, rmsf and radius
of gyration profiles from a trajectory and plot them using ggplot. This can be done by
invoking doitGROMACS and selecting the option rmsf at the prompt:
doitGROMACS.sh -b acrm -n 2bhl -t 150 -e 2bhl 150.edr -s 2bhl 150.tpr
-f 2bhl 150.xtc -g
During MD experiments, GROMACS records information about all the energies of
the simulation (potential energy, temperature, pressure, . . .) in an .edr file. This file
(2bhl 150.edr in the example) is passed to doitGROMACS using the -e flag. To work
properly, doitGROMACS needs two additional files: 2bhl 150.tpr and 2bhl 150.xtc. The
first contains the simulation parameters (starting structure and molecular topology) and
the latter stores the coordinates of the system during the entire trajectory. After check-
ing the existence of the required files, rmsdfg calculates in sequence rmsd, radius of
gyration and rmsf. The user has the option of deciding which group to use for the
calculation by editing the configuration file.
optionRMSD=’Backbone ’
optionGYRATION=’Protein ’
optionRMSFb=’Backbone ’
optionRMSFsc=’SideChain ’
At the end of the execution, doitGROMACS outputs 4 files named after the values of
the flags -n and -t (2bhl 150 in the example). These files are:
• 2bhl 150 rmsd.xvg: rmsd profile;
• 2bhl 150 rgyr.xvg: radius of gyration profile;
• 2bhl 150 rmsf bb.xvg: rmsf profile of the backbone;
• 2bhl 150 rmsf sc.xvg: rmsf profile of the side-chains.
Appendix. doitGROMACS 172
These files can be visualised with the software grace (xmgrace) (Figure A.2) or they can
be further processed by doitGROMACS to obtained enhanced figures (Figure A.3).
Figure A.2: This figure presents an example of an rmsf profile visualised in grace. In
the default representation, the two chains are connected together resulting in a diagonal
line on screen.
This can be achieved through choosing the ggplot option at the prompt. This function
calls an R script (doitRGROMACS.R) that produces the required figure using ggplot .
Figure A.3: This figure presents the same rsmf profile as Figure A.2, obtained by
running doitRGROMACS.R.
A.4.3 PCA
The doitGROMACS function dedicated to PCA is called gromPCA() and can be used
by invoking doitGROMACS and selecting the option pca at prompt:
doitGROMACS.sh -b acrm -n 2bhl -t 150 -e 2bhl 150.edr -s 2bhl 150.tpr
-f 2bhl 150.xtc
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gromPCA first looks for a directory named PCA 2bhl, creates one if it is not there,
and then checks the existence of the covariance matrix (covariance.xpm) which captures
the correlation of motion between atom pairs. This step is necessary to avoid having
to recalculate the matrix every time the same trajectory is analysed. If the matrix is
not found, gromPCA calculates it using the Cα atoms if not otherwise specified in the
configuration file:
optionSTARTime=’0’ # [ps] [option used for cluster/pca/dssp/sas]
#==================================== pca options =============================
optionPCA=’C-alpha ’ #
optionDTpca =’100’ # jump in [ps]
doitGROMACS allows the user to skip some frames of the trajectory and to run the
analysis only on a portion of the trajectory only. This is done by changing optionSTAR-
Time and optionDTpca in the configuration file. The covariance matrix now calculated is
diagonalised to obtain eigenvectors (collective motion per atom) and eigenvalues (value
of the involvement of the atom in the motion). Generally, only the first eigenvectors
capture the important motions of the protein, this is why the user is required to input
the number of eigenvalues to study.
how many eigenvalues do you want to use for the analysis?
The choice is facilitated by a pop-up window which presents all the eigenvectors and
their respective amplitude (Figure A.4).
Figure A.4: Default visualisation of the eigenvalues plot with grace.
For each eigenvalue selected, doitGROMACS calculates its projection over time and it
extracts the extreme structures from the trajectory, saving them in a pdb file (ev1.pdb,
ev2.pdb, . . . ). These PDB files allow the observation of the motion along the cartesian
axis in PyMOL or any other visualisation program (Figure A.5). Finally, gromPCA
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plots the projections of the first two eigenvectors against each other to obtain the PES
profile (Figure A.6).
Figure A.5: Representation of the motions along one eigenvector visualised using
PyMOL.
Figure A.6: Example of the PES profile obtained from the first two eigenvectors of a
simulation.
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A.5 Discussion
doitGROMACS was written to optimise the use of the different GROMACS tools in my
workflow. Great efforts were made to rewrite the functions in a more general way, so
that the use of doitGROMACS is possible for any protein system. Nevertheless there
are some things that need to be improved. For example, the function that creates
indexes of atoms (indexCreator()) is still very rudimentary. It requires the user to
specify the exact syntax used by the GROMACS tools and it does not check for other
user-defined indexes. It would also be ideal to reduce the user interactions by adding
default values to some parameters, that can be overwritten, if needed, from the command
line. However, the increase in functionalities and in complexity suggests a rethink of
the role of doitGROMACS, a software written with simplicity in mind. One possible
strategy would be the split into several scripts that do one single task each. The scripts
will independently handle I/O files and error-control, and the new doitGROMACS would
simply consist in a wrap that connects them together.
Appendix. doitGROMACS 176
F
ig
ur
e
A
.7
:
Fl
ow
ch
ar
t
of
do
itg
ro
m
ac
s.s
h.
Appendix B
PSN alignments
In the alignments, the hubs are marked in blue while the residues involved in binding
are circled using different colour depending on the binding site: red for the G6P binding
site, blue for the co-enzyme binding site and orange for the structural NADP+ binding
site.
B.1 Hubs for the 310 K dynamics
β β α
• I• I o^^ o^ o^ o^o^o^o^o^
wt XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G306R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G306S XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G204R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
L140P XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
A338E XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
Y70H XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
R136C XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
R227Q XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
C232Y XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
C269Y XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
A461T XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
.
10
.
20
.
30
.
40
.
50
177
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α β α
o^^ o^ o^ o^o^o^ • I o^^ o^ o^ o^o^o^o^o^o^o^o^o^
wt TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G306R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G306S TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G204R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
L140P TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
A338E TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
Y70H TIWWLFRDGLLPENTFIVGHARSRLTVADIRKQSEPFFKATPEEKLKLED 100
R136C TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
R227Q TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
C232Y TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
C269Y TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
A461T TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
.
60
.
70
.
80
.
90
.
100
β α β α
• I o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^ • I o^^ o^ o^ o^o^o^
wt FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G306R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G306S FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G204R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
L140P FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYPALPPTVYEAV 150
A338E FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
Y70H FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
R136C FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANCLFYLALPPTVYEAV 150
R227Q FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
C232Y FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
C269Y FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
A461T FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
.
110
.
120
.
130
.
140
.
150
α α β α β
o^^ o^ o^ o^o^ o^^ o^ o^o^o^o^o^ • I o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^ •
wt TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G306R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G306S TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G204R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
L140P TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
A338E TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
Y70H TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
R136C TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
R227Q TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
C232Y TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
C269Y TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
A461T TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
.
160
.
170
.
180
.
190
.
200
β α α β
I o^^ o^ o^ o^o^o^o^o^o^ o^^ o^ o^o^o^o^ • I
wt HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G306R HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G306S HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G204R HYLRKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
L140P HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
A338E HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
Y70H HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
R136C HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
R227Q HYLGKEMVQNLMVLRFANRIFGPIWNQDNIACVILTFKEPFGTEGRGGYF 250
C232Y HYLGKEMVQNLMVLRFANRIFGPIWNRDNIAYVILTFKEPFGTEGRGGYF 250
C269Y HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
A461T HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
.
210
.
220
.
230
.
240
.
250
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α α α
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^ o^^
wt DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G306R DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G306S DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G204R DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
L140P DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
A338E DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
Y70H DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
R136C DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
R227Q DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
C232Y DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
C269Y DEFGIIRDVMQNHLLQMLYLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
A461T DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
.
260
.
270
.
280
.
290
.
300
α β β
o^^ o^ • I • I
wt NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G306R NNVVLRQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G306S NNVVLSQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G204R NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
L140P NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
A338E NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFEAVVLYVENERWD 350
Y70H NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
R136C NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
R227Q NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
C232Y NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
C269Y NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
A461T NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
.
310
.
320
.
330
.
340
.
350
β β β
• I • I •
wt GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G306R GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G306S GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G204R GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
L140P GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
A338E GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
Y70H GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
R136C GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
R227Q GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
C232Y GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
C269Y GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
A461T GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
.
360
.
370
.
380
.
390
.
400
β β α α
I • I o^^ o^ o^ o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^
wt YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G306R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G306S YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G204R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
L140P YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
A338E YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
Y70H YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
R136C YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
R227Q YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
C232Y YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
C269Y YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
A461T YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
.
410
.
420
.
430
.
440
.
450
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α β α
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^ • I o^^ o^ o^ o^o^o^o^
wt HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306S HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G204R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
L140P HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
A338E HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
Y70H HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
R136C HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
R227Q HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
C232Y HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
C269Y HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
A461T HFVRSDELRETWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
.
460
.
470
.
480
.
490
.
500
wt FQYEG 505
G306R FQYEG 505
G306S FQYEG 505
G204R FQYEG 505
L140P FQYEG 505
A338E FQYEG 505
Y70H FQYEG 505
R136C FQYEG 505
R227Q FQYEG 505
C232Y FQYEG 505
C269Y FQYEG 505
A461T FQYEG 505
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B.2 Hubs for the 400 K dynamics
β β α
• I• I o^^ o^ o^ o^o^o^o^o^
wt XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G306R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G306S XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G204R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
L140P XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
A338E XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
Y70H XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
R136C XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
R227Q XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
C269Y XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
A461T XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
A- XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
L137P XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
L264R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
E287K XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
G359R XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
R370W XXXXXXXXXXXXXXXXXXXXXXXXXXVQSDTHIFIIMGASGDLAKKKIYP 50
.
10
.
20
.
30
.
40
.
50
α β α
o^^ o^ o^ o^o^o^ • I o^^ o^ o^ o^o^o^o^o^o^o^o^o^
wt TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G306R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G306S TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G204R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
L140P TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
A338E TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
Y70H TIWWLFRDGLLPENTFIVGHARSRLTVADIRKQSEPFFKATPEEKLKLED 100
R136C TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
R227Q TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
C269Y TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
A461T TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
A- TIWWLFRDGLLPENTFIMGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
L137P TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
L264R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
E287K TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
G359R TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
R370W TIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLED 100
.
60
.
70
.
80
.
90
.
100
β α β α
• I o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^ • I o^^ o^ o^ o^o^o^
wt FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G306R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G306S FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G204R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
L140P FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYPALPPTVYEAV 150
A338E FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
Y70H FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
R136C FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANCLFYLALPPTVYEAV 150
R227Q FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
C269Y FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
A461T FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
A- FFARNSYVAGQYDDAASYQRLNSHMDALHLGSQANRLFYLALPPTVYEAV 150
L137P FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRPFYLALPPTVYEAV 150
L264R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
E287K FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
G359R FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
R370W FFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAV 150
.
110
.
120
.
130
.
140
.
150
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α α β α β
o^^ o^ o^ o^o^ o^^ o^ o^o^o^o^o^ • I o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^ •
wt TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G306R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G306S TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G204R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
L140P TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
A338E TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
Y70H TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
R136C TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
R227Q TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
C269Y TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
A461T TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
A- TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
L137P TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
L264R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
E287K TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
G359R TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
R370W TKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRID 200
.
160
.
170
.
180
.
190
.
200
β α α β
I o^^ o^ o^ o^o^o^o^o^o^ o^^ o^ o^o^o^o^ • I
wt HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G306R HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G306S HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G204R HYLRKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
L140P HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
A338E HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
Y70H HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
R136C HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
R227Q HYLGKEMVQNLMVLRFANRIFGPIWNQDNIACVILTFKEPFGTEGRGGYF 250
C269Y HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
A461T HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
A- HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
L137P HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
L264R HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
E287K HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
G359R HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
R370W HYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYF 250
.
210
.
220
.
230
.
240
.
250
α α α
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^ o^^
wt DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G306R DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G306S DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
G204R DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
L140P DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
A338E DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
Y70H DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
R136C DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
R227Q DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
C269Y DEFGIIRDVMQNHLLQMLYLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
A461T DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
A- DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
L137P DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
L264R DEFGIIRDVMQNHRLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
E287K DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDKKVKVLKCISEVQA 300
G359R DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
R370W DEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA 300
.
260
.
270
.
280
.
290
.
300
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α β β
o^^ o^ • I • I
wt NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G306R NNVVLRQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G306S NNVVLSQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G204R NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
L140P NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
A338E NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFEAVVLYVENERWD 350
Y70H NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
R136C NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
R227Q NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
C269Y NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
A461T NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
A- NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
L137P NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
L264R NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
E287K NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
G359R NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
R370W NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWD 350
.
310
.
320
.
330
.
340
.
350
β β β
• I • I •
wt GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G306R GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G306S GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G204R GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
L140P GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
A338E GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
Y70H GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
R136C GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
R227Q GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
C269Y GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
A461T GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
A- GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
L137P GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
L264R GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
E287K GVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
G359R GVPFILRCRKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
R370W GVPFILRCGKALNERKAEVWLQFHDVAGDIFHQQCKRNELVIRVQPNEAV 400
.
360
.
370
.
380
.
390
.
400
β β α α
I • I o^^ o^ o^ o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^
wt YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G306R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G306S YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G204R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
L140P YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
A338E YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
Y70H YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
R136C YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
R227Q YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
C269Y YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
A461T YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
A- YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
L137P YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
L264R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
E287K YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
G359R YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
R370W YTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQM 450
.
410
.
420
.
430
.
440
.
450
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α β α
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^ • I o^^ o^ o^ o^o^o^o^
wt HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G306S HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G204R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
L140P HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
A338E HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
Y70H HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
R136C HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
R227Q HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
C269Y HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
A461T HFVRSDELRETWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
A- HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
L137P HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
L264R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
E287K HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
G359R HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
R370W HFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVG 500
.
460
.
470
.
480
.
490
.
500
wt FQYEG 505
G306R FQYEG 505
G306S FQYEG 505
G204R FQYEG 505
L140P FQYEG 505
A338E FQYEG 505
Y70H FQYEG 505
R136C FQYEG 505
R227Q FQYEG 505
C269Y FQYEG 505
A461T FQYEG 505
A- FQYEG 505
L137P FQYEG 505
L264R FQYEG 505
E287K FQYEG 505
G359R FQYEG 505
R370W FQYEG 505
Appendix C
All-atom tables
Tables containing the principal energies presented as averages over the trajectories.
C.1 Wild-type
Table C.1: The main measurements for the simulations performed on the wild-type
as averages over the entire trajectories.
Mutant T [K] n◦ time [ns] Epot [kJ/mol] density [kg/m3] Rmsd [nm] Gyration [nm]
Wild-type 310 1 250 -2.49×106 1002.9 0.22 3.65
2 200 -2.49×106 1002.9 0.19 3.66
3 250 -2.49×106 1002.9 0.27 3.69
700 -2.49×106 1002.9 2.23 33.6
400 1 1000 -1.99×106 906.3 0.38 3.72
2 200 -1.99×106 906.5 0.43 3.77
1200 -1.99×106 906.4 0.45 3.74
450 1 500 -1.92×106 829.7 0.87 3.57
500 1 200 -1.8×106 724.9 1.38 3.43
2 200 -1.8×106 724.9 1.23 3.46
3 200 -1.8×106 724.9 1.38 3.47
600 -1.8×106 724.9 1.33 3.45
9 3000
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Table C.2: The values (nm2) of the area exposed to the solvent (SAS) as averages
over the entire trajectories. All the values but SAStot-prob were calculated using a
probe of standard size (0.14 nm), while for SAStot-prob the probe was increased to 0.7
nm (see Section 3.3.5)
Mutant T [K] n◦ SAStot-prob SAStot SASG6P SASco−enzyme SASstruNADP+
Wild-type 310 1 368.6 405.5 8.1 14.15 12.72
2 370.3 405.3 7.87 13.9 13.43
3 370.6 407.6 8.71 14.4 14.16
369.8 406.1 8.22 14.1 13.4
400 1 375.1 407.3 8.48 14.47 12.82
2 375.9 408.8 9.25 14.84 12.09
375.5 408 8.86 14.6 12.4
450 1 371.8 428 5.94 10.66 13.54
500 1 3723 458.4 5.70 11.73 11.6
2 375.1 451.5 5.22 11.5 12.6
3 377.4 459.6 6.63 15.15 12.06
374.9 456.5 5.85 12.8 12.1
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C.2 Mutants
Table C.3: The main measurements for the simulations performed on the mutants as
averages over the entire trajectories.
Mutant T [K] n◦ time [ns] Epot [kJ/mol] density [kg/m3] Rmsd [nm] Gyration [nm]
G306R 310 1 200 -2.39×106 1004 0.24 3.69
400 1 500 -2.1×106 904 0.37 3.7
450 1 500 -1.92×106 829.7 0.8 3.75
3 1200
G306S 310 1 200 -2.49×106 1003 0.2 3.66
2 100 -2.49×106 1003 0.2 3.67
300 -2.49×106 1003 0.2 3.66
400 1 200 -2.1×106 904.8 0.3 3.71
2 200 -2.1×106 904.9 0.3 3.68
400 -2.1×106 904.9 0.3 3.69
4 700
A− 400 1 500 -2.18×106 903.7 0.32 3.67
450 1 500 -2.0×106 828.3 0.68 3.72
470 1 500 -1.76×106 795 1.04 3.69
3 1500
Y70H 310 1 150 -2.49×106 1002 0.3 3.67
400 1 200 -1.99×106 906.4 0.42 3.69
2 350
R136C 310 1 150 -2.48×106 1002.9 0.23 3.68
400 1 200 -2.1×106 904.7 0.32 3.7
2 200 -2.1×106 904.8 0.36 3.7
3 550
G204R 310 1 200 -2.39×106 1004 0.3 3.73
400 1 200 -1.99×106 906.4 0.4 3.74
2 400
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Mutant T [K] n◦ time [ns] Epot [kJ/mol] density [kg/m3] Rmsd [nm] Gyration [nm]
A461T 310 1 150 -2.48×106 1002.9 0.21 3.67
400 1 200 -2.1×106 904.8 0.45 3.74
2 350
R227Q 310 1 150 -2.49×106 1002.9 0.24 3.69
400 1 200 -1.99×106 906.5 0.33 3.67
2 350
A338E 310 1 200 -2.39×106 1004 0.26 3.68
400 1 500 -2.1×106 904.8 0.27 3.68
450 1 500 -1.84×106 831.4 0.68 3.69
3 1200
L140P 310 1 200 -2.39×106 1004 0.24 3.69
400 1 500 -2.1×106 904.8 0.32 3.66
2 700
C269Y 310 1 150 -2.48×106 1002.9 0.26 3.68
400 1 200 -1.99×106 906.5 0.37 3.72
2 350
Appendix. all-atom tables 189
Table C.4: The values (nm2) of the area exposed to the solvent (SAS) as averages
over the entire trajectories. All the values but SAStot-prob were calculated using a
probe of standard size (0.14 nm), while for SAStot-prob the probe was increased to 0.7
nm (see Section 3.3.5)
Mutant T [K] n◦ SAStot-prob SAStot SASG6P SASco−enzyme SASstruNADP+
G306R 310 1 371.2 409.9 7.6 13.8 14.8
400 1 367.9 404.5 7.2 13.6 13.3
450 1 384.1 436.3 5.2 10.83 12.3
G306S 310 1 373.2 409.6 8.8 15.2 12.4
2 369.6 407.4 8.4 14.0 13.6
471.4 408.5 8.6 14.6 13
400 1 373.7 405.6 8.2 14.7 12.8
2 371.6 404.3 7.5 14.3 12.8
372.4 404.9 7.8 14.5 12.8
G204R 310 1 374.1 409.5 8.3 14.4 12.7
400 1 377.5 407.3 7.7 13.9 11.8
C269Y 310 1 372.4 409.9 8.0 13.3 13.4
400 1 373.2 405.7 8.1 14.9 12.7
R227Q 310 1 372.2 405.3 7.9 14.8 13.0
400 1 367.7 400.9 7.1 13.9 11.5
A461T 310 1 369.9 403.3 8.1 14.2 12.6
400 1 377.8 407.9 9.2 14.7 13.0
R136C 310 1 369.7 410.6 8.4 13.9 12.7
400 1 372.3 406.7 7.4 13.4 12.6
2 372.3 401.9 8.6 15.3 12
A− 400 1 373.5 404.5 6.8 14.1 11.2
450 1 373 419.8 4.8 9 12.9
470 1 371.2 431.7 4.1 9.4 10.9
A338E 310 1 375.7 408.9 7.5 14.6 12.9
400 1 376.7 408.9 8.7 14.7 13.1
450 1 373.6 420.8 4.56 10.9 12.9
L140P 310 1 372.5 406.8 8.6 15.2 12.0
400 1 367.4 395.8 6.1 13.8 12.1
3Y70H 310 1 376.9 410.2 8.9 15.8 12.5
400 1 405.5 8.2 14.9 12.5
Bibliography
[1] J. K. Baird, “Neglect of Plasmodium vivax malaria,” Trends Parasitol., vol. 23,
pp. 533–539, Nov 2007.
[2] R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey,
“Vivax malaria: neglected and not benign,” Am. J. Trop. Med. Hyg., vol. 77,
pp. 79–87, Dec 2007.
[3] J. Field and P. Shute, “Plasmodium vivax. in the microscopuic diagnosis of human
malaria. a morphological study of the erythrocytic parasites.,” Institute for Medical
Research, vol. 2, 1956.
[4] M. Karyana, L. Burdarm, S. Yeung, E. Kenangalem, N. Wariker, R. Maristela,
K. G. Umana, R. Vemuri, M. J. Okoseray, P. M. Penttinen, P. Ebsworth, P. Sug-
iarto, N. M. Anstey, E. Tjitra, and R. N. Price, “Malaria morbidity in Papua
Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium
falciparum,” Malar. J., vol. 7, p. 148, 2008.
[5] C. J. Hemmer, F. G. Holst, P. Kern, C. B. Chiwakata, M. Dietrich, and E. C.
Reisinger, “Stronger host response per parasitized erythrocyte in Plasmodium vi-
vax or ovale than in Plasmodium falciparum malaria,” Trop. Med. Int. Health,
vol. 11, pp. 817–823, Jun 2006.
[6] N. D. Karunaweera, G. E. Grau, P. Gamage, R. Carter, and K. N. Mendis, “Dy-
namics of fever and serum levels of tumor necrosis factor are closely associated
during clinical paroxysms in Plasmodium vivax malaria,” Proc. Natl. Acad. Sci.
U.S.A., vol. 89, pp. 3200–3203, Apr 1992.
[7] R. Suwanarusk, B. M. Cooke, A. M. Dondorp, K. Silamut, J. Sattabongkot, N. J.
White, and R. Udomsangpetch, “The deformability of red blood cells parasitized
by Plasmodium falciparum and P. vivax,” J. Infect. Dis., vol. 189, pp. 190–194,
Jan 2004.
[8] S. Handayani, D. T. Chiu, E. Tjitra, J. S. Kuo, D. Lampah, E. Kenangalem, L. Re-
nia, G. Snounou, R. N. Price, N. M. Anstey, and B. Russell, “High deformability
190
Bibliography 191
of Plasmodium vivax-infected red blood cells under microfluidic conditions,” J.
Infect. Dis., vol. 199, pp. 445–450, Feb 2009.
[9] J. K. Baird, E. Schwartz, and S. L. Hoffman, “Prevention and treatment of vivax
malaria,” Curr Infect Dis Rep, vol. 9, pp. 39–46, Jan 2007.
[10] C. S. Boutlis, T. W. Yeo, and N. M. Anstey, “Malaria tolerance–for whom the cell
tolls?,” Trends Parasitol., vol. 22, pp. 371–377, Aug 2006.
[11] E. Tjitra, N. M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem, M. Karyana,
D. A. Lampah, and R. N. Price, “Multidrug-resistant Plasmodium vivax associated
with severe and fatal malaria: a prospective study in Papua, Indonesia,” PLoS
Med., vol. 5, p. e128, Jun 2008.
[12] J. J. Lipa, “Twentieth report from the WHO Expert Commitee on Malaria. WHO
technical report No. 892, Geneva,” Wiad Parazytol, vol. 46, no. 4, pp. 523–524,
2000.
[13] R. Feachem and O. Sabot, “A new global malaria eradication strategy,” Lancet,
vol. 371, pp. 1633–1635, May 2008.
[14] B. Sina, “Focus on Plasmodium vivax,” Trends Parasitol., vol. 18, pp. 287–289,
Jul 2002.
[15] J. K. Baird, “Chloroquine resistance in Plasmodium vivax,” Antimicrob. Agents
Chemother., vol. 48, pp. 4075–4083, Nov 2004.
[16] M. Arevalo-Herrera, C. Chitnis, and S. Herrera, “Current status of Plasmodium
vivax vaccine,” Hum Vaccin, vol. 6, pp. 124–132, Jan 2010.
[17] J. M. Carlton, A. A. Escalante, D. Neafsey, and S. K. Volkman, “Comparative
evolutionary genomics of human malaria parasites,” Trends Parasitol., vol. 24,
pp. 545–550, Dec 2008.
[18] K. C. Kain, A. E. Brown, H. K. Webster, R. A. Wirtz, J. S. Keystone, M. H.
Rodriguez, J. Kinahan, M. Rowland, and D. E. Lanar, “Circumsporozoite geno-
typing of global isolates of Plasmodium vivax from dried blood specimens,” J.
Clin. Microbiol., vol. 30, pp. 1863–1866, Jul 1992.
[19] R. Tewari, R. Spaccapelo, F. Bistoni, A. A. Holder, and A. Crisanti, “Function of
region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein
in sporozoite motility and infectivity,” J. Biol. Chem., vol. 277, pp. 47613–47618,
Dec 2002.
[20] A. Coppi, C. Pinzon-Ortiz, C. Hutter, and P. Sinnis, “The Plasmodium circum-
sporozoite protein is proteolytically processed during cell invasion,” J. Exp. Med.,
vol. 201, pp. 27–33, Jan 2005.
Bibliography 192
[21] M. Yuda and T. Ishino, “Liver invasion by malarial parasites–how do malarial
parasites break through the host barrier?,” Cell. Microbiol., vol. 6, pp. 1119–1125,
Dec 2004.
[22] W. O. Rogers, K. Gowda, and S. L. Hoffman, “Construction and immunogenic-
ity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine
antigens,” Vaccine, vol. 17, pp. 3136–3144, Aug 1999.
[23] A. Castellanos, M. Arevalo-Herrera, N. Restrepo, L. Gulloso, G. Corradin, and
S. Herrera, “Plasmodium vivax thrombospondin related adhesion protein: im-
munogenicity and protective efficacy in rodents and Aotus monkeys,” Mem. Inst.
Oswaldo Cruz, vol. 102, pp. 411–416, Jun 2007.
[24] J. H. Adams, D. E. Hudson, M. Torii, G. E. Ward, T. E. Wellems, M. Aikawa,
and L. H. Miller, “The Duffy receptor family of Plasmodium knowlesi is located
within the micronemes of invasive malaria merozoites,” Cell, vol. 63, pp. 141–153,
Oct 1990.
[25] J. Cole-Tobian and C. L. King, “Diversity and natural selection in Plasmodium
vivax Duffy binding protein gene,” Mol. Biochem. Parasitol., vol. 127, pp. 121–132,
Apr 2003.
[26] E. M. Riley, S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs,
H. J. Schonfeld, A. A. Holder, and B. M. Greenwood, “Naturally acquired cellular
and humoral immune responses to the major merozoite surface antigen (PfMSP1)
of Plasmodium falciparum are associated with reduced malaria morbidity,” Para-
site Immunol., vol. 14, pp. 321–337, May 1992.
[27] M. A. Herrera, F. Rosero, S. Herrera, P. Caspers, D. Rotmann, F. Sinigaglia,
and U. Certa, “Protection against malaria in Aotus monkeys immunized with a
recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of
serum gamma interferon levels with protection,” Infect. Immun., vol. 60, pp. 154–
158, Jan 1992.
[28] P. Graves and H. Gelband, “Vaccines for preventing malaria (blood-stage),”
Cochrane Database Syst Rev, no. 4, p. CD006199, 2006.
[29] D. L. Doolan and S. L. Hoffman, “Multi-gene vaccination against malaria: A mul-
tistage, multi-immune response approach,” Parasitol. Today (Regul. Ed.), vol. 13,
pp. 171–178, May 1997.
[30] G. H. Mitchell, A. W. Thomas, G. Margos, A. R. Dluzewski, and L. H. Bannister,
“Apical membrane antigen 1, a major malaria vaccine candidate, mediates the
close attachment of invasive merozoites to host red blood cells,” Infect. Immun.,
vol. 72, pp. 154–158, Jan 2004.
Bibliography 193
[31] M. H. Rodrigues, K. M. Rodrigues, T. R. Oliveira, A. N. Comodo, M. M. Ro-
drigues, C. H. Kocken, A. W. Thomas, and I. S. Soares, “Antibody response of
naturally infected individuals to recombinant Plasmodium vivax apical membrane
antigen-1,” Int. J. Parasitol., vol. 35, pp. 185–192, Feb 2005.
[32] H. Hisaeda, A. W. Stowers, T. Tsuboi, W. E. Collins, J. S. Sattabongkot,
N. Suwanabun, M. Torii, and D. C. Kaslow, “Antibodies to malaria vaccine candi-
dates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect
mosquitoes,” Infect. Immun., vol. 68, pp. 6618–6623, Dec 2000.
[33] T. Tsuboi, D. C. Kaslow, M. M. Gozar, M. Tachibana, Y. M. Cao, and M. Torii,
“Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins,
Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates,” Mol.
Med., vol. 4, pp. 772–782, Dec 1998.
[34] T. N. Wells, J. N. Burrows, and J. K. Baird, “Targeting the hypnozoite reservoir of
Plasmodium vivax: the hidden obstacle to malaria elimination,” Trends Parasitol.,
vol. 26, pp. 145–151, Mar 2010.
[35] D. R. Hill, J. K. Baird, M. E. Parise, L. S. Lewis, E. T. Ryan, and A. J. Magill,
“Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I,”
Am. J. Trop. Med. Hyg., vol. 75, pp. 402–415, Sep 2006.
[36] J. Soto, J. Toledo, M. Rodriquez, J. Sanchez, R. Herrera, J. Padilla, and
J. Berman, “Double-blind, randomized, placebo-controlled assessment of chloro-
quine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers,”
Clin. Infect. Dis., vol. 29, pp. 199–201, Jul 1999.
[37] E. Schwartz and G. Regev-Yochay, “Primaquine as prophylaxis for malaria for non-
immune travelers: A comparison with mefloquine and doxycycline,” Clin. Infect.
Dis., vol. 29, pp. 1502–1506, Dec 1999.
[38] L. Luzzatto and G. Battistuzzi, “Glucose-6-phosphate dehydrogenase,” Adv. Hum.
Genet., vol. 14, pp. 217–329, 1985.
[39] L. Luzzatto and U. Testa, “Human erythrocyte glucose 6-phosphate dehydroge-
nase: structure and function in normal and mutant subjects,” Curr Top Hematol,
vol. 1, pp. 1–70, 1978.
[40] J. K. Baird and K. H. Rieckmann, “Can primaquine therapy for vivax malaria be
improved?,” Trends Parasitol., vol. 19, pp. 115–120, Mar 2003.
[41] J. L. Goller, D. Jolley, P. Ringwald, and B. A. Biggs, “Regional differences in
the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy,”
Am. J. Trop. Med. Hyg., vol. 76, pp. 203–207, Feb 2007.
Bibliography 194
[42] N. J. Elmes, P. E. Nasveld, S. J. Kitchener, D. A. Kocisko, and M. D. Edstein,
“The efficacy and tolerability of three different regimens of tafenoquine versus
primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the
Southwest Pacific,” Trans. R. Soc. Trop. Med. Hyg., vol. 102, pp. 1095–1101, Nov
2008.
[43] P. Cohen and M. A. Rosemeyer, “Subunit interactions of glucose-6-phosphate de-
hydrogenase from human erythrocytes,” Eur. J. Biochem., vol. 8, pp. 8–15, Mar
1969.
[44] P. Cohen and M. A. Rosemeyer, “Subunit interactions of glucose-6-phosphate de-
hydrogenase from human erythrocytes,” European Journal of Biochemistry, vol. 8,
no. 1, pp. 8–15, 1969.
[45] H.-G. Zimmer, Pentose Phosphate Pathway. John Wiley & Sons, Ltd, 2001.
[46] J. E. Smith and E. Beutler, “Anomeric specificity of human erythrocyte glucose-
6-phosphate dehydrogenase,” Proc. Soc. Exp. Biol. Med., vol. 122, pp. 671–673,
Jul 1966.
[47] W. Scientific Group, “Standardization of procedures for the study of glucose-6-
phosphate dehydrogenase. Report of a WHO Scientific Group,” World Health Or-
gan Tech Rep Ser, vol. 366, pp. 1–53, 1967.
[48] P. J. Mason, J. M. Bautista, and F. Gilsanz, “G6PD deficiency: the genotype-
phenotype association,” Blood Rev, vol. 21, pp. 267–283, 2007.
[49] M. J. Maisels, “Neonatal jaundice,” Pediatr Rev, vol. 27, pp. 443–454, Dec 2006.
[50] Y. H. Weng, Y. H. Chou, and R. I. Lien, “Hyperbilirubinemia in healthy neonates
with glucose-6-phosphate dehydrogenase deficiency,” Early Hum. Dev., vol. 71,
pp. 129–136, Apr 2003.
[51] U. Bienzle, O. Sodeinde, C. E. Effiong, and L. Luzzatto, “Glucose 6-phosphate
dehydrogenase deficiency and sickle cell anemia: frequency and features of the
association in an African community,” Blood, vol. 46, pp. 591–597, Oct 1975.
[52] S. C. Bernstein, J. E. Bowman, and L. K. Noche, “Interaction of sickle cell trait
and glucose-6-phosphate dehydrogenase deficiency in Cameroon,” Hum. Hered.,
vol. 30, no. 1, pp. 7–11, 1980.
[53] A. Tagarelli, A. Piro, L. Bastone, and G. Tagarelli, “Identification of glucose 6-
phosphate dehydrogenase deficiency in a population with a high frequency of tha-
lassemia,” FEBS Lett., vol. 466, pp. 139–142, Jan 2000.
Bibliography 195
[54] M. H. Steinberg, M. S. West, D. Gallagher, and W. Mentzer, “Effects of glucose-
6-phosphate dehydrogenase deficiency upon sickle cell anemia,” Blood, vol. 71,
pp. 748–752, Mar 1988.
[55] A. M. Than, T. Harano, K. Harano, A. A. Myint, T. Ogino, and S. Okadaa, “High
incidence of 3-thalassemia, hemoglobin E, and glucose-6-phosphate dehydrogenase
deficiency in populations of malaria-endemic southern Shan State, Myanmar,” Int.
J. Hematol., vol. 82, pp. 119–123, Aug 2005.
[56] J. L. Vives-Corrons, W. Kuhl, M. A. Pujades, and E. Beutler, “Molecular genet-
ics of the glucose-6-phosphate dehydrogenase (G6PD) Mediterranean variant and
description of a new G6PD mutant, G6PD Andalus1361A,” Am. J. Hum. Genet.,
vol. 47, pp. 575–579, Sep 1990.
[57] T. J. Vulliamy, A. Othman, M. Town, A. Nathwani, A. G. Falusi, P. J. Mason, and
L. Luzzatto, “Polymorphic sites in the African population detected by sequence
analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of
the variants A and A-,” Proc. Natl. Acad. Sci. U.S.A., vol. 88, pp. 8568–8571, Oct
1991.
[58] D. T. Chiu, L. Zuo, E. Chen, L. Chao, E. Louie, B. Lubin, T. Z. Liu, and C. S.
Du, “Two commonly occurring nucleotide base substitutions in Chinese G6PD
variants,” Biochem. Biophys. Res. Commun., vol. 180, pp. 988–993, Oct 1991.
[59] A. C. Allison, “Glucose-6-phosphate dehydrogenase deficiency in red blood cells
of East Africans,” Nature, vol. 186, pp. 531–532, May 1960.
[60] A. G. Motulsky, “Metabolic polymorphisms and the role of infectious diseases in
human evolution,” Hum. Biol., vol. 32, pp. 28–62, Feb 1960.
[61] M. Cappadoro, G. Giribaldi, E. O’Brien, F. Turrini, F. Mannu, D. Ulliers, G. Sim-
ula, L. Luzzatto, and P. Arese, “Early phagocytosis of glucose-6-phosphate dehy-
drogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum
may explain malaria protection in G6PD deficiency,” Blood, vol. 92, pp. 2527–
2534, Oct 1998.
[62] P. A. Marks and R. T. Gross, “Erythrocyte glucose-6-phosphate dehydrogenase
deficiency: evidence of differences between Negroes and Caucasians with respect
to this genetically determined trait,” J. Clin. Invest., vol. 38, pp. 2253–2262, Dec
1959.
[63] P. J. Mason, M. F. Sonati, D. MacDonald, C. Lanza, D. Busutil, M. Town,
C. M. Corcoran, J. S. Kaeda, D. J. Stevens, and S. al Ismail, “New glucose-
6-phosphate dehydrogenase mutations associated with chronic anemia,” Blood,
vol. 85, pp. 1377–1380, Mar 1995.
Bibliography 196
[64] L. Luzzatto and N. C. Allan, “Different properties of glucose 6-phosphate dehy-
drogenase from human erythrocytes with normal and abnormal enzyme levels,”
Biochem. Biophys. Res. Commun., vol. 21, pp. 547–554, Dec 1965.
[65] H. N. Kirkman and E. M. Hendrickson, “Glucose 6-phosphate dehydrogenase from
human erythrocytes. II. Subactive states of the enzyme from normal persons,” J.
Biol. Chem., vol. 237, pp. 2371–2376, Jul 1962.
[66] L. Longo, O. C. Vanegas, M. Patel, V. Rosti, H. Li, J. Waka, T. Merghoub, P. P.
Pandolfi, R. Notaro, K. Manova, and L. Luzzatto, “Maternally transmitted severe
glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal,” EMBO J.,
vol. 21, pp. 4229–4239, Aug 2002.
[67] P. E. Meissner, B. Coulibaly, G. Mandi, U. Mansmann, S. Witte, W. Schiek,
O. Muller, R. H. Schirmer, F. P. Mockenhaupt, and U. Bienzle, “Diagnosis of red
cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent
enzyme test on filter paper with polymerase chain reaction based genotyping,”
Br. J. Haematol., vol. 131, pp. 395–399, Nov 2005.
[68] N. Carter, A. Pamba, S. Duparc, and J. N. Waitumbi, “Frequency of glucose-6-
phosphate dehydrogenase deficiency in malaria patients from six African countries
enrolled in two randomized anti-malarial clinical trials,” Malar. J., vol. 10, p. 241,
2011.
[69] G. J. Brewer, A. R. Tarlov, and A. S. Alving, “Methaemoglobin reduction test:
a new, simple, in vitro test for identifying primaquine-sensitivity,” Bull. World
Health Organ., vol. 22, pp. 633–640, 1960.
[70] B. Keats, “Genetic mapping: X chromosome,” Hum. Genet., vol. 64, no. 1, pp. 28–
32, 1983.
[71] F. Kiani, S. Schwarzl, S. Fischer, and T. Efferth, “Three-dimensional modeling
of glucose-6-phosphate dehydrogenase-deficient variants from German ancestry,”
PLoS One, vol. 2, pp. e625–e625, 2007.
[72] N. G. Wrigley, J. V. Heather, A. Bonsignore, and A. De Flora, “Human erythro-
cyte glucose 6-phosphate dehydrogenase: electron microscope studies on structure
and interconversion of tetramers, dimers and monomers,” J. Mol. Biol., vol. 68,
pp. 483–499, Jul 1972.
[73] S. W. Au, S. Gover, V. M. Lam, and M. J. Adams, “Human glucose-6-phosphate
dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and
provides insights into enzyme deficiency,” Structure, vol. 8, pp. 293–303, Mar 2000.
Bibliography 197
[74] D. J. Stevens, W. Wanachiwanawin, P. J. Mason, T. J. Vulliamy, and L. Luzzatto,
“G6PD Canton a common deficient variant in South East Asia caused by a 459
Arg—-Leu mutation,” Nucleic Acids Res., vol. 18, p. 7190, Dec 1990.
[75] R. Notaro, A. Afolayan, and L. Luzzatto, “Human mutations in glucose 6-
phosphate dehydrogenase reflect evolutionary history,” FASEB J., vol. 14, pp. 485–
494, Mar 2000.
[76] Y. S. Cheng, T. K. Tang, and M. Hwang, “Amino acid conservation and clinical
severity of human glucose-6-phosphate dehydrogenase mutations,” J. Biomed. Sci.,
vol. 6, no. 2, pp. 106–114, 1999.
[77] S. W. N. Au, C. E. Naylor, S. Gover, L. Vandeputte-Rutten, D. A. Scopes, P. J.
Mason, L. Luzzatto, V. M. S. Lam, and M. J. Adams, “Solution of the structure of
tetrameric human glucose 6-phosphate dehydrogenase by molecular replacement,”
Acta Crystallographica Section D, vol. 55, pp. 826–834, Apr 1999.
[78] L. Camardella, C. Caruso, B. Rutigliano, M. Romano, G. Di Prisco, and
F. Descalzi-Cancedda, “Human erythrocyte glucose-6-phosphate dehydrogenase.
Identification of a reactive lysyl residue labelled with pyridoxal 5’-phosphate,”
Eur. J. Biochem., vol. 171, pp. 485–489, Feb 1988.
[79] W. T. Lee and H. R. Levy, “Lysine-21 of Leuconostoc mesenteroides glucose 6-
phosphate dehydrogenase participates in substrate binding through charge-charge
interaction,” Protein Sci., vol. 1, pp. 329–334, Mar 1992.
[80] J. Jeffery, B. Persson, I. Wood, T. Bergman, R. Jeffery, and H. Jornvall, “Glucose-
6-phosphate dehydrogenase. Structure-function relationships and the Pichia jadinii
enzyme structure,” Eur. J. Biochem., vol. 212, pp. 41–49, Feb 1993.
[81] M. Kotaka, S. Gover, L. Vandeputte-Rutten, S. W. Au, V. M. Lam, and M. J.
Adams, “Structural studies of glucose-6-phosphate and NADP+ binding to hu-
man glucose-6-phosphate dehydrogenase,” Acta Crystallogr. D Biol. Crystallogr.,
vol. 61, pp. 495–504, May 2005.
[82] J. M. Bautista, P. J. Mason, and L. Luzzatto, “Human glucose-6-phosphate dehy-
drogenase. Lysine 205 is dispensable for substrate binding but essential for catal-
ysis,” FEBS Lett., vol. 366, pp. 61–64, Jun 1995.
[83] M. Born and R. Oppenheimer, “Zur quantentheorie der molekeln,” Ann. Phys.
(Leipzig), vol. 84 (20), p. 457, 1927.
[84] B. R. Brooks, R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan,
and M. Karplus, “Charmm: A program for macromolecular energy, minimization,
Bibliography 198
and dynamics calculations,” Journal of Computational Chemistry, vol. 4, no. 2,
pp. 187–217, 1983.
[85] W. D. Cornell, P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, D. M. Ferguson,
D. C. Spellmeyer, T. Fox, and J. W. Caldwell, “A Second Generation Force Field
for the Simulation of Proteins, Nucleic Acids, and Organic Molecules,” Journal of
The American Chemical Society, vol. 117, pp. 5179–5197, 1995.
[86] M. Christen, P. H. Hunenberger, D. Bakowies, R. Baron, R. Burgi, D. P. Geerke,
T. N. Heinz, M. A. Kastenholz, V. Krautler, C. Oostenbrink, C. Peter, D. Trzes-
niak, and W. F. van Gunsteren, “The GROMOS software for biomolecular simu-
lation: GROMOS05,” J Comput Chem, vol. 26, pp. 1719–1751, Dec 2005.
[87] A. D. Mackerell, “Empirical force fields for biological macromolecules: overview
and issues,” J Comput Chem, vol. 25, pp. 1584–1604, Oct 2004.
[88] C. J. Cramer, Essentials of Computational Chemistry Theories and Models - sec-
ond edition. WILEY, 2004.
[89] E. W. Weisstein, ““newton’s method.”,” From MathWorld–A Wolfram Web Re-
source.
[90] C. J. Kwok, A. C. Martin, S. W. Au, and V. M. Lam, “G6PDdb, an integrated
database of glucose-6-phosphate dehydrogenase (G6PD) mutations,” Hum. Mutat.,
vol. 19, pp. 217–224, Mar 2002.
[91] J. M. Hurst, L. E. McMillan, C. T. Porter, J. Allen, A. Fakorede, and A. C.
Martin, “The SAAPdb web resource: a large-scale structural analysis of mutant
proteins,” Hum. Mutat., vol. 30, pp. 616–624, Apr 2009.
[92] A. C. Martin, A. M. Facchiano, A. L. Cuff, T. Hernandez-Boussard, M. Olivier,
P. Hainaut, and J. M. Thornton, “Integrating mutation data and structural anal-
ysis of the TP53 tumor-suppressor protein,” Hum. Mutat., vol. 19, pp. 149–164,
Feb 2002.
[93] N. S. Al-Numail and A. C. Martin, “The SAAP pipeline and database: tools to
analyze the impact and predict the pathogenicity of mutations,” BMC Genomics,
vol. 14 Suppl 3, p. S4, 2013.
[94] P. C. Ng and S. Henikoff, “SIFT: Predicting amino acid changes that affect protein
function,” Nucleic Acids Res., vol. 31, pp. 3812–3814, Jul 2003.
[95] P. D. Thomas, M. J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman,
K. Diemer, A. Muruganujan, and A. Narechania, “PANTHER: a library of protein
families and subfamilies indexed by function,” Genome Res., vol. 13, pp. 2129–
2141, Sep 2003.
Bibliography 199
[96] B. Reva, Y. Antipin, and C. Sander, “Predicting the functional impact of protein
mutations: application to cancer genomics,” Nucleic Acids Res., vol. 39, p. e118,
Sep 2011.
[97] I. A. Adzhubei, S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova, P. Bork,
A. S. Kondrashov, and S. R. Sunyaev, “A method and server for predicting dam-
aging missense mutations,” Nat. Methods, vol. 7, pp. 248–249, Apr 2010.
[98] A. Gonzalez-Perez and N. Lopez-Bigas, “Improving the assessment of the outcome
of nonsynonymous SNVs with a consensus deleteriousness score, Condel,” Am. J.
Hum. Genet., vol. 88, pp. 440–449, Apr 2011.
[99] A. Liaw and M. Wiener, “Classification and regression by randomforest,” R News,
vol. 2, no. 3, pp. 18–22, 2002.
[100] M. Hall, E. Frank, G. Holmes, B. Pfahringer, P. Reutemann, and I. H. Witten,
“The weka data mining software: An update.”
[101] A. Minucci, K. Moradkhani, M. J. Hwang, C. Zuppi, B. Giardina, and E. Capolu-
ongo, “Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review
of the ”old” and update of the new mutations,” Blood Cells Mol. Dis., vol. 48,
pp. 154–165, Mar 2012.
[102] A. C. Martin, “Mutmodel v1.17,” UCL, 1996-2011.
[103] H. H. Shih, J. Brady, and M. Karplus, “Structure of proteins with single-site
mutations: a minimum perturbation approach,” Proc. Natl. Acad. Sci. U.S.A.,
vol. 82, pp. 1697–1700, Mar 1985.
[104] S. Pronk, S. Pa´ll, R. Schulz, P. Larsson, P. Bjelkmar, R. Apostolov, M. R. Shirts,
J. C. Smith, P. M. Kasson, D. van der Spoel, B. Hess, and E. Lindahl, “Gro-
macs 4.5: a high-throughput and highly parallel open source molecular simulation
toolkit,” Bioinformatics, vol. 29, no. 7, pp. 845–854, 2013.
[105] H. Berendsen, D. van der Spoel, and R. van Drunen, “Gromacs: A message-
passing parallel molecular dynamics implementation,” Computer Physics Com-
munications, pp. 43 – 56, 1995.
[106] D. Van Der Spoel, E. Lindahl, B. Hess, G. Groenhof, A. E. Mark, and H. J. C.
Berendsen, “Gromacs: Fast, flexible, and free,” Journal of Computational Chem-
istry, vol. 26, no. 16, pp. 1701–1718, 2005.
[107] B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, “Gromacs 4: Algorithms
for highly efficient, load-balanced, and scalable molecular simulation,” Journal of
Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008.
Bibliography 200
[108] K. Lindorff-Larsen, S. Piana, K. Palmo, P. Maragakis, J. L. Klepeis, R. O. Dror,
and D. E. Shaw, “Improved side-chain torsion potentials for the Amber ff99SB
protein force field,” Proteins, vol. 78, pp. 1950–1958, Jun 2010.
[109] W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L.
Klein, “Comparison of simple potential functions for simulating liquid water,”
The Journal of Chemical Physics, vol. 79, no. 2, pp. 926–935, 1983.
[110] C. Oostenbrink, A. Villa, A. E. Mark, and W. F. Van Gunsteren, “A biomolecular
force field based on the free enthalpy of hydration and solvation: The gromos
force-field parameter sets 53a5 and 53a6,” Journal of Computational Chemistry,
vol. 25, no. 13, pp. 1656–1676, 2004.
[111] K. Lindorff-Larsen, P. Maragakis, S. Piana, M. P. Eastwood, R. O. Dror, and D. E.
Shaw, “Systematic validation of protein force fields against experimental data,”
PLoS ONE, vol. 7, no. 2, p. e32131, 2012.
[112] M. Rueda, C. Ferrer-Costa, T. Meyer, A. Perez, J. Camps, A. Hospital, J. L.
Gelpi, and M. Orozco, “A consensus view of protein dynamics,” Proceedings of the
National Academy of Sciences, vol. 104, no. 3, pp. 796–801, 2007.
[113] T. Darden, D. York, and L. Pedersen, “Particle mesh ewald: An nlog(n) method
for ewald sums in large systems,” The Journal of Chemical Physics, vol. 98, no. 12,
1993.
[114] H. J. C. Berendsen, J. P. M. Postma, W. F. van Gunsteren, A. DiNola, and J. R.
Haak, “Molecular dynamics with coupling to an external bath,” The Journal of
Chemical Physics, vol. 81, no. 8, pp. 3684–3690, 1984.
[115] M. Parrinello and A. Rahman, “Polymorphic transitions in single crystals: A
new molecular dynamics method,” Journal of Applied Physics, vol. 52, no. 12,
pp. 7182–7190, 1981.
[116] W. G. Hoover, “Canonical dynamics: Equilibrium phase-space distributions,”
Phys. Rev. A, vol. 31, pp. 1695–1697, Mar 1985.
[117] S. Nose´, “A unified formulation of the constant temperature molecular dynamics
methods,” The Journal of Chemical Physics, vol. 81, no. 1, pp. 511–519, 1984.
[118] B. Hess, H. Bekker, H. J. C. Berendsen, and J. G. E. M. Fraaije, “Lincs: A linear
constraint solver for molecular simulations,” Journal of Computational Chemistry,
vol. 18, no. 12, pp. 1463–1472, 1997.
[119] J.-P. Ryckaert, G. Ciccotti, and H. J. Berendsen, “Numerical integration of the
cartesian equations of motion of a system with constraints: molecular dynamics of
n-alkanes,” Journal of Computational Physics, vol. 23, no. 3, pp. 327 – 341, 1977.
Bibliography 201
[120] W. B. Langdon, “Initial experiences of the emerald: e-infrastructure south GPU
supercomputer,” Research Note RN/12/08, Department of Computer Science,
University College London, Gower Street, London WC1E 6BT, UK, 17 June 2012.
[121] R Core Team, R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing, Vienna, Austria, 2014.
[122] H. Wickham, ggplot2: elegant graphics for data analysis. Springer New York, 2009.
[123] R. J. Pantazes and C. D. Maranas, “OptCDR: a general computational method for
the design of antibody complementarity determining regions for targeted epitope
binding,” Protein Eng. Des. Sel., vol. 23, pp. 849–858, Nov 2010.
[124] Molecular modeling of proteins 1st edition. Andreas Kukol.
[125] K. Suhre and Y.-H. Sanejouand, “Elne´mo: a normal mode web server for protein
movement analysis and the generation of templates for molecular replacement,”
Nucleic Acids Research, vol. 32, no. suppl 2, pp. W610–W614, 2004.
[126] K. Suhre and Y.-H. Sanejouand, “On the potential of normal-mode analysis for
solving difficult molecular-replacement problems,” Acta Crystallographica Section
D, vol. 60, pp. 796–799, Apr 2004.
[127] B. Halle, “Flexibility and packing in proteins,” Proceedings of the National
Academy of Sciences, vol. 99, pp. 1274–1279, Feb. 2002.
[128] D. Roos, R. van Zwieten, J. T. Wijnen, F. Gomez-Gallego, M. de Boer, D. Stevens,
C. J. Pronk-Admiraal, T. de Rijk, C. J. van Noorden, R. S. Weening, T. J. Vul-
liamy, J. E. Ploem, P. J. Mason, J. M. Bautista, P. M. Khan, and E. Beutler,
“Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase
volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and
increased susceptibility to infections,” Blood, vol. 94, pp. 2955–2962, Nov 1999.
[129] C. Neale, R. Pomes, and A. E. Garcia, “Peptide Bond Isomerization in High-
Temperature Simulations,” J Chem Theory Comput, Mar 2016.
[130] L. T. Chao, C. S. Du, E. Louie, L. Zuo, E. Chen, B. Lubin, and D. T. Chiu, “A
to G substitution identified in exon 2 of the G6PD gene among G6PD deficient
Chinese,” Nucleic Acids Res., vol. 19, p. 6056, Nov 1991.
[131] T. J. Vulliamy, M. D’Urso, G. Battistuzzi, M. Estrada, N. S. Foulkes, G. Martini,
V. Calabro, V. Poggi, R. Giordano, and M. Town, “Diverse point mutations in the
human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild
or severe hemolytic anemia,” Proc. Natl. Acad. Sci. U.S.A., vol. 85, pp. 5171–5175,
Jul 1988.
Bibliography 202
[132] O. Babalola, R. Cancedda, and L. Luzzatto, “Genetic variants of glucose 6-
phosphate dehydrogenase from human erythrocytes: unique properties of the A
- variant isolated from “deficient” cells,” Proc. Natl. Acad. Sci. U.S.A., vol. 69,
pp. 946–950, Apr 1972.
[133] F. Gomez-Gallego, A. Garrido-Pertierra, and J. M. Bautista, “Structural defects
underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-)
deficiency,” J. Biol. Chem., vol. 275, pp. 9256–9262, Mar 2000.
[134] M. Ganczakowski, M. Town, D. K. Bowden, T. J. Vulliamy, A. Kaneko, J. B. Clegg,
D. J. Weatherall, and L. Luzzatto, “Multiple glucose 6-phosphate dehydrogenase-
deficient variants correlate with malaria endemicity in the Vanuatu archipelago
(southwestern Pacific),” Am. J. Hum. Genet., vol. 56, pp. 294–301, Jan 1995.
[135] R. Zarza, A. Pujades, A. Rovira, R. Saavedra, J. Fernandez, M. Aymerich, and
J. L. Vives Corrons, “Two new mutations of the glucose-6-phosphate dehydroge-
nase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and
molecular relationships,” Br. J. Haematol., vol. 98, pp. 578–582, Sep 1997.
[136] X. Ren, Y. He, C. Du, W. Jiang, L. Chen, and Q. Lin, “A novel mis-sense mutation
(G1381A) in the G6PD gene identified in a Chinese man,” Chin. Med. J., vol. 114,
pp. 399–401, Apr 2001.
[137] E. Beutler, B. Westwood, J. T. Prchal, G. Vaca, C. S. Bartsocas, and L. Baron-
ciani, “New glucose-6-phosphate dehydrogenase mutations from various ethnic
groups,” Blood, vol. 80, pp. 255–256, Jul 1992.
[138] T. Takizawa, H. Fujii, S. Takegawa, K. Takahashi, A. Hirono, T. Morisaki,
H. Kanno, R. Oka, H. Yoshioka, and S. Miwa, “A unique electrophoretic slow-
moving glucose 6-phosphate dehydrogenase variant (G6PD Asahikawa) with a
markedly acidic pH optimum,” Hum. Genet., vol. 68, no. 1, pp. 70–72, 1984.
[139] I. Sillitoe, T. E. Lewis, A. Cuff, S. Das, P. Ashford, N. L. Dawson, N. Furnham,
R. A. Laskowski, D. Lee, J. G. Lees, et al., “CATH: comprehensive structural and
functional annotations for genome sequences,” Nucleic acids research, p. gku947,
2014.
[140] I. G. Kevrekidis, C. W. Gear, and G. Hummer, “Equation-free: The computer-
aided analysis of complex multiscale systems,” AIChE Journal, vol. 50, no. 7,
pp. 1346–1355, 2004.
[141] C. Theodoropoulos, Y. H. Qian, and I. G. Kevrekidis, “”Coarse” stability and
bifurcation analysis using time-steppers: a reaction-diffusion example,” Proc. Natl.
Acad. Sci. U.S.A., vol. 97, pp. 9840–9843, Aug 2000.
Bibliography 203
[142] A. Laio and F. L. Gervasio, “Metadynamics: a method to simulate rare events and
reconstruct the free energy in biophysics, chemistry and material science,” Reports
on Progress in Physics, vol. 71, no. 12, p. 126601, 2008.
[143] D. Cvijovic´ and J. Klinowski, Handbook of Global Optimization: Volume 2,
ch. Taboo Search: An Approach to the Multiple-Minima Problem for Continu-
ous Functions, pp. 387–406. Boston, MA: Springer US, 2002.
[144] T. Huber, A. E. Torda, and W. F. van Gunsteren, “Local elevation: A method for
improving the searching properties of molecular dynamics simulation,” Journal of
Computer-Aided Molecular Design, vol. 8, no. 6, pp. 695–708, 1994.
[145] E. Zurek and W. Grochala, “Predicting crystal structures and properties of mat-
ter under extreme conditions via quantum mechanics: the pressure is on,” Phys.
Chem. Chem. Phys., vol. 17, pp. 2917–2934, 2015.
[146] G. Bussi, F. L. Gervasio, A. Laio, and M. Parrinello, “Free-energy landscape for
beta hairpin folding from combined parallel tempering and metadynamics,” J. Am.
Chem. Soc., vol. 128, pp. 13435–13441, Oct 2006.
[147] K. Gaalswyk and C. N. Rowley, “An explicit-solvent conformation search method
using open software,” PeerJ, vol. 4, p. e2088, 2016.
[148] M. Bonomi, D. Branduardi, G. Bussi, C. Camilloni, D. Provasi, P. Raiteri,
D. Donadio, F. Marinelli, F. Pietrucci, R. A. Broglia, and M. Parrinello, “Plumed:
A portable plugin for free-energy calculations with molecular dynamics,” Com-
puter Physics Communications, vol. 180, no. 10, pp. 1961 – 1972, 2009.
[149] P. Rowland, A. K. Basak, S. Gover, H. R. Levy, and M. J. Adams, “The three-
dimensional structure of glucose 6-phosphate dehydrogenase from Leuconostoc
mesenteroides refined at 2.0 A resolution,” Structure, vol. 2, pp. 1073–1087, Nov
1994.
[150] G. G. Maisuradze, P. Senet, C. Czaplewski, A. Liwo, and H. A. Scheraga, “Inves-
tigation of protein folding by coarse-grained molecular dynamics with the UNRES
force field,” J Phys Chem A, vol. 114, pp. 4471–4485, Apr 2010.
[151] A. Liwo, M. Khalili, C. Czaplewski, S. Kalinowski, S. Odziej, K. Wachucik, and
H. A. Scheraga, “Modification and optimization of the united-residue (UNRES)
potential energy function for canonical simulations. I. Temperature dependence
of the effective energy function and tests of the optimization method with single
training proteins,” J Phys Chem B, vol. 111, pp. 260–285, Jan 2007.
Bibliography 204
[152] U. Kozowska, G. G. Maisuradze, A. Liwo, and H. A. Scheraga, “Determination
of side-chain-rotamer and side-chain and backbone virtual-bond-stretching poten-
tials of mean force from AM1 energy surfaces of terminally-blocked amino-acid
residues, for coarse-grained simulations of protein structure and folding. II. Re-
sults, comparison with statistical potentials, and implementation in the UNRES
force field,” J Comput Chem, vol. 31, pp. 1154–1167, Apr 2010.
[153] Y. He, Y. Xiao, A. Liwo, and H. A. Scheraga, “Exploring the parameter space of
the coarse-grained UNRES force field by random search: selecting a transferable
medium-resolution force field,” J Comput Chem, vol. 30, pp. 2127–2135, Oct 2009.
[154] U. Kozowska, A. Liwo, and H. A. Scheraga, “Determination of side-chain-rotamer
and side-chain and backbone virtual-bond-stretching potentials of mean force from
AM1 energy surfaces of terminally-blocked amino-acid residues, for coarse-grained
simulations of protein structure and folding. I. The method,” J Comput Chem,
vol. 31, pp. 1143–1153, Apr 2010.
[155] J. G. Gay and B. J. Berne, “Modification of the overlap potential to mimic a linear
site-site potential,” The Journal of Chemical Physics, vol. 74, no. 6, 1981.
[156] J. Lee, A. Liwo, D. R. Ripoll, J. Pillardy, and H. A. Scheraga, “Calculation of pro-
tein conformation by global optimization of a potential energy function,” Proteins,
vol. Suppl 3, pp. 204–208, 1999.
[157] J. Pillardy, C. Czaplewski, A. Liwo, J. Lee, D. R. Ripoll, R. Ka?mierkiewicz,
S. Oldziej, W. J. Wedemeyer, K. D. Gibson, Y. A. Arnautova, J. Saunders, Y. J.
Ye, and H. A. Scheraga, “Recent improvements in prediction of protein structure
by global optimization of a potential energy function,” Proc. Natl. Acad. Sci.
U.S.A., vol. 98, pp. 2329–2333, Feb 2001.
[158] M. Khalili, A. Liwo, F. Rakowski, P. Grochowski, and H. A. Scheraga, “Molecular
dynamics with the united-residue model of polypeptide chains. I. Lagrange equa-
tions of motion and tests of numerical stability in the microcanonical mode,” J
Phys Chem B, vol. 109, pp. 13785–13797, Jul 2005.
[159] A. Liwo, M. Khalili, and H. A. Scheraga, “Ab initio simulations of protein-folding
pathways by molecular dynamics with the united-residue model of polypeptide
chains,” Proc. Natl. Acad. Sci. U.S.A., vol. 102, pp. 2362–2367, Feb 2005.
[160] A. V. Rojas, A. Liwo, and H. A. Scheraga, “Molecular dynamics with the United-
residue force field: ab initio folding simulations of multichain proteins,” J Phys
Chem B, vol. 111, pp. 293–309, Jan 2007.
[161] G. G. Maisuradze, A. Liwo, and H. A. Scheraga, “Principal component analysis
for protein folding dynamics,” J. Mol. Biol., vol. 385, pp. 312–329, Jan 2009.
Bibliography 205
[162] D. D. Humphreys, R. A. Friesner, and B. J. Berne, “A multiple-time-step molecu-
lar dynamics algorithm for macromolecules,” The Journal of Physical Chemistry,
vol. 98, no. 27, pp. 6885–6892, 1994.
[163] M. Levitt and J. Greer, “Automatic identification of secondary structure in glob-
ular proteins,” J. Mol. Biol., vol. 114, pp. 181–239, Aug 1977.
[164] J. H. W. Jr., “Hierarchical grouping to optimize an objective function,” Journal
of the American Statistical Association, vol. 58, no. 301, pp. 236–244, 1963.
[165] W. Yan, J. Zhou, M. Sun, J. Chen, G. Hu, and B. Shen, “The construction of
an amino acid network for understanding protein structure and function,” Amino
Acids, vol. 46, pp. 1419–1439, Jun 2014.
[166] S. Khor, “Towards an integrated understanding of the structural characteristics of
protein residue networks,” Theory in Biosciences, vol. 131, no. 2, pp. 61–75, 2012.
[167] M. Vendruscolo, N. V. Dokholyan, E. Paci, and M. Karplus, “Small-world view of
the amino acids that play a key role in protein folding,” Phys. Rev. E, vol. 65, Jun
2002.
[168] L. D. Paola, M. D. Ruvo, P. Paci, D. Santoni, and A. Giuliani, “Protein contact
networks: An emerging paradigm in chemistry,” Chemical Reviews, vol. 113, no. 3,
pp. 1598–1613, 2013.
[169] P. Csermely, “Creative elements: network-based predictions of active centres in
proteins and cellular and social networks,” Trends in Biochemical Sciences, vol. 33,
no. 12, pp. 569 – 576, 2008.
[170] D. Piovesan, G. Minervini, and S. C. Tosatto, “The ring 2.0 web server for high
quality residue interaction networks,” 2016.
[171] N. T. Doncheva, K. Klein, F. S. Domingues, and M. Albrecht, “Analyzing and vi-
sualizing residue networks of protein structures,” Trends in Biochemical Sciences,
vol. 36, no. 4, pp. 179 – 182, 2011.
[172] M. Munz and P. C. Biggin, “JGromacs: a Java package for analyzing protein
simulations,” J Chem Inf Model, vol. 52, pp. 255–259, Jan 2012.
[173] J. Eargle and Z. Luthey-Schulten, “NetworkView: 3D display and analysis of
proteinÂůRNA interaction networks,” Bioinformatics, vol. 28, pp. 3000–3001, Nov
2012.
[174] M. Bhattacharyya, C. R. Bhat, and S. Vishveshwara, “An automated approach to
network features of protein structure ensembles,” Protein Sci., vol. 22, pp. 1399–
1416, Oct 2013.
Bibliography 206
[175] M. Pasi, M. Tiberti, A. Arrigoni, and E. Papaleo, “xPyder: a PyMOL plugin to
analyze coupled residues and their networks in protein structures,” J Chem Inf
Model, vol. 52, pp. 1865–1874, Jul 2012.
[176] M. Vendruscolo, E. Paci, C. M. Dobson, and M. Karplus, “Three key residues form
a critical contact network in a protein folding transition state,” Nature, vol. 409,
pp. 641–645, Feb 2001.
[177] M. Vendruscolo, N. V. Dokholyan, E. Paci, and M. Karplus, “Small-world view of
the amino acids that play a key role in protein folding,” Phys Rev E Stat Nonlin
Soft Matter Phys, vol. 65, p. 061910, Jun 2002.
[178] G. Bagler and S. Sinha, “Assortative mixing in Protein Contact Networks and
protein folding kinetics,” Bioinformatics, vol. 23, pp. 1760–1767, Jul 2007.
[179] Y. Li, G. Li, Z. Wen, H. Yin, M. Hu, J. Xiao, and M. Li, “Novel feature for
catalytic protein residues reflecting interactions with other residues,” PLoS ONE,
vol. 6, pp. 1–9, 03 2011.
[180] K. V. Brinda and S. Vishveshwara, “A network representation of protein struc-
tures: implications for protein stability,” Biophys. J., vol. 89, pp. 4159–4170, Dec
2005.
[181] X. Jiao and S. Chang, “Scoring function based on weighted residue network,” Int
J Mol Sci, vol. 12, no. 12, pp. 8773–8786, 2011.
[182] G. Amitai, A. Shemesh, E. Sitbon, M. Shklar, D. Netanely, I. Venger, and
S. Pietrokovski, “Network analysis of protein structures identifies functional
residues,” J. Mol. Biol., vol. 344, pp. 1135–1146, Dec 2004.
[183] K. Z. Szalay and P. Csermely, “Perturbation centrality and turbine: A novel cen-
trality measure obtained using a versatile network dynamics tool,” PLoS ONE,
vol. 8, 10 2013.
[184] M. Seeber, A. Felline, F. Raimondi, S. Muff, R. Friedman, F. Rao, A. Caflisch,
and F. Fanelli, “Wordom: a user-friendly program for the analysis of molecu-
lar structures, trajectories, and free energy surfaces,” J Comput Chem, vol. 32,
pp. 1183–1194, Apr 2011.
[185] M. Seeber, M. Cecchini, F. Rao, G. Settanni, and A. Caflisch, “Wordom: a pro-
gram for efficient analysis of molecular dynamics simulations,” Bioinformatics,
vol. 23, pp. 2625–2627, Oct 2007.
[186] J. A. McCammon, “Protein dynamics,” Reports on Progress in Physics, vol. 47,
no. 1, p. 1, 1984.
Bibliography 207
[187] N. Kannan and S. Vishveshwara, “Identification of side-chain clusters in protein
structures by a graph spectral method,” J. Mol. Biol., vol. 292, pp. 441–464, Sep
1999.
[188] D. J. Watts and S. H. Strogatz, “Collective dynamics of’small-world’networks.,”
Nature, vol. 393, no. 6684, pp. 409–10, 1998.
[189] R. P. Joosten, T. A. te Beek, E. Krieger, M. L. Hekkelman, R. W. Hooft, R. Schnei-
der, C. Sander, and G. Vriend, “A series of PDB related databases for everyday
needs,” Nucleic Acids Res., vol. 39, pp. D411–419, Jan 2011.
